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This thesis is submitted to Newcastle University for the degree of Doctor of 
Philosophy by Published Work.  It includes a series of published papers as well as 
new unpublished work. 
 
Chapter 1 provides an introduction to epidemiology, particularly in relation to the 
description and analysis of malformations and birth defects.  Chapter 2 gives a brief 
introduction to the complex topic of cardiovascular malformations, in particular the 
problems of definitions and terminology and the importance of diagnostic hierarchy 
of multiple malformations.  Chapter 3 describes the paediatric cardiology database 
and the preliminary studies which produced the first five published papers. 
 
Chapter 4 presents 10 important papers on aspects of the epidemiology of 
cardiovascular malformations – which together form the main part of this thesis.   
 
Chapter 5 presents a systematic review of published studies of the prevalence of 
congenital cardiovascular malformations which investigates whether there is any 
evidence of a real difference between populations.  It finds wide variation in the 
reported prevalence at live birth of all congenital cardiovascular malformations (2-30 
per 1000 live births) and of individual malformations and concludes that differences 
are almost certainly explained by various types of ascertainment bias.  Specific 
malformations predicted to show least susceptibility to ascertainment bias show 
least variation in reported prevalence.  The review makes recommendations for 
consistent methodology for future reports to allow proper comparison between 
different populations. 
 
Chapter 6 looks forward to consider the directions in which research might go in the 
future, looking in particular at outcome research and its use in performance analysis, 
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Why write a PhD thesis, particularly at my age and at this stage in my career?  As a 
paediatric cardiologist I have found that an interest in cardiovascular malformations 
led naturally to an interest in epidemiology.  Why do cardiovascular malformations 
occur?  Why are there such wide morphological variations?  Why are some rare and 
others common?  Do the same variations occur in other populations?  The answers 
are perhaps more likely to come from epidemiology and genetics than from physical 
study of the anatomy, embryology and morphology of the malformations 
themselves. 
 
Epidemiology depends fundamentally on population-based data.  Working in the 
North East has given me the opportunity to establish and develop the Northern 
Regional Paediatric Cardiology Database with great help and support from the 
Northern Congenital Abnormality Survey, with whom we maintain very close ties.  
Our data have been used for a series of research papers published over the last 17 
years.  This thesis gives the opportunity to pull together several of these papers with 
a common theme as well as to look forward to see in which directions the research 
might go in the future. 
 
Although I am a graduate of the University of Birmingham, I have been living and 
working in Newcastle upon Tyne since 1981.  I am very grateful to Newcastle 
University for the opportunity to complete and submit this thesis.  I am also grateful 
for advice, support and encouragement from my supervisor Professor Alastair Burt, 
Dean of Clinical Medicine. 
 
I also value highly support from Professor Carol Dezateux, professor of paediatric 
epidemiology and head of the Centre for Paediatric Epidemiology and Biostatistics 
at the Institute of Child Health in London, and Dr Kate Bull, now Medical Advisor in 
Family Policy at the Institute of Child Health, who share and have encouraged my 
interest in the epidemiology of cardiovascular malformations.  I continue to work with 
Carol and Kate and others at the Institute of Child Health on a number of 
epidemiological studies. 
 
Although this is my own work, this thesis would not have come about without the 
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CHAPTER 1: AN INTRODUCTION TO EPIDEMIOLOGY 
 
1.1 DEFINITION OF EPIDEMIOLOGY 
Epidemiology is the study of the distribution of disease in a population, and of the 
factors which influence this distribution.  A broader definition is that it is the study of 
the distribution and determinants of health related states or events in specified 
populations and the application of this study to control of health problems. [Gordis 
2004] 
  
1.2 AIMS OF EPIDEMIOLOGICAL RESEARCH 
The main aims of epidemiology are: 
1. To study the causes of disease and/or risk factors for development of 
disease. 
2. To measure the extent of disease in the population.  This is vital for planning 
health services and the provision of training and facilities for healthcare 
providers. 
3. To study the natural history and prognosis of disease.  This is fundamental 
to assessment of the efficacy of treatment (especially surgery within our 
context) and the development of effective screening strategies. 
4. To assess the effect of prevention, treatment, and the mode of healthcare 
delivery.  Added impetus was given to this by the Bristol Royal Infirmary 
Inquiry, which recommended in 2001 that “national standards should be 
developed, as a matter of priority, for all aspects of the care and treatment of 
children with congenital heart disease.  The standards should address 
diagnosis, surgical and other treatments, and continuing care.” [BRI Inquiry 
Panel 2001] 
5. To provide the foundation for developing public health policy and to make 
decisions about regulation of environmental problems.  Within the context of 
cardiovascular malformations this relates both to the development of 
screening programmes and to identification of causative factors (such as the 
association between maternal rubella infection and persistence of the ductus 
arteriosus in the offspring, or the association between advanced maternal 
age, an increased incidence of Down syndrome, and its associated 
cardiovascular malformations).   
  
               C Wren 2008                                      Page 1
1.3 TYPES OF EPIDEMIOLOGICAL STUDY 
Various types of study are used in epidemiology, many of them with the aim of 
identifying aetiological or causal relationships.  Only some of these are appropriate 
for the investigation of congenital malformations. 
  
Cohort studies 
A cohort study is a form of longitudinal study which is used to investigate a 
suspected association between cause and disease.  Fundamentally, the cohort has 
to be identified before the appearance of the disease under investigation and this 
type of study cannot normally be used to investigate a group who already have the 
disease.  A good example of a cohort study is the Framingham Heart Study of risk 
factors for cardiovascular disease in the United States has been under way for more 
than 50 years. 
  
Cross-sectional studies 
A cross-sectional study investigates the relationship between exposure and disease 
but determines both at the same time.  It begins with a defined population and 
gathers information on both disease and exposure.  Four groups are then identified: 
those who are exposed and have the disease; those who are exposed but do not 
have the disease; those who are not exposed but have the disease; and those who 
are not exposed and do not have the disease.  This type of study investigates 
known cases of disease and is also known as a prevalence study. The results of this 
type of investigation can be displayed in a 2x2 table.  A good example of a cross-
sectional study is our investigation of cardiovascular malformations in the offspring 
of mothers with insulin dependent diabetes, discussed in more detail in chapter 
4. [Wren 2003] 
  
Case-control studies  
A case-control study compares a group of individuals with a disease (cases) with a 
group of individuals without the disease (controls).  They are then examined 
retrospectively for exposure to a possible cause of the disease.  Case control 
studies are rare in the literature on cardiovascular malformations.  They are prone to 
many biases, particularly selection bias for both cases and controls and recall bias 
(also known as rumination bias).  The best example of a case control study of 
cardiovascular malformations is the Baltimore-Washington Infant Study 1981-1989. 
[Ferencz 1993]  The aims of this study were to develop descriptive data on infants 
with cardiovascular malformations and their families compared with non-affected 
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infants in the same birth cohort; to develop a classification of cardiovascular 
malformations; to evaluate genetic and environmental factors and relate these to the 
diagnostic subgroups; and to define methods for future research.  The study was an 
enormous undertaking.  It was originally planned to be a three year study with a 
regional birth cohort of around 300,000 births.  To generate adequate statistical 
power, the study size was increased twice and eventually dealt with a birth 
population of almost one million births over nine years.  The study had many of the 
problems inherit in case control studies.  Whilst it produced many reports, most of 
these were descriptive and the investigations threw little light on the detailed causes 
of congenital cardiovascular malformations.  Many associations between various 
environmental exposures and individual malformations were identified but these 
have not led to establishment of causal relationships.  The Baltimore-Washington 
Infant Study is one of the reports considered in detail in the systematic review in 
chapter 5. 
  
Longitudinal observational studies  
Longitudinal observational studies are mostly descriptive and do not set out to 
investigate causes of disease.  However, they are important in addressing some of 
the aims of epidemiology discussed above, such as measuring the extent of disease 
in the population, studying its natural history and prognosis, predicting the need for 
resources, and assessing efficacy of prevention, treatment, and screening 
strategies.  Several of the studies in chapter 4 are of this type.   
 
1.4 MEASURES OF DISEASE FREQUENCY 
A fundamental requirement of epidemiology is to be able to measure the occurrence 
or frequency of disease within a population.  This can be done using rates or 
proportions.  Rates measure how frequently a disease occurs within a population, 
whereas proportions measure the fraction of the population affected.  Rates and 
proportions are both used to measure morbidity or mortality. 
  
Incidence 
The incidence of disease measures the number of new cases arising over a period 
of time in a population at risk.  One critical element of incidence is that it measures 
new cases within the population, so the numerator should be free from disease at 
the start of the study and the denominator should be the population at risk of 
developing the disease.  Incidence studies can measure risk, which is the probability 
of the new development of the disease, and rate, which is the average rate of 
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development of disease over time, also known as incidence density.  Because risk 
and rate cannot be measured instantaneously, data are usually collected over a 
period of time to produce a cumulative incidence.  Although epidemiological reports 
of cardiovascular malformations do refer to incidence, as will be seen, the term is 
not directly applicable to this type of investigation. 
  
Prevalence 
Prevalence is a measure of the disease burden in a population.  This can be 
measured instantaneously, to produce point prevalence, or over a period of time 
(such as one year) to produce period prevalence. 
  
There is an obvious inter-relationship between incidence and prevalence.  If the 
number of new cases within a population exceeds the death or cure rate, the 
prevalence will increase.  If prevention, cure and death rates exceed the incidence, 
the prevalence will decrease.  The dramatic improvements in the treatment of 
cardiovascular malformations have led to a substantial fall in mortality and thus to an 
increase in prevalence (see chapter 6).  Neither incidence nor prevalence in their 
classical definitions is directly applicable to descriptive studies of congenital 
malformations.  Some cardiovascular malformations have a genetic cause and are 
effectively present from the moment of conception.  Others are probably due to 
environmental influences which affect the embryo and fetus during gestation.  The 
main development of the heart is complete by the sixth week of pregnancy.  The 
heart is the earliest main organ to be complete because it is essential for the 
development and growth of the embryo and fetus.  Very major cardiovascular 
malformations are incompatible with life and lead to embryonic or fetal death 
causing miscarriage or stillbirth.  This means that the disease frequency of 
cardiovascular malformations is unknown.  With both new cases (caused by fetal 
environmental influences) and deaths occurring before ascertainment, neither the 
classical definition of incidence or prevalence is useful to us in describing the 
occurrence of cardiovascular malformations. 
  
Most cases of congenital cardiovascular malformation are not immediately apparent 
at birth but come to notice over time.  In one report in chapter 4, we found that 74% 
of cases are identified in the first year of life, another 18% at age 1-4 years and 8% 
between 5 and 15 years. [Wren 2001]  Even this does not take account of 
malformations diagnosed in adult life, even though they are present from early 
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embryonic life.  Thus it can be seen that the period of ascertainment will have a 
significant effect on the measure of disease frequency. 
 
Incidence or prevalence? 
Despite all these problems, Julien Hoffman, one of the leading authorities in the 
field, has argued extensively that the frequency of cardiovascular malformations 
should be known as the incidence. [Hoffman 2002] [Hoffman & Kaplan 2002]   
Charlotte Ferencz and Stephen Daniels both favour the use of the term “prevalence 
at live birth”. [Ferencz 1990] [Ferencz 1992] [Daniels 1990]  Because many 
diagnoses are made retrospectively (that is, after birth) the prevalence would appear 
to increase with time yet this is only due to increasing retrospective diagnosis.  
Open-ended ascertainment obviously gives the opportunity for further increase in 
the apparent prevalence at live birth.  Ferencz has therefore suggested that 
ordinarily diagnoses should be made within a year from birth. 
  
Prevalence at live birth 
The standard definition of disease frequency used throughout this work will be 
prevalence at live birth, that is, the number of cases of cardiovascular malformation 
within the population present at birth and diagnosed within the first year of life.  
Obviously this is not a true measure of disease occurrence or frequency.  It does not 
take account of cardiovascular malformations causing stillbirth or early fetal loss.  
There is good evidence that the rates of cardiovascular malformations in stillbirths 
are many times higher than those in live births. [Hoffman 2002]  There is also a very 
different spectrum, with some individual malformations more likely to be associated 
with or to cause stillbirth.  However, ascertainment in such reports is very patchy 
and no true measure can be obtained.  Prevalence at live birth also cannot take 
account of cases identified antenatally leading to termination of pregnancy and such 
reports have to be made separately.  This means that prevalence at live birth is the 
best measure we have but can never be a precise measure of total disease 
frequency.  The total amount of disease will be higher because of failure to take 
account of cases causing death before birth, continued ascertainment in childhood 
and adult life, and the necessarily restrictive definition of cardiovascular 
malformation.  As will be discussed in chapter two, most epidemiological 
assessments of cardiovascular malformations exclude abnormalities such as patent 
ductus arteriosus associated with pre-term birth, isolated bicuspid aortic valve, 
isolated cardiac arrhythmias etc.  These are cardiovascular abnormalities, if not 
malformations, and they represent work for the cardiologist and surgeon.  If they 
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were taken into account they would increase the apparent “prevalence at live birth” 
of cardiovascular abnormality to well over 1%.  As many children are seen by a 
paediatric cardiologist because of a suspicion of abnormality which turns out not to 
be confirmed, the total proportion of live born children seen by a cardiologist is 
probably nearer 5%.  Nevertheless most of the work generated is related to true 
cardiovascular malformations and prevalence at live birth thus remains a useful 
epidemiological measure of disease occurrence.  
  
In order to be able to define the frequency of disease within a population we need to 
be able to identify both the numerators and denominators.  For prevalence at live 
birth of cardiovascular malformations, denominators should not present too much of 
a problem if applied to a complete birth cohort with a defined age at ascertainment.  
However, there are many opportunities for bias, particularly ascertainment bias, and 
these are discussed at length in chapter 5.  Identification of numerators is potentially 
more difficult.  Several possible data sources can be identified.  These include birth 
certificates, death certificates, hospital records, national disease registers, and local 
surveys or databases.  Each has its potential advantages and disadvantages. 
 
Because congenital cardiovascular malformations are relatively uncommon in 
population terms, we would ideally study a large population to provide sufficient 
denominators (live births) but we would then run the risk of not being able to identify 
all numerators (cases of cardiovascular malformation).  A study based on a small 
population is likely to have more complete ascertainment but its findings would be 
limited because of the small study size.  Thus studies based on national registers or 
birth certificates have consistently been shown to suffer from inadequate 
ascertainment. [Gillum 1994, Williams & McCrindle 2002, Boyd 2005]  Regional or 
local surveys are likely to have as complete ascertainment as is possible and if 
linked to a sufficient birth cohort or continued over a period of time, they are likely to 
provide the ideal compromise between completeness of ascertainment and 
adequate study size. [Richmond & Atkins 2005]  Hospital based information suffers 
the obvious disadvantage that it is not necessarily linked to a birth cohort and 
hospital data systems are not sufficiently reliable to be able to identify all cases or all 
activity.  Hospital episodes statistics were used for some of the analyses of cardiac 
surgical mortality in the Bristol Royal Infirmary Inquiry but their accuracy has been 
challenged. [Aylin 2004] 
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1.5 REGISTRIES AND DATABASES 
Two types of databases can be identified, disease registries and academic 
databases. [Williams & McCrindle 2002]  A registry collects some data on all 
patients.  Resources are applied to collection and entry of data and limit the amount 
of information which can be collected.  As discussed above, used locally they may 
be the practical ideal.  If diagnostic coding is consistent in different centres, multi-
institutional registries increase the power.  Such devices are particularly useful for 
analysis of surgical outcome but are of less use in descriptive epidemiology of 
cardiovascular malformations within whole populations. [Moller 2005, Jacobs 2007]  
A research database collects all of the information for some of patients.  Its aim is to 
investigate a specific sub-group to provide new knowledge.  It may also be multi-
institutional if sufficient care is taken to harmonise definitions and data collection. 
  
1.6 ETHICAL ASPECTS OF INFORMATION IN DATABASES 
In addition to the obvious academic interest in epidemiology, we have a 
responsibility to our patients and their families to collect valid data on the occurrence 
and outcome of cardiovascular malformations in order to monitor the effect of 
diagnostic and screening policies and to monitor the quality and outcome of 
treatment.  Therefore, we have a responsibility to make the data as complete and 
accurate as is feasible.  Disease registries have recently seemed to be under threat 
from legislative changes brought about by the Data Protection Act 1998 which came 
into force in March 2000.  The protection for population based disease registries 
probably lies in the anonymisation of data for analysis and output.  Health research 
is unquestionably in the public interest.  The Data Protection Act means that consent 
is required for identifiable patient data.  The Information Commissioner has said that 
“it is a major misconception that the Act always requires the consent of data 
subjects …” but also says that there is an implied requirement to obtain 
consent. [Parkes 2004]  However, patients are used to the fact that hospital records 
contain identifiable details and, in fact, could not function without them.  Patient 
confidentiality remains a prime responsibility but so also does valid research, which 
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CHAPTER 2:  CARDIOVASCULAR MALFORMATIONS 
 
2.1 INTRODUCTION 
Cardiovascular malformations account for about 10% of all infant deaths in 
developed countries and nearly half of all deaths from malformation. [Abu-Harb 
1994] [Rosamond 2007]  As a group they are the most common type of congenital 
malformation. [March of Dimes 2007]  The cause of an increasing number of 
malformations is known to be genetic [Pierpont 2007] and a few are environmental 
in origin [Mone 2004] [Jenkins 2007], but for the majority the cause is unknown.  The 
descriptive epidemiology of cardiovascular malformations has generated much 
interest over the last 50 years but has not so far provided major clues to the 
aetiology.  There have been many descriptions of disease frequency but comparison 
between them is hampered by the lack of a common method.  Early studies were 
limited by their inclusion of many unconfirmed clinical diagnoses (before ultrasound 
was widely available) and some more recent studies, which are institution based, 
are limited by their inability to define the population from which their patients were 
derived.  Comparisons between studies are also made more difficult by uncertainties 
over ascertainment and because of the different diagnostic categories and 
diagnostic hierarchies employed. 
 
2.2 TERMINOLOGY 
Congenital heart disease is the group name commonly employed for a wide variety 
of cardiovascular malformations.  They are grouped together for convenience but 
individually they vary in their aetiology, embryology, morphology, presentation, 
physiology, management and outcome.  There are problems with the use of this 
term.  Firstly, some “congenital” heart disease is not truly congenital if it leads to 
fetal death or termination of pregnancy, or if it develops after birth, as in persistence 
of the ductus arteriosus.  Secondly, some congenital “heart” disease does not 
directly affect the heart (for example coarctation of the aorta, persistent ductus 
arteriosus, aortopulmonary window etc.).  Thirdly, some congenital heart “disease” is 
little more than a curiosity and certainly doesn’t amount to a significant problem 
(such as isolated bicuspid aortic valve or persistence of the foramen ovale).  
Throughout this review the term cardiovascular malformation is preferred. 
  
2.3 DEFINITIONS, INCLUSIONS AND EXCLUSIONS 
Most reports adopt the classic definition first proposed by Mitchell, that is “a gross 
structural abnormality of the heart or intrathoracic great vessels that is actually or 
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potentially of functional importance”. [Mitchell 1971]  This means that minor 
variations such as isolated systemic venous anomalies (e.g. persistence of the left 
superior vena cava connecting to the coronary sinus) are almost always excluded.  
Other very common exclusions are patent ductus arteriosus associated with 
prematurity, cardiomyopathies, isolated cardiac arrhythmias, cardiac tumours and 
conditions regarded as physiological variants - such as neonatal pulmonary artery 
branch stenosis.   
 
The ductus arteriosus is patent at birth and usually closes within hours or days.  
Persistence of the ductus arteriosus is generally defined as a ductus remaining 
patent more than six weeks post term.  This has an increased prevalence in babies 
who were born preterm but excludes the situation in which the duct causes 
problems, and requires treatment, in the preterm baby. 
  
An atrial septal communication, that is a foramen ovale, is a universal finding in fetal 
life and is a common and normal finding in early postnatal life.  It is often not 
possible to predict whether a neonatal “atrial septal defect” seen on 
echocardiography will turn out to be a true atrial septal defect, that is one which 
persists into childhood and may require closure.  There is, however, good evidence 
that the smaller the atrial septal defect detected in infancy, the greater the likelihood 
of spontaneous closure. [Radzik 1993]  Therefore, there is no accepted true 
definition of an atrial septal defect in infancy.  It is also recognised that most atrial 
septal defects present after infancy. [Wren & O’Sullivan 2001]  These factors 
obviously lead to considerable problems in ascertainment of atrial septal defects in 
infancy and childhood. 
 
Another common structural abnormality, which is almost always excluded from 
definitions of congenital heart disease or cardiovascular malformation, is a bicuspid 
aortic valve without stenosis or regurgitation.  The reported prevalence of bicuspid 
aortic valve ranges from 0.4% to 2.25%. [Ward 2000, Hoffman 2002]  Two of the 
larger reports came up with 0.9% and 1.37%. [Roberts 1970] [Larson & Edwards 
1984]  However, there is obvious potential for error in trying to predict the 
prevalence at birth by examining adult autopsies.  A recent small but prospective 
neonatal echocardiographic study found a bicuspid aortic valve in five of 1075 
consecutive neonates (0.46%). [Tutar 2005]   Because this was a small study the 
95% confidence intervals are wide at 0.2-1.2%, i.e. little different from the autopsy 
studies. 
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Another condition which is probably common, but is difficult to define, is mitral valve 
prolapse. [Freed 1999] [Freed 2002] [Warth 1985]  It is very rarely diagnosed in 
infancy.  As a minor echocardiographic observation it seems to be relatively 
common but as a clinical problem it is rare in childhood and most epidemiological 
studies exclude mitral valve prolapse without regurgitation. 
  
Many congenital cardiovascular malformations are easy to define and one would 
expect clinical ascertainment to be complete.  Two conditions which are exceptions 
to this but are very common are mild pulmonary valve stenosis and mild aortic valve 
stenosis.  The diagnosis of stenosis implies that the Doppler velocity measured by 
echocardiography is higher than normal.  Very few reports of the prevalence of 
cardiovascular malformations define the “upper limit” of normal and thus define mild 
aortic valve stenosis.  Exceptions are Kitchiner [1993a] [1993b] where aortic 
stenosis is a Doppler velocity >2 m/s and Ooshima [1995] who uses >1.6 m/s (a low 
upper limit which will obviously lead to more diagnoses).  The diagnosis of mild 
pulmonary valve stenosis is also based on the finding of increased flow velocity 
through the valve on Doppler echocardiography.  Again the “upper limit” of normal is 
rarely defined and also varies with age.  Exceptions are Ooshima [1995] (>1.2 m/s), 
Gielen [1999] (>1.6 m/s) and Chehab [2004] (>2 m/s).  The frequent lack of a 
definition, and lack of consistency when there is one, means that there is likely to be 
considerable variation between studies and this will lead to ascertainment bias. 
  
In some reports double outlet right ventricle is a relatively common diagnosis 
whereas in others it does not occur at all.  Double outlet right ventricle defines one 
part of a malformation, which is of importance when contemplating surgical repair 
[Jacobs 1997], but it does not have a constant definition [Kleinert 1997] [Samanek 
1999] and does not define an anatomically or physiologically distinct group of 
malformations [Kleinert 1997].  It includes diagnoses that will otherwise be described 
as transposition of the great arteries, tetralogy of Fallot, ventricular septal defect 
etc.  There are other instances of methods of classification leading to apparent 
inconsistencies in birth prevalence of cardiovascular malformations.  In many North 
American reports, pulmonary atresia with ventricular septal defect is considered as a 
variation of tetralogy of Fallot and is coded as tetralogy of Fallot.  This accounts for 
the apparent lack of cases of pulmonary atresia with ventricular septal defect in 
many US reports. [Ferencz 1993]   
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2.4 DESCRIPTION OF COMPLEX MALFORMATIONS 
There is a roughly inverse relationship between the prevalence and the complexity 
of severity of cardiovascular malformations.  The most common are minor and do 
not require treatment.  Many of those that are rare are complex and severe.  Most 
cardiovascular malformations are easily described by a single term such as 
ventricular septal defect or coarctation of the aorta.  Some common abnormalities, 
such as tetralogy of Fallot are in fact made up of more than one morphological 
abnormality but occur together so frequently that the pattern is universally 
recognised.  On the other hand, individual malformations occur much more 
commonly in association with others than by chance and these need to be described 
separately.  Some malformations are complex and cannot be described by a single 
term or combination of terms. [Kurosawa 2006]  In this case sequential analysis is 
employed to describe the total cardiac morphology and connections beginning at the 
venous end of the heart and progressing to the great arteries. [Anderson 2002]  
Such analysis was developed in the 1980s and can theoretically cope with a 
malformation of any degree of complexity although it is unnecessary for the large 
majority.   
 
2.5 DIAGNOSTIC CODING 
The descriptive epidemiology of cardiovascular malformations relies on precise and 
accurate structural diagnosis.  Diagnostic coding is becoming increasingly 
harmonised internationally, both for diagnosis and for description of surgery. 
[Franklin 2006]  The “European” codes have evolved in the past few years and are 
now accepted and employed internationally.  In parallel, European and American 
coding has evolved to provide a universally accepted description and classification 
of surgery for cardiovascular malformations. [Jacobs 2005]  Only when this is 
achieved can we confidently combine and compare data from difference centres, 
different registries and different countries. 
  
Because cardiovascular malformations are many and varied they are often grouped 
and classified, although in several different ways.  Simple groupings relate to the 
presentation or outcome, such as division into cyanotic and non-cyanotic defects.  
Individual malformations are sometimes grouped together to allow better analysis 
where the numbers of individual malformations might be relatively small.  Reports 
have thus grouped “complex”, “significant”, and “minor” malformations [Abu-Harb 
1995] or “severe”, “moderate”, and “mild” defects [Hoffman 2002].  Other accounts 
deal with malformations which either do, or do not, require surgery, or group 
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together abnormalities which are morphologically varied but suitable for a common 
type of palliative surgery. [Jacobs 2006] 
  
In accounts of the descriptive epidemiology of cardiovascular malformations, 
individual diagnoses are usually presented in tabular form.  They might be listed in 
order of prevalence, in which case ventricular septal defect is always the first 
mentioned.  Other classifications are by anatomical severity (worst to least), 
functional importance [Knowles 2005] or by presumed embryological aetiology.  
Several methods have been proposed to group anatomical diagnoses into 
speculative aetiological groups.  They include a “mechanistic classification” [Ferencz 
1993] and a “potential morphogenetic classification” [Jackson 1996].  There are 
similarities but also inconsistencies between these classifications and they group 
together malformations that may be unrelated embryologically, aetiologically, or 
physiologically.  In other reports malformations of the same part of the heart are 
often grouped together (such as “conotruncal” abnormalities). [Adams 1989]  
However, there is no real logic to this as malformations of the same part of the heart 
would not necessarily have the same cause or embryology and certainly do not 
present in the same way and are treated differently.   
  
2.6 DIAGNOSTIC HIERARCHY 
Classification of cases with multiple cardiovascular malformations is a difficult 
problem and almost all reports have allocated all cases a single diagnosis based on 
the malformation which is judged to be most important.  This means that the number 
of cases of various diagnoses can be added to equal the total number of patients in 
the series.  If cases with more than one diagnosis have to be given one label, some 
type of hierarchy is required to decide in which category they fit best.  Unfortunately, 
there is no consensus on how this can best be achieved.  Many reports, particularly 
older ones, ignore the problem altogether and don’t define how multiple diagnoses 
were dealt with. 
 
The main hierarchies which have been employed can be described as anatomical, 
physiological, embryological, and functional.  Many reports have adopted either the 
classification proposed in the New England Regional Infant Cardiac Programme 
which defined a hierarchy based mainly on anatomical severity [Fyler 1980] or that 
in the Baltimore-Washington Infant Study in which priority was given to “the 
malformation components with the earliest embryonic disturbance” [Ferencz 1993 ].  
In practice these two approaches, which both use a broadly “anatomical” hierarchy, 
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are fairly similar.  Reports which are institution-based and which cannot define the 
denominator population, usually adopt a “physiological” hierarchy, taking as the 
most significant that abnormality which requires the earliest intervention or which 
causes the greatest haemodynamic disturbance. 
 
A good example of the problem is the common association between ventricular 
septal defect and coarctation of the aorta.  Both are common abnormalities but they 
frequently occur together in the same patient.  A common clinical situation is a 
neonate presenting at a week of life with sudden onset of heart failure caused by the 
presence of a coarctation.  Further assessment reveals the presence of a ventricular 
septal defect which may be large, and therefore will require later separate surgery, 
or may be small and functionally unimportant.  With a physiological hierarchy, the 
baby would be coded as having a coarctation and the ventricular septal defect would 
be ignored.  With an anatomical hierarchy the baby with coarctation with a large 
ventricular septal defect would be coded as having a ventricular septal defect.  In 
contrast the baby with coarctation associated with a small ventricular septal defect 
would be coded as having coarctation of the aorta.  There are several other 
common clinical situations which present similar problems.  The lack of a consensus 
on hierarchical classification means there will continue to be considerable variation 
in reported prevalence because of this type of selection or ascertainment bias. 
  
Some reports get round the problem by coding multiple malformations separately as 
“miscellaneous” or “complex”. [Garne 2004] [Forrester 2004]  Others employ double 
counting which obviously means the total of individual malformations is higher than 
the number of individuals in the report and doesn’t really make much sense. 
[Abushaban 2003] [Cleves 2003]  In other descriptions of hierarchies reported, 
cases are coded according to the malformation which is “most important” [Howie 
1970], “most grave” [Czeizel 1972], “most severe” [O'Brien 1972], “predominant” 
[Cloarec 1999] [Chehab 2004], “leading” [Andersen 1994], or are “arbitrary” [Meberg 
2005]. 
  
The only report which tried to assess the inherent variation caused by different 
hierarchical classification is discussed in more detail in chapter 4. [Wren 2000]  It 
showed that the use of a one dimensional anatomical classification would lead to 
under ascertainment of coarctation of the aorta by 39%, of pulmonary atresia by 
27%, and of interruption of the aortic arch by 100% when compared with a 
physiological classification.  
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2.7 AETIOLOGY OF CARDIOVASCULAR MALFORMATIONS 
As discussed in chapter 1, one of the main aims of the descriptive epidemiology of 
cardiovascular malformations is to try to elucidate the aetiology.  At present the 
cause of around 75% of cases is unknown.  Somewhere around 15-20% are caused 
by chromosal or other genetic or syndromic abnormalities. [Pierpont 2007]  Perhaps 
around 5% are related to fetal environmental effects – mostly factors such as 
maternal illness (e.g. diabetes mellitus, phenylketonuria), maternal drug ingestion 
(eg anticonvulsants), or maternal infection (e.g. rubella). [Jenkins 2007]  There have 
been isolated reports of associations with factors such as contaminations such as 
drinking water but these often do not stand up to scrutiny. [Goldberg 1990] [Watson 
2006]  The Baltimore-Washington Infant Study was a case control study, the optimal 
design for investigating the influence of environmental factors. [Ferencz 1993]  It 
found an increased number of specific malformations related to maternal 
occupational or environmental exposure to factors such as degreasing solvents, 
pesticides or lead soldering.  Obviously this only reports associations, which may 
not be causal.  Statistical analysis in this situation is also difficult and complex.  The 
use of 95% confidence intervals may not be appropriate in the examination of very 
many individual malformations and very many environmental exposures as, by 
chance, the findings would be outside the 95% confidence intervals in one case in 
twenty.  The Baltimore-Washington Infant Study failed to find any association with 
maternal exposure to anticonvulsants, phenytoin, codeine, and ampicillin where 
other previous smaller reports had done so. [Ferencz 1993] 
 
2.8 CONCLUSIONS 
Congenital cardiovascular malformation is a term used to describe a wide variety of 
malformations of the heart and great vessels.  The cause of most is unknown and 
they differ in aetiology, embryology, clinical presentation and management.  
Cardiovascular malformations occur in association much more frequently than by 
chance.  There is no consensus on how to decide the relative hierarchy of multiple 
malformations in the same patient – a subject of great importance to descriptive 
epidemiology studies. Most studies fail to define the common malformations, leading 
to the potential for ascertainment bias. 
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CHAPTER 3: THE NORTHERN REGIONAL PAEDIATRIC CARDIAC DATABASE: 
EARLY EPIDEMIOLOGICAL RESEARCH STUDIES 
 
3.1 INTRODUCTION 
Good epidemiological research is based on good data.  A registry database is a 
structured collection of information containing some data for all the patients of 
interest. [Williams & McCrindle 2002]  This means that, as a minimum, every patient 
can be identified.  Depending on the project in hand, it may be necessary to obtain 
some more detailed information retrospectively. 
 
3.2 EPIDEMIOLOGICAL DATABASES IN THE NORTHERN REGION 
The Northern Health Region has an unrivalled record in collecting and analysing 
information in two widely renowned registries based at the Northern Regional 
Maternity Survey Office (RMSO).  The Northern Regional Perinatal Mortality Survey 
(PMS) was established in 1980 to collect information on all registered perinatal 
deaths in babies born to mothers resident within the region.  It was a collaborative 
enterprise based in every health district and maternity unit in the region and 
collected information from obstetricians, paediatricians, midwives, as well as 
pathologists and other specialists.  In a report on the first two years’ data collection, 
published in 1984, it was already the largest perinatal mortality survey in England 
and Wales. [Northern Regional Health Authority Co-ordinating Group 1984]. The 
PMS is now well established and was recently able to report trends over 19 years 
from 1982-2000. [Bell 2004] 
 
A closely associated registry, the Northern Congenital Abnormality Survey 
(NorCAS), previously known as the Fetal Abnormality Survey (FAS), was 
established in 1984 as a pilot project. [Northern Regional Survey Steering Group 
1992]  It has collected data prospectively since 1985.  It uses multiple sources of 
ascertainment including obstetric ultrasonographers, obstetricians, neonatologists, 
clinical geneticists, cytogeneticists, perinatal pathologists, paediatric cardiologists, 
paediatric surgeons and general paediatricians.  Details of any antenatal or 
postnatal investigations are reported to the survey office.  Data are collected on 
malformations in any baby born to a mother resident in the region, wherever birth 
occurs and regardless of whether the abnormality was first diagnosed in utero, at 
birth, or during the first year of life.   
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The original establishment of this survey was approved by the ethics committees of 
all districts involved.  Data are held by NorCAS in compliance with the data 
protection act 1998 and the survey has appropriate exemption under Section 60 of 
the Health and Social Care Act 2001. [Parkes 2004]   A recent comparison of data 
from four local surveys, including NorCAS, with national data found that 
ascertainment by local surveys was considerably more complete and that NorCAS 
had the most complete ascertainment of postnatally diagnosed anomalies currently 
available. [Boyd 2005]  The survey has been validated from the start by cross 
checking the information available from District Health Authority SD56 Returns to 
the Office of Population Censuses and Surveys (OPCS) [now the Office of National 
Statistics (ONS)].  Notifications to NorCAS consistently outnumber those submitted 
to OPCS.  A recent report was able to summarise trends in accuracy of prenatal 
diagnosis compared with postnatal findings over sixteen years. [Richmond & Atkins 
2005].  
 
As one would expect, the administrative structure of both surveys improved over 
time.  Access to data for both is controlled by steering groups.  In the late 1980s 
Liam Donaldson, the Regional Medical Officer (later Professor Sir Liam Donaldson, 
Chief Medical Officer), took over chairmanship of the NorCAS steering group.  It was 
apparent at that time that the survey contained very few data on cardiovascular 
malformations, despite the fact that these are the most common type of congenital 
malformation.  In 1990 Professor Donaldson funded the appointment of a research 
fellow to establish the regional paediatric cardiology database.  Although this is 
based in Freeman Hospital, it has always worked very closely with the RMSO, with 
bidirectional cross validation.   Cardiology data were ascertained retrospectively for 
babies born in 1985-1989 and have been ascertained prospectively since 1990.  A 
research fellow did the initial case finding and coding but in more recent years there 
has been a full time data manager funded by the Children Heart Unit’s Fund.  
 
Original case finding used multiple sources of ascertainment from original files.  
These included hospital case notes for all ward admissions and all ward and 
outpatient attenders.  Data were also obtained from theatre books, which 
documented every operation performed, and ward and intensive care admission 
books.  Data were also checked in all original NorCAS files.  During this process it 
became apparent that NorCAS and PMS had recorded a number of deaths from 
babies with cardiovascular malformations who had never been known to the 
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paediatric cardiology service.  These data were analysed in more detail to produce 
the second report from the paediatric cardiology database (see below). 
 
3.3 EARLY PUBLISHED REPORTS 
3.3.1 Stuart AG, Wren C, Sharples PM, Hunter S, Hey EN. Hypoplastic left heart 
syndrome: more potential transplant recipients than suitable donors. Lancet 
1991;337:957-9.  The first published report based on regional data was an 
investigation into the possibility of finding donors for primary neonatal cardiac 
transplantation for treatment of hypoplastic left heart.  At the time there was a wide-
ranging debate on the use of neonatal donors for infant heart transplantation.  The 
dominant indication for transplantation was hypoplastic left heart, which at that time 
was an almost universally fatal condition.  Primary heart transplantation seemed to 
offer some hope and had been proven to be feasible in North American centres, 
most notably that based at Loma Linda. [Bailey 1993]  Because regional data were 
available, this first report ascertained all live births and terminations of pregnancy 
with hypoplastic left heart in the eight years 1983-1990 (figure 3.1).  The first 
antenatal diagnosis was made in 1987 and there were a few terminations of 
pregnancy in the last four years.  41 babies were live born in eight years, 31 of 
whom would have been suitable for transplantation.  In a modelling exercise, these 
were matched against potential donors from the same population.  Two groups were 
examined.  The first theoretical donor pool was live born babies with anencephaly 
with a birth weight >2 kg.  Of 228 cases of anencephaly in eight years, three could 
potentially have been sources of donor hearts (figure 3.2) (There are obvious major 
ethical concerns about the use of anecephalic donors, which were widely debated at 
the time. [Landwirth]  Such a practice is now not acceptable. [Pasquerella])  In the 
USA and Canada most infant cardiac donors at that time had died of trauma, birth 
asphyxia or sudden infant death syndrome.  We also analysed eight years’ data on 
fatal head injury in infants and small children.  There were 30 such cases, one of 
which might potentially have been suitable to be a donor (figure 3.3)  Thus there 
were four potential donors in eight years for a potential 31 recipients.  Data from a 
further three years (1986-1989) were examined for a potentially wider donor pool 
including late deaths from sudden infant death and birth asphyxia.  Of 426 cases of 
post-neonatal sudden infant death syndrome there were only two potential donors 
and there were no late deaths from birth asphyxia in this time. 
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Figure 3.1.  Cases of hypoplastic left heart recorded in eight years 1983-90.  Maroon = live born 
(LB) postnatal diagnosis; hatched = live born prenatal diagnosis; grey = prenatal diagnosis and 
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Figure 3.2.  Cases of anencephaly recorded in eight years 1983-90.  Maroon = live born with 
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Figure 3.3.  Cases of fatal head injury recorded in eight years 1979-86.  Maroon = potential 
donor; grey = not suitable as donor (see text). 
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Given the fact that there was at the time a maximum two week window from 
diagnosis to transplantation and that ABO compatibility between donor and recipient 
was required, it was obvious that primary neonatal cardiac transplantation within the 
UK was not a feasible option.  Google Scholar lists 18 citations for this paper at the 
end of 2006. 
 
3.3.2 Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised 
congenital heart disease. Arch Dis Child 1994;71:3-7.  During the initial data 
collection to make good the deficit in ascertainment of cardiovascular malformations, 
it became apparent that the PMS and NorCAS contained many cases of deaths 
from or with cardiovascular malformations which were not recognised in life.  
Detailed analysis of these cases led to our first report based on data on all 
malformations collected consecutively from January 1985. Data were collected 
retrospectively on all births in 1985-1990.  We found that 56 of 1074 cases of 
cardiovascular malformation were identified only after death.  Because of the initially 
retrospective data collection, the live birth prevalence of cardiovascular 
malformations was relatively low at 4.7 per 1000 live births.  This was due to under-
ascertainment of minor cardiovascular malformations.  Thus the finding that 5% of 
all cases were diagnosed only after death is probably an overestimate.  
Nevertheless, the finding that 30% of deaths from or with a cardiovascular 
malformation were unknown in life (2.8% of all infant deaths) would not have been 
affected by ascertainment.  About half of these infants who died had severe non-
cardiovascular malformations, which either led to early death or discouraged other 
investigations because they were intrinsically fatal problems such as trisomy 13 or 
trisomy 18.  This report highlighted the difficulty in clinical diagnosis of potentially 
fatal heart disease and led to our interest in subsequent reports discussed in 
chapters 4 and 5.  The paper has been very widely quoted - Google Scholar lists 65 
citations at the end of 2006.  A more recent analysis of the timing and mode of 
presentation of potentially life-threatening cardiovascular malformation in the 20 
years 1985-2004 shows that post-mortem diagnosis is now rare (see section 4.11). 
 
3.3.3 Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C. Presentation of 
obstructive left heart malformations in infancy. Arch Dis Child 1994;71:F179-
F183.  Because the previous paper had identified certain malformations which had 
the potential to cause early death but were suitable for treatment, these cases were 
analysed further in a subsequent study.  The leading diagnoses were various types 
of left heart obstruction, notably hypoplastic left heart, aortic stenosis, coarctation of 
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the aorta and interruption of the aortic arch. The paper was a retrospective analysis 
of the mode and timing of presentation of these four diagnoses in 120 consecutive 
infants born in 1987-1991.  The slightly later timeframe was used because of under-
ascertainment of minor cardiovascular malformations in the early part of the survey, 
although this had no effect on the numerator in this investigation.   Our analysis 
showed that 10% of all cases became symptomatic or died within the first 24 hours 
of life.  Only 34 of 108 babies had an abnormal neonatal examination and only 14 of 
these were diagnosed before discharge.  Thus 94 babies were sent home with no 
diagnosis and 58 of these (62%) became symptomatic or died before six weeks of 
age, the time of the next scheduled examination.  A six week check was performed 
in 36 babies and this led to another 16 diagnoses.  Of the remaining 20 babies 18 
were late clinical diagnoses and two with aortic stenosis were diagnosed only after 
death.  Figure 3.4 shows the age at onset of symptoms of heart failure (as opposed 




















Figure 3.4.  Age in days at the onset of symptoms of heart failure in 81 infants.  As can be seen, 
78/81 (96%) developed symptoms by the age of three weeks. 
 
These four diagnoses remain difficult to detect and they are still the most likely to be 
found after discharge from hospital, as discussed in chapter 5.  This paper was 
widely cited (Google Scholar lists 32 citations at the end of 2006) and influenced the 
subsequent research strategy especially the group of three papers (Ainsworth et al, 
Gregory et al, and Wren 1999 et al) discussed in detail in chapter 4.  The paper also 
had a significant influence on epidemiological research on the topic of screening for 
neonatal heart disease and has been used to help define national screening policy. 
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3.3.4 Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C. Antenatal diagnosis 
of congenital heart disease and Down’s syndrome: the potential effect on the 
practice of paediatric cardiology.  Br Heart J 1995;71:192-8.  The third paper 
based on data in the paediatric cardiology database was published in 1995. This 
used data on the prevalence at live birth of cardiovascular malformations and Down 
syndrome in a modelling exercise to predict the influence of antenatal diagnosis and 
termination of pregnancy on the practice of paediatric cardiology.  At the time it was 
being predicted that cardiovascular malformations would follow the model of neural 
tube defects, with the large majority being diagnosed antenatally and a policy of 
termination of pregnancy leading to a large reduction in live births. [Murphy 1996] 
[Northern Regional Survey Steering Group 1992]  In this study all live born 
cardiovascular malformations were classified as being either “detectable” or “not 
detectable”, based on the likelihood of recognition in a routine examination by an 
obstetric sonographer (as opposed to an expert fetal echocardiographer).  All 
diagnoses were also classified as being complex, significant, or minor.  Complex 
malformations were those with an absent or hypoplastic ventricle or valve.  
Significant malformations had four valves and chambers but required surgical repair.  
Minor malformations (mostly small ventricular septal defects and mild valve 
stenosis) were those that did not require intervention. 
 
The usefulness of this dual classification of detectability and severity of 
cardiovascular malformations was validated by the relationship between 
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Figure 3.5.  Outcome for live born cardiovascular malformations based on severity of the 
malformation and potential for antenatal diagnosis (see text). 
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 The effect of antenatal diagnosis on outcome obviously depends on the product of 
the potential detectability, the achieved detection rate and the termination rate as 
shown in figure 3.6 (taken from the paper) below. 
 
 
Figure 3.6. Cumulative effect of detection rate and termination rate on the prevalence at live 
birth of congenital heart disease. 15% of all cases were “detectable” so a detection rate of 
100%plus a termination rate of 100% would reduce live born congenital heart disease by 15%. 
Assuming 20% of “detectable” and two thirds of detested cases are terminated, the reduction in 
live born congenital heart disease would be 2%.  The effect of any detection rate with any 
termination rate ccan be calculated from this graph. 
 
Analysis of surgical activity showed that 78% of operations were done in patients 
with antenatally undetectable malformations.  Our data on the prevalence and 
spectrum of malformations enabled prediction of the impact of antenatal diagnosis.   
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Further analysis showed that a 20% detection rate and 67% termination rate would 
lead to a 2% reduction in live born cardiovascular malformations, a 5% reduction in 
infant mortality from cardiovascular malformations and a 3% reduction in paediatric 
cardiac surgical activity.  A similar analysis of live born Down syndrome assumed 
75% uptake of triple screening, 60% detection and 100% termination of detected 
affected pregnancies.  This would lead to a 45% reduction in Down syndrome, a 
3.5% reduction in cardiovascular malformations, and a 2.6% reduction in cardiac 
surgery.  These levels were used as they were widely quoted by “modelling” studies 
in that era, although we thought at the time and said in the paper that these were 
unlikely to be achieved. It is interesting to look back ten years later.  The number of 
cardiovascular malformations continues to rise (see papers in chapter 4). The 
numbers of paediatric cardiac surgical operations is increasing as a result of 
improvements in outcome leading to more and more survivors requiring further 
surgery.  Live born Down syndrome is also increasing as the population effect of 
increasing maternal age is outpacing the effect of antenatal diagnosis and 
termination of pregnancy (see below: Irving et al, paper submitted for publication).  
Google Scholar lists 14 citations for this paper at the end of 2006. 
 
3.3.5 Wyllie JP, Madar RJ, Wright M, Burn J, Wren C. Strategies for antenatal 
detection of Down’s syndrome. Arch Dis Child 1997;76:F26-F30.  This paper 
explored further the theme of trends in live birth of Down syndrome. It used data on 
all Down syndrome pregnancies in the region in 1985-1991.  Ascertainment used all 
available sources including the fetal medicine, genetics, paediatric cardiology and 
NorCAS databases.  412 affected pregnancies were identified and those in mothers 
under 35 and 35 and over were analysed separately.  A theoretical population with 
no termination of pregnancy was produced by allocating all cases ending in 
termination of pregnancy to have been live born or stillborn according to the 
proportions observed in non-terminated pregnancies and according to maternal age.  
In the observed population there were 18% terminations, 6% stillbirths, and 76% live 
births. In the theoretical population there were 93% live births and 7% stillbirths 
(figure 3.7). 
 
Further analysis of the data showed that age-related amniocentesis with a predicted 
50% uptake and 100% termination (both high estimates and unlikely to be achieved) 
would lead to a 16% termination rate and 78% live births.  A similar analysis of 
maternal serum screening assumed 81% uptake, 70% detection, 79% 
amniocentesis, and 90% termination (all the highest published figures at the time but 
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again unlikely to be achieved). The predicted effect overall would be termination in 
0.81 x 0.70 x 0.79 x 0.90, i.e. in 38% of cases, with 58% being live born.  The 
combined effect of age-related amniocentesis, maternal serum screening, and fetal 
echocardiography was predicted to result in 40% termination and 56% live births in 
































Terminations Stillbirths Live births
 
Figure 3.7. The predicted effects of different screening strategies on the outcome of 
pregnancies with Down syndrome.  (Amnio = amniocentesis; MSS = maternal serum screening; 
echo = echocardiography; combined = amnio + MSS) 
 
Table 3.1, taken from the paper, shows the predicted effects per 100,000 
pregnancies and per year in the UK. 
 




This report attracted criticism despite the modelling using the highest reported 
detection, amniocentesis, and termination rates. [Sharland 1997]  In fact, as noted 
above, the prevalence at live birth of Down syndrome continues to rise.  In the 
Northern Region in 2000-2004 amniocentesis and chorionic villus biopsy have 
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reached a plateau at around 35 per 1000 registered births (3.5%), maternal serum 
screening at around 35% of registered births, and termination of pregnancies at 
around 0.9 per 1000 registered births.  As can be seen from figure 3.8, the 
prevalence at live birth of Down syndrome continues to rise with significant 
implications for those planning long term medical and other care for people with 
Down syndrome. 
Fig 3.8. 20 year trends in birth prevalence of Down syndrome (per 1000 registered births) 
showing an overall doubling of the rate and the changing effect on live births. 
Black = stillbirths, hatched = termination of pregnancy, white = live births with death in infancy, 
grey = live births alive after infancy. 
(From Irving C, Basu A, Burn J, Wren C.  Twenty-year trends in prevalence and survival of Down 
syndrome. Eur J Hum Genet 2008;16:1336-40.) 
 
The overall theme of the first five papers was the use of sound, reliable data with 
high ascertainment rates and good validation from a defined population for 
descriptive and predictive analyses of the occurrence and influence of 
cardiovascular malformations. These themes were developed further in a series of 
linked reports discussed in more detail in chapter 4.  
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The recent published output from analysis of data in the regional paediatric 
cardiology database is presented in this chapter.  Ten papers published in high 
impact journals in 1999-2008 are included.  The first three, which were published 
together, deal with the important topic of how congenital cardiovascular 
malformations come to notice.  The fourth examines influences on intrinsic variability 
of birth prevalence and how ascertainment and classification of malformations affect 
apparent birth prevalence. 
 
The fifth paper uses data on birth prevalence and survival to predict the growth of 
the population of adults with congenital heart disease and provides unique 
population-based data on post infant ascertainment of cardiovascular 
malformations.  The next two focus on specific malformations – an analysis of 
outcome and quality of life in all forms of pulmonary atresia and a study of the 
influence of cardiovascular malformations on the outcome of infants with 
oesophageal atresia. 
 
The next two papers examine the effects on the prevalence at live birth of 
cardiovascular malformations of maternal diabetes and prematurity. 
 
The final paper, published since the original submission of this thesis, analyses 
trends in the presentation of life-threatening cardiovascular malformations in 
neonates over twenty years. 
 
The ten papers employ similar methods to, and develop the themes of, the earlier 
studies presented in chapter three.  They use population-based data with near 
complete ascertainment, accurate diagnosis and good validation and employ similar 
techniques of analysis and modelling.  Their analyses and conclusions will influence 






               C Wren 2008                                      Page 26
 
4.2 Ainsworth S, Wyllie J, Wren C. The prevalence and significance of cardiac 
murmurs detected at the routine newborn examination. Arch Dis Child 
1999;80:F43-F45. 
 
Background:  The first of three papers, published together in Archives of Disease in 
Childhood, this two year prospective cohort study investigated the prevalence and 
significance of murmurs detected in more than 7000 neonates undergoing routine 
clinical examination by neonatal senior house officers in a large district general 
hospital.  The regional paediatric cardiology database was used to identify those 
who presented earlier or later in infancy. 
 
Key messages:  Murmurs were detected in 6‰ (6 per 1000) neonates on routine 
examination before discharge and 25/46 (54)% had an underlying cardiovascular 
malformation.  32 presented later and 10 were diagnosed antenatally, or before 
routine examination, or after admission to the neonatal intensive care unit.  Routine 
clinical examination detected only 44% of infant heart disease.  The most important 
finding was that absence of a murmur does not exclude the presence of a serious 
cardiovascular malformation. 
 
Impact:  This report is a standard reference in all papers on neonatal heart defects 
and reviews of neonatal screening for cardiovascular malformations.  Its findings 
have stimulated interest in the use of pulse oximetry to increase detection of serious 
malformation but real improvement is more likely to come from better antenatal 
diagnosis. 
 
Citations:  Google Scholar lists 49 citations at the end of 2007. 
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4.3 Gregory J, Emslie A, Wyllie J, Wren C. Examination for cardiac 
malformations at six weeks of age. Arch Dis Child 1999;80:F46-F48. 
 
Background:  Clinical examination at 6-8 weeks of age, including auscultation of 
the heart, is a fundamental part of health surveillance.  The second of a trilogy of 
papers, this was a retrospective cohort study to assess the efficacy of examination 
at six - eight weeks of age.   
 
Key messages:  Only 83% of babies eligible for examination attended and only 
56% were examined at the intended time.  Murmurs were heard in 8.7‰.  After 
clinical assessment, half were referred for investigation and half of those were found 
a cardiovascular malformation.  The 6-8 week examination led to the detection of 
31% of cardiovascular malformations in the study population.  Findings included 
significant abnormalities such as transposition of the great arteries and tetralogy of 
Fallot and this suggests that all infants with murmurs at this age should undergo 
further assessment. 
 
Examination at 6-8 weeks could meet the criteria for a screening test.  This study 
examined the efficacy of the examination as it is done rather than as it should be 
done.  It found major deficiencies in what could be a useful screening test.  
Screening was performed with poor records, inconsistent action in the face of an 
abnormality, and no assessment of outcome. 
 
Impact:  This paper has some limitations, notably the inability to define a precise 
birth cohort, as the study was based on a population and was organised through the 
department of community paediatrics.  Nevertheless, there is no other assessment 
of screening at 6-8 weeks in the literature.   
 
Citations:  Google Scholar lists 5 citations at the end of 2007. 
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4.4 Wren C, Richmond S, Donaldson L. Presentation of congenital heart 
disease in infancy – implications for routine examination. Arch Dis Child 
1999;80:F49-F53. 
 
Background:  This is the third of three papers published together in Archives of 
Disease in Childhood.   It was funded by the Northern Regional Health Authority and 
was a major retrospective review of the mode and timing of presentation of all infant 
heart disease in the region in eight years.  Compared with the previous assessments of 
neonatal and 6-8 week routine examination, it looked at the detection of cardiovascular 
malformations from the other end of the telescope. 
 
Key messages:  Cardiovascular malformations were confirmed in 1590 infants (5.3 
per 1000 live births).  33% came to notice before clinical examination because of 
symptoms or major non-cardiac abnormalities.  Neonatal examination was abnormal in 
45% but only a third of these were referred.  83% of babies were discharged without a 
diagnosis and a third of them presented with symptoms or died before the next 
scheduled examination at 6 weeks of age.   Two thirds of those having a 6-8 week 
examination were abnormal but 31% of all infants remained undiagnosed by 12 weeks. 
 
There was no correlation between the mortality for individual diagnoses and the 
likelihood of an abnormality being detected on examination.  Detection rates were no 
higher in the four units providing neonatal intensive care than in smaller units. 
 
The findings reinforce the difficulty of detecting cardiovascular malformations in 
asymptomatic infants and have encouraged the development of other screening 
strategies such as better antenatal diagnosis and routine pulse oximetry, although the 
efficacy of these methods is yet to be proven.  The data from this study were used for 
further analysis in a recent HTA report: Knowles R, Griebsch I, Dezateux C, Brown J, 
Bull C, Wren C.  Newborn screening for congenital heart defects: a systematic 
review and cost-effectiveness analysis.  Health Technol Assess 2005;9(44). 
 
Impact:  This is a very important paper which has been widely quoted by many 
authorities, including ACC/AHA guidelines.  It has had a major impact on clinical 
practice and has been used as evidence in defining national screening policy by the 
Royal College of Paediatrics and Child Health and the National Screening Committee. 
 
Citations:  Google Scholar lists 72 citations at the end of 2007. 
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4.5 Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence 
of cardiovascular malformations. Heart 2000;83:414-9. 
 
Background:  This is a retrospective analysis of data which were collected (mostly 
prospectively) in 1985-1997.  Its main aim was to examine year-to-year variations in 
numbers of individual malformations and to look for trends over time.  A second aim 
was to compare the effect of “anatomical” and “physiological” diagnostic hierarchies 
on apparent numbers (discussed at more length in section 2.6).  It has a 
denominator of almost half a million live births within the Northern Region. 
 
Key messages:  The number of diagnoses increased steadily over the study period.  
There was no change in complex or other significant malformations but a very 
significant rise in minor abnormalities, mainly small ventricular septal defects.  Year-
to-year variations in prevalence of rarer defects were more pronounced and make it 
impossible to ascribe short term change to anything other than natural variation, 
even in a study as large as this. 
 
“Anatomical” hierarchies list cases with more than one diagnosis in relation to the 
major structural malformation.  “Physiological” hierarchies give prominence to the 
abnormality with the greatest haemodynamic effect.  The use of an anatomical 
hierarchy alone underestimates the numbers of pulmonary atresia by 27%, 
coarctation of the aorta by 39% and of interruption of the aortic arch by 100%.  A 
physiological hierarchy alone underestimates the numbers of major structural 
malformations by 6%. 
 
Impact:  The apparent increase in prevalence at live birth of cardiovascular 
malformations had been reported in smaller series previously but was here shown to 
be entirely due to better ascertainment over time (largely because of easier 
recognition of small ventricular septal defects with colour Doppler echocardio-
graphy).  The “two-dimensional” hierarchy showed for the first time the effect on 
ascertainment of one or the other.  The increase in termination of pregnancy after 
antenatal diagnosis was documented with no discernable effect on live births.  The 
data in this study were further analysed by Hoffman and Kaplan’s review of birth 
prevalence discussed in chapter 6. 
 
Citations:  Google Scholar lists 46 citations at the end of 2007. 
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4.6 Wren C, O’Sullivan JJ. Survival with congenital heart disease and need for 
follow up in adult life. Heart 2001;85:438-43. 
 
Background:  The long term outlook for children with congenital cardiovascular 
malformations has improved steadily over the years, with more survivors with 
complex malformations.  The care of “adults with congenital heart disease” has 
become a separate sub-specialty.  By default the service is usually provided by 
paediatric cardiologists, although in recent years a few specially trained consultants 
have been appointed.  Trainees are recruited from paediatric cardiology or adult 
cardiology.  The provision of staff and resources has, predictably, lagged far behind 
the need.  The aim of this project was to predict the future needs of the population of 
adults with congenital cardiovascular malformations. 
 
Method: This was a modelling study, using data on cardiovascular malformations 
on children live born in 1985-1994.  Unlike all the others in this series, it had open-
ended ascertainment.  We made correction for the variable length of ascertainment, 
depending on year of birth, and this allowed the proportion and spectrum of post 
infant diagnoses within a population to be defined for the first time.  A theoretical 
birth-to-adult cohort was thus defined.  Correction for the observed total infant 
mortality was applied.  Survival to adult life for each individual malformation was 
then predicted from reports in the literature to define the number and spectrum of 
malformations in a population reaching adult life.  The need for expert long term 
follow up was then defined for each diagnosis. 
 
Key messages:  The population of adults with congenital heart disease needing 
long term specialist review grows by 200 per 105 live births each year, ie by over 
1600 per year in the UK.  The complexity of malformations in the adult population is 
greater than in infancy or childhood.  Increasing survival of even the most complex 
abnormalities means that the numbers and complexity will continue to grow for the 
foreseeable future. 
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 Impact:  This paper has been the most influential of all those in this series.  It has 
had a major impact on planning services for adults with cardiovascular 
malformations.  Its data have been used by planning taskforce groups in the UK 
(Fifth report on the provision of services for patients with heart disease.  
Heart 2002;88:iii1-56); Europe (Deanfield J et al. The European task force on the 
management of grown up congenital heart disease.  Eur Heart J 2003;24:1035-84); 
and the USA (Warnes CA, et al. Task Force 1: the changing profile of congenital 
heart disease in adult life. J Am Coll Cardiol 2001;37:1170-5). 
 
Citations: Google Scholar lists 76 citations by the end of 2007. 
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 4.7 Leonard H, Derrick G, O’Sullivan J, Wren C. Natural and unnatural history of 
pulmonary atresia. Heart 2000;84:499-503. 
 
Background:  Pulmonary atresia is characterised by the absence of a direct 
connection between the heart and the lungs.  It occurs in several situations – with a 
hypoplastic right ventricle (pulmonary atresia with intact ventricular septum - 
PA/IVS); as an extreme form of tetralogy of Fallot (pulmonary atresia with ventricular 
septal defect - PA/VSD); and in a wide variety of rare complex malformations 
(known in this report as complex pulmonary atresia - complex PA).  Previous reports 
have all been either surgical series or from single institutions and dealt with only one 
of these groups.  The main aim of this study was to define the prevalence and 
outcome for each type of pulmonary atresia within a defined population.  Because 
these are severe malformations ascertainment is complete and we were able to 
collect data from 1980. 
 
This was a descriptive cohort study.  The combined birth prevalence of pulmonary 
atresia was 21/105 live births with follow up of 555 patient years.  We used 
innovative non-linear survival plots to provide a graphic illustration of outcome. 
 
Key messages:  These are rare and complex malformations.  Overall survival was 
poor compared with many other malformations.  Actuarial survival was better for 
PA/VSD and worse for complex-PA.  Mortality was often before palliative surgery or 
from non-cardiac causes, but also reflects the era of the study.  Current total 
mortality is lower and surgical survival is much higher.  Despite this, these relatively 
rare patients need a disproportionate amount of hospital admissions, investigations 
and surgery to improve their outcome. 
 
Impact:  This was the first report to define the total prevalence of these rare 
conditions and to measure total mortality.  Data are needed to inform discussion 
about management in the face of antenatal or postnatal diagnosis. 
  
Citations:  Google Scholar lists 25 citations at the end of 2007. 
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4.8 Leonard H, Barrett AM, Scott JES, Wren C. The influence of congenital heart 




Background:  Oesophageal atresia is a rare condition causing immediate post-
natal deterioration and requiring emergency surgery.  It may be an isolated 
malformation but commonly occurs in babies with multiple abnormalities – most 
often congenital heart disease.  Previous reports were all either surgical series or 
single institution reports.  The aim of this study was to define the prevalence of 
oesophageal atresia within a population and to investigate the influence of 
cardiovascular malformations on outcome.  This was a descriptive cohort study with 
a denominator of > 500,000 live births.  It was performed in collaboration with the 
department of paediatric surgery.  It is a good example of interdisciplinary co-
operation in use of data in NorCAS.      
 
Key messages:  The prevalence of oesophageal atresia was 30 per 105 live births.  
One year survival was high, being 95% without and 67% with associated 
cardiovascular malformation.  However, heart defects were mostly indicators of 
babies with multiple abnormalities and only 1 of 10 deaths was primarily cardiac.  
Most deaths were from associated pulmonary, renal or chromosomal abnormalities.  
Cardiovascular malformations were 23 times more common in babies with 
oesophageal atresia compared to normal and this high prevalence is an indication 
for early screening, even in the absence of cyanosis or a murmur. 
 
Impact:  Oesophageal atresia is a rare condition with a very good outcome as an 
isolated anomaly.  This study is the largest of its kind and defines for the first time 
the influence of multiple abnormalities on survival. 
 
Citations:  Google Scholar lists 6 citations at the end of 2007. 
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4.9 Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of 
diabetic mothers. Heart 2003;89:1217-20. 
 
 
Background:  The cause of most cardiovascular malformations is unknown 
although about 5% are thought to have an environmental origin.  The increased risk 
to infants of diabetic mothers is recognised but not well defined. 
 
This six-year prospective cohort study had a denominator of almost 20020 
,000 live births.  It was performed in collaboration with the Northern Diabetic 
Pregnancy Register, which was set up in 1993 to investigate the outcome of 
pregnancy in women with pre-existing insulin-dependent diabetes. 
 
Key messages:  Cardiovascular malformations were present in 36‰ live births with 
diabetic mothers compared with 7‰ without (odds ratio 5.0).  Because individual 
malformations are rare, we combined our data with the five previously published 
reports for more detailed analysis.  The prevalence at live birth of transposition is 
518 per 100 000 in maternal diabetes compared with 30 per 100 000 for non-
diabetic mothers – a 17 fold excess.  We also looked for coding of maternal diabetes 
in 180 consecutive live born babies with transposition in 1985-2000.  Although 
retrospective coding of maternal diabetes might be incomplete, it was recorded in 
2.8% of mothers of infants with transposition, compared with a population 
prevalence of 0.32% in our main study.   
 
Impact:  This study is the largest, most complete, and only prospective study of 
cardiovascular malformations in infants of diabetic mothers.  It reinforces advice that 
diabetic mothers should have an expert fetal echocardiogram.  It poses interesting 
questions but does not tell us why cardiovascular malformations, in particular 
transposition, are so common. 
 
Citations:  Google Scholar lists 20 citations at the end of 2007. 
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4.10 Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm 
infants. Pediatrics 2005;116:e833-e838. 
 
 
Background:  Preterm birth and cardiovascular malformations are the two leading 
causes of neonatal and infant mortality.  This is the first population-based report of 
the association between them.  The aim was to compare the prevalence of 
cardiovascular malformations in preterm and term infants and to look at the 
influence of prematurity on mortality. 
 
This was a retrospective cohort study with a denominator of >500,000 live births.  
Gestation data were cross-checked with NorCAS.  Atrial septal defect and patent 
ductus arteriosus were excluded to prevent ascertainment bias.   
 
Key messages:  Cardiovascular malformations were present in 12.5‰ preterm and 
5‰ term infants (odds ratio (OR) 2.4).  16% of all babies with cardiovascular 
malformations were preterm. Increasing prematurity is associated with an increasing 
mortality risk.  The presence of a cardiovascular malformation further increases the 
risk (OR 1.8 at <28 weeks gestation) but the effect is much greater at term (OR 
35.6) because the one year mortality for term normal babies is so low. 
 
Analysis of gestation in all infants in NorCAS with Down syndrome showed that the 
increased prevalence of prematurity partly explains the association with 
atrioventricular septal defect.  Cardiovascular malformations are thought to be more 
common in twins and 50% of twins are preterm.  Analysis of NorCAS data showed 
that this association does not explain the association between cardiovascular 
malformations and preterm birth.  
 
Impact:  This paper defines the association between preterm birth and 
cardiovascular malformations for the first time and shows the excess mortality risk.  
The reason for the association is not clear.  
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4.11 Wren C, Reinhardt Z, Khawaja K.  Twenty-year trends in diagnosis of life-
threatening neonatal cardiovascular malformations.  Arch Dis Child 2008;93:F33-
F35. 
 
This paper was published after the original submission of this thesis and was originally 
included in full text unpublished form.  It analyses temporal trends in the timing and 
mode of cardiovascular malformations in neonates.  It finds that around 30% of infants 
with potentially life-threatening maformations were undiagnosed at discharge from 
hospital. Specific malformations most likely to go unrecognised were coarctation of the 
aorta (54%), interruption of the aortic arch (44%), aortic valve stenosis (41%), and total 
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 CHAPTER 5:  PREVALENCE AT LIVE BIRTH OF CONGENITAL 
CARDIOVASCULAR MALFORMATIONS: A SYSTEMATIC REVIEW 
 
5.1 INTRODUCTION 
The prevalence at live birth of cardiovascular malformations was a subject of 
interest even before paediatric cardiology became a recognised specialty.  Reports 
have been published on different populations around the world over the last fifty 
years but many early papers do not contain sufficient detail to be useful for analysis.  
Although attempts have been made at comparison between studies, their 
usefulness is limited by the absence of a common methodology. [Ferencz 1990] 
 
The cause of most cardiovascular malformations is unknown.  Some have genetic 
causes [Lin 2005, Pierpont 2007], others are environmental in origin [Mone 2004, 
Jenkins 2007], but most have traditionally been regarded as “idiopathic” or 
“multifactorial” [Nora 1968].  Comparisons between different populations are 
potentially valuable because different environmental exposure, diet, or genetic 
make-up might produce a true variation in the prevalence and/or spectrum of 
cardiovascular malformations.  However, before populations can usefully be 
compared, there has to be a proper evaluation of other possible reasons for 
differences between reports.  
 
The aims of this study were: 
1. To identify all published observational studies of the prevalence of congenital 
cardiovascular malformations. 
2. To examine these studies for potential sources of bias. 
3. To predict which malformations are most liable to ascertainment bias and to test 
the prediction against analysis of variation in the published prevalence rates. 
4. To identify studies with sufficiently common methodology for further analysis. 
5. To investigate whether there is evidence of a real difference between 
populations. 
6. To produce recommendations for consistent methodology for future reports to 
allow proper comparison between different populations. 
 
5.2 SYSTEMATIC REVIEWS 
Improvements in the conduct and reporting of research over time led to the 
development of the concept of evidence-based medicine.  Various levels of 
evidence are defined, depending on the validity of the research underlying them.  
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 The levels range from level 1A which might be a systematic review of randomised 
controlled trials to level 5 which is expert opinion without explicit critical appraisal.  
Criteria for the conduct and reporting of randomised control trials and for meta-
analysis of randomised control trials were published in Lancet in 1999 by the 
QUOROM (Quality of Reporting of Meta-Analyses) Group. [Moher 1999]  Editors of 
most major medical journals now require compliance with these recommendations. 
 
Similar concepts have since been applied to the conduct and reporting of 
observational epidemiological studies.  Proposals have been published by the 
MOOSE (Meta-analysis of Observational Studies in Epidemiology) Group in JAMA 
in 2000 and are reproduced in appendix A. [Stroup 2000] 
 
A systematic review is a review which is prepared using a strategy to avoid bias and 
which defines the materials and methods to make the process transparent.  A 
systematic review may or may not include a meta-analysis, which is “a statistical 
analysis which combines or integrates the results of several independent clinical 
trials considered by the analyst to be ‘combinable’”. [Egger 2003] 
 
Systematic reviews are not infallible.  Some which address the same subject have 
reached opposite conclusions. [Higgins 2006]  Two factors which are central to the 
validity of systematic reviews and meta-analyses are: 
• Inclusion of all relevant studies (or an unbiased sample of relevant studies). 
• The methodological quality of the component studies. 
 
The STROBE (Standards for the Reporting of Observational Studies in 
Epidemiology) Group have published a checklist of essential items to be taken into 
account when publishing an observational epidemiological study or when performing 
a systematic review of such studies – see appendix B. [von Elm 2007] 
 
5.3 REPORTING BIAS 
It has been recognised for a long time that only a proportion of research projects 
performed are eventually published in an indexed journal and thus become available 
and identifiable for systemic review.  The fact that not all research results are 
published is a major concern, more so for meta-analyses of randomised controlled 
trials rather than for systematic reviews of epidemiological studies.  “Positive” results 
are more likely to be published, more likely to published quickly, more likely to be 
published in English, more likely to be published more than once, and more likely to 
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 be cited.  These problems are grouped together under the heading of reporting 
bias.  Types of reporting bias are listed in table 5.1.  
Table 5.1. Types of reporting bias.  Adapted from Egger 2003. 
Type of reporting bias Definition 
Publication bias The publication or non-publication of research findings 
depending on the nature and direction of results. 
Multiple publication bias The multiple or singular publication of research findings, 
depending on the nature and direction of results. 
Language bias The publication of research findings in a particular 
language, depending on the nature and direction of the 
results.  This is often more likely to be English if the 
findings are positive. 
Database bias The inclusion or exclusion of research findings from 
widely used bibliographic databases such as MEDLINE, 
depending on the nature and direction of results. 
Citation bias  The citation or non-citation of research findings, 
depending on the nature and direction of results. 
Outcome reporting bias The selective reporting of some outcomes, but not 
others, depending on the nature and direction of results.
 
Other types of bias in the raw material of clinical trials also threaten the validity of 
systematic meta-analysis.  They include selection bias, performance bias, detection 
bias, and attrition bias. [Egger 2003]. 
 
Assessment for bias 
Several methods have been developed for assessment of the impact of various 
biases on randomised control trials and systematic reviews.  One in particular is the 
funnel plot which is used to measure publication bias.  The smaller a study is, the 
larger the treatment effect that will be needed for the results to be considered 
“statistically significant”.  Bias in a systematic review may therefore be present if 
there is an association between treatment effect and study size.  This is assessed 
using a funnel plot which is a scatter plot of treatment effect in individual studies 
against study size or standard error.  In the absence of bias the plot will be 
symmetrical.  Bias produced by failure to report, publish or include smaller studies 
showing no significant effect will produce asymmetry in the funnel plot.  However, an 
asymmetrical funnel plot may be due to study factors other than publication 
bias. [Cochrane Collaboration 2002].  These include other types of selection bias, 
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 poor methodological quality or design of smaller studies, inadequate analysis, fraud, 
chance, artefact and true heterogeneity.  Egger et al used these techniques to 
assess the importance of comprehensive literature searches and assessment of trial 
quality in systematic reviews. [Egger 2003]  They found that systematic reviews 
based on easily accessible English languages reports often produced results similar 
to those from more comprehensive reviews free from language bias.  They also 
found that trial results which were difficult to locate were often of low quality, raising 
the prospect that a more diligent systematic review might introduce rather than 
reduce bias, by inclusion of studies of dubious worth.  Egger et al also confirmed the 
usefulness of the funnel plot and used a regression method to assess funnel plot 
asymmetry in the detection of small study effects – that is the tendency for smaller 
studies to show larger treatment effects. 
 
5.4 BIAS IN DESCRIPTIVE EPIDEMIOLOGY 
Descriptive epidemiological studies are also susceptible to bias of various types.  
Whilst this may include publication bias, the main concern is that reports of the 
prevalence at live birth of cardiovascular malformations may be affected by various 
types of ascertainment bias.  Table 5.2 lists various types of bias which may affect 
such epidemiological studies, most of which were discussed in chapter 1. 
 
From the list in table 5.2 it seems very likely that some specific cardiovascular 
malformations will be more susceptible to certain types of bias than others.  For 
example, ventricular septal defect is the most common diagnosis in every reported 
survey.  One would expect ventricular septal defects to be affected by ascertainment 
bias (more intensive surveillance or more recent colour Doppler echocardiography 
studies will be expected to find a higher number of very small ventricular septal 
defects) and classification bias (ie there may be fewer large ventricular septal 
defects using a physiological hierarchy - see section 2.6).  Hypoplastic left heart has 
a relatively constant definition but is likely to be affected by variable ascertainment 
as it will be influenced by termination of pregnancy and by death before diagnosis, 
probably both relatively minor effects.  Double outlet right ventricle and pulmonary 
atresia with ventricular septal defect suffer from the problem of variable definition 
and variable use in different studies.  The Baltimore-Washington Infant Study 
considered pulmonary atresia with ventricular septal defect to be a variant of 
tetralogy of Fallot and didn’t code it separately. [Ferencz 1993]  However, this report 
did use double outlet right ventricle, a diagnostic group ignored by many others.  
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 Double outlet right ventricle covers a variety of malformations that in other reports 
are variously coded as transposition of the great arteries, tetralogy of Fallot etc. 
Table 5.2. Types of ascertainment bias. 
Type of bias Example 
Population or 
institution based 
Whole population including all live births preferred. 
Bias from single institution – may not reflect whole population. 
Bias from social group (e.g. health care insurance). 
Referral bias Historical referral pattern. 
Mild disease not referred.  
Severe disease not recognised before death. 
Failure to refer because of co-existing severe non-cardiac disease 
(e.g. lethal trisomy). 
Ascertainment bias Limited availability of paediatric cardiologists in less affluent 
countries. 
“Screening” by murmur, echocardiography etc. 
Small studies with more intensive surveillance. 
Inclusion or exclusion of terminations, stillbirths. 
Diagnostic bias No echocardiography in early era, with failure to diagnose minor 
malformations or inclusion of unconfirmed clinical diagnoses. 
Variable inclusion/exclusion criteria (e.g. bicuspid aortic valve, mitral 
valve prolapse, preterm patent ductus, arrhythmia, cardiomyopathy, 
etc.) – see text. 
Inclusion of patent foramen ovale / atrial septal defect / very mild 
valve stenosis. 
Selection bias Limited or open-ended ascertainment. 
Antenatal diagnosis and termination of pregnancy. 
Down’s syndrome screening and termination of pregnancy. 
Classification bias Variable diagnostic classification – e.g. pulmonary atresia, double 
outlet right ventricle etc – see text. 
Effect of hierarchy. 
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 5.5 METHODS 
The design of this study was influenced by guidelines published by the Health 
Technology Assessment programme [Sutton 1998], the NHS Centre for Reviews 
and Dissemination (CRD) [CRD 2001], the Meta-analysis of Observational Studies 
in Epidemiology group (MOOSE) [Stroup 2000], and Standards for the Reporting of 
Observational Studies in Epidemiology (STROBE) [STROBE 2006].  A prior search 
of the Cochrane database was made to ensure that no similar investigation had 
already been done. 
 
Criteria for considering studies 
The objective was to identify all cohort studies reporting the prevalence at live birth 
of cardiovascular malformations in 1950-2005.  Copies were obtained of all 
published reports and many colleagues helped with translating those not published 
in English (see Acknowledgements page xi). 
 
The literature search strategy 
The author performed a database search of MEDLINE (PubMed and OVID) and 
Google Scholar to identify all reports relating to the prevalence, incidence or 
epidemiology of congenital heart disease or cardiovascular malformations published 
before the end of December 2005.  Hand searching of references cited in published 
review articles [Ferencz 1990, Hoffman 1995, Loffredo 2000, Hoffman 2002] and in 
each of the included primary reports was also performed.  In a few cases where key 
information was missing from a report apparently otherwise suitable for inclusion or 
analysis, authors were contacted directly for advice or additional data.  Publications 
in all languages were included and copies were obtained with the help of the staff of 
Freeman Hospital library.  PubMed was specifically searched for papers in German, 
Spanish, Russian, Chinese and Japanese to minimise language bias.  In a very few 
cases, for example papers published in Russia or India in the 1960s, reports were 
untraceable and, therefore, had to be excluded (they are unlikely to have contained 
useful information).  Many papers in languages other than English contained 
sufficient information in the English abstract to assess whether they were suitable 
for analysis (e.g. if they were autopsy series they were not useful for inclusion).  Full 
copies of potentially useful publications in languages other than English were 
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 Appraisal of studies 
All studies were examined to determine whether a denominator population could be 
identified.  Those dealing with consecutive births in a single hospital or group of 
hospitals covering a defined population were included but papers describing 
admissions to, or attendance at, a hospital or clinic were excluded.  Also excluded 
were papers reporting only neonates or only symptomatic infants or diagnoses 
made only in children beyond infancy (e.g. in schoolchildren) and those dealing only 
with selected malformations.  Where there was more than one report from the same 
institution or population, only the later one was included. 
  
Analysis 
Particular note was made of whether studies (a) limited diagnoses to those made in 
the first year of life or had open ended ascertainment; (b) included only confirmed 
diagnoses (by echocardiography, cardiac catheterisation, surgery or autopsy); and 
(c) had a defined denominator population of live births.  Studies which included 
stillbirths and/or terminations of pregnancy in the numerator, and in which data for 
live born babies could not be identified separately were excluded from secondary 
analysis.  Also excluded from secondary analysis were studies which did not include 
infants with chromosomal or genetic abnormalities [Borman 1987, Mayberry 1990] 
as these account for up to 10-15% of cardiovascular malformations [Ferencz 1989, 
Johnson 1997].  For each of the reports the prevalence at live birth of cardiovascular 
malformations was calculated and the diagnostic hierarchy used for classification of 
patients with more than one main malformation was analysed.   
 
Further analysis of prevalence at live birth of specific malformations 
The 15 papers that included only live-births, limited ascertainment to infancy, 
excluded clinical diagnoses, and had a population base to permit calculation of birth 
prevalence were grouped for further analysis.   
 
Prediction of susceptibility of individual cardiovascular malformations to 
ascertainment bias 
Before analysis of any results from the selected reports, each individual 
cardiovascular malformation was assessed for susceptibility to various types of 
ascertainment bias (Table 5.3).  In particular, a prospective assessment was made 
of whether ascertainment was lively to be influenced by: 
• Variable ascertainment (ie more diligent diagnosis of, or coding of, minor 
malformations) 
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 • Variable definition 
• Variable (or undefined) diagnostic hierarchy 
• Rarity 
• Reduced live birth prevalence because of termination of pregnancy after 
antenatal diagnosis 
• Death before diagnosis 
• Post-infant open-ended ascertainment 
 
As can be seen from table 5.3, the malformations predicted to be least likely to be 
affected by these factors are transposition of the great arteries, tetralogy of Fallot, 
complete atrioventricular septal defect and hypoplastic left heart.  These were 
selected for more detailed analysis of prevalence, along with coarctation of the aorta 
(predicted to be more susceptible to factors affecting ascertainment – most notably 
the effects of diagnostic hierarchy and open ended ascertainment), and ventricular 
septal defect (because it is the most common and is predicted to be one of the most 
affected by the variables in table 5.3). 
 
Statistical analysis 
Most of the statistics used are descriptive.  They include presentation of data with 
means, medians and range.  Box and whisker plots were produced in Microsoft 
Excel.  Funnel plots were produced with the help of data analysis programmes 
produced by the Eastern Region Public Heath Observatory, ERPHO, 
(http://www.erpho.org.uk/) and available at: http://www.erpho.org.uk/tools.aspx. 
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 Table 5.3.  Susceptibility of individual malformations to various types of 
ascertainment or selection bias.  Malformations are listed in order of an 






































































         
 Hypoplastic left heart (HLH)  x   x x  
 Mitral Atresia (MA)    X x   
 Tricuspid Atresia (TA)    X x   
 Double Inlet Left Ventricle (DILV)    X x   
 Pulmonary Atresia with Intact Ventricular Septum (PA/IVS)    X x   
 Pulmonary Atresia with Ventricular Septal Defect (PA/VSD)  X x  x   
 Congenitally Corrected Transposition of the Great Arteries  (CCTGA)   x X    
 Truncus arteriosus (CAT)    X x   
 Total Anomalous Pulmonary Venous Connection (TAPVC)   X X    
 Hypoplastic Right Heart (HRH)  X  X x   
 Double Outlet Right Ventricle (DORV)  X X     
 Complete Atrioventricular Septal Defect (CAVSD)   x  x   
 Partial Atrioventricular Septal Defect (P/AVSD)    X   X
 Tetralogy of Fallot (ToF)  x      
 Transposition of the Great Arteries (TGA)        
 Interruption of the Aortic Arch (IAA)   X X  x  
 Coarctation of the Aorta (CoA)   X   x X
 Ventricular Septal Defect (VSD) X x X    X
 Aortic Valve Stenosis (AS) X X    x X
 Pulmonary Valve Stenosis (PS) X X X    X
 Atrial Septal Defect (ASD) X X X    X
 Persistent Ductus Arteriosus (PDA) X      X
                
  X  major effect      
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 5.6 RESULTS 
 
Papers examined 
The initial literature search identified 317 papers from 67 countries published in 
1951-2005 that reported the prevalence or incidence of cardiovascular 
malformations.  Figure 5.1 shows their geographical distribution.  Of the 317 papers, 
233 (74%) either had no identifiable birth cohort or included only neonates or only 








































































Figure 5.1.  The geographical spread of the 67 countries producing reports on cardiovascular 
malformations.  Sources of individual papers are not shown. 
 
Description of papers included in analysis 
Eighty-four papers from 38 countries published between 1951 and 2005 contained 
sufficiently detailed data for inclusion.  Figure 5.2 shows the geographical 
distribution of these papers.  As one might predict, reports from Western countries 
predominate. 













































Figure 5.2.  The geographical spread of the 38 countries producing reports suitable for analysis.  
Sources of individual papers are not shown. 
 
The denominator populations in the 84 papers ranged from 2,500 to over 2,000,000 
and totalled over 18,500,000.  They included over 100,000 cases of cardiovascular 
malformation.  The 84 papers are listed in table 5.4 along with their main 
characteristics.  The country abbreviations are taken from the United Nations 
abbreviations - details are at: http://unstats.un.org/unsd/methods/m49/m49alpha.htm 
 
Of the 84 papers, 47 (56%) included clinical (i.e. unconfirmed) diagnoses, 19 (23%) 
included stillbirths and/or terminations of pregnancy in the denominator and/or 
numerator, and 48 (57%) extended ascertainment beyond infancy (the first year of 
life).  Most papers excluded isolated bicuspid aortic valve with no stenosis, patent 
ductus arteriosus in prematurity, cardiomyopathy, isolated positional abnormalities 
of the heart, isolated cardiac arrhythmias, and tumours but others also excluded 
trisomies and syndromes [Borman 1987, Mayberry 1990], and specific ethnic groups 
[Arbour 2004].   
 
In some cases precise numbers of stillbirths or of abnormalities such as cardio-
myopathy or bicuspid aortic valve were given so that they could be removed for 
more appropriate analysis.  In a few cases the exact birth cohort was not defined but 
could be calculated fairly precisely as both the number of cardiovascular 
malformations and the birth prevalence were given. [Tikkanen 1990, Roy 1994, 
Pradat 2003, Abushaban 2003] 
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Gardiner 1951 CAN 48-49 134367 291 2.2 no no yes yes none 
Richards 1955 USA 46-53 5652 42 7.4 yes no yes yes none 
Carlgren 1959 SWE 41-50 58105 369 6.4 no no yes yes none 
Renwick 1964 CAN 55-60 34138 973 4.3 no no yes no none 
Gupta 1967 NGA 64 4054 10 2.5 no no hosp yes none 
Howie 1970 NZL 64-67 16103 80 4.7 yes no hosp no "most important" 
Feldt 1971 USA 50-69 32393 186 4.9 no no yes yes none 
Bound 1971 GBR 57-71 56982 338 5.9 no no yes yes none 
Mitchell 1971 USA 58-65 54765 420 7.7 no no yes yes none 
Darsinos 1971 GRC 54-68 99254 369 3.7 yes no hosp yes list 
Hay 1971 USA 63 58686 233 4.0 yes no yes no none 
Czeizel 1972 HUN 63-65 52549 371 7.1 no yes yes no most grave 
O'Brien 1972 IRL 66-71 32978 125 3.8 yes no hosp yes most severe 
Levin 1973 ZAF 66-70 21810 141 6.5 no no yes yes none 
Kenna 1974 GBR 60-69 163692 1081 6.5 no no yes no "pecking order" 
Henriksen 1974 NOR 67-68 133719 716 5.4 no no yes yes none 
Pentek 1975 HUN 55-69 97482 744 7.6 yes no yes yes none 
Ishihara  1974 JPN 69-71 36554 205 5.6 no no yes yes none 
Gravinghoff  1975 DEU 69 22605 152 6.7 no no yes ? none 
Hoffman 1978 USA 59-66 19044 163 8.8 no no yes yes none 
Pongpanich 1978 THA 69-75 26152 70 2.7 yes no hosp yes none 
Kopecka 1979 CZA 75-77 756335 3213 4.3 no no yes yes none 
Zajadacz 1979 POL 65-77 8564 57 6.7 no no yes yes specific 
Laursen 1980 DNK 63-73 854886 5249 6.1 no no yes yes none 
Stocker 1980 CHE 75 78464 494 6.3 yes no yes yes none 
Fyler 1980 USA 68-74 1083083 2190 2.0 yes yes yes yes anatomical 
Dickinson 1981 GBR 60-69 160480 884 5.5 no no yes yes none 
Squarcia 1981 ITA 72-80 33245 327 9.8 ? no yes yes none 
Dolara 1981 ITA 75-80 32561 337 10.3 yes no yes yes none 
Philippi  1986 CHL 83 7360 99 13.5 no no yes yes none 
Nakazawa 1986 JPN 84-85 72745 773 10.6 yes no yes yes none 
Borman 1987 NZL 78 51777 181 3.5 yes no yes yes predominant 
Carlgren 1987 SWE 81 93678 708 7.6 yes yes yes no none 
Grabitz 1988 CAN 81-84 103411 573 5.5 yes yes yes yes embryological 
Stoll 1989 FRA 79-86 105299 757 7.2 yes yes yes no none 
Diez Tomas 1989 ESP 76-85 53578 282 5.2 no no yes yes none 
Schmidt  1989 DEU 71-80 229846 1638 7.1 no no yes yes none 
Mayberry 1990 USA 70-88 16474 120 7.3 no no yes yes physiological 
Tikkanen 1990 FIN 82-83 132993 583 4.4 yes yes yes no none 
Klimentova 1990 CZE 81-87 61420 480 7.8 yes no yes yes first 
Fixler 1990 USA 71-84 379561 2509 6.6 no no yes yes embryological 
Fischer 1991 AUT 79-83 41725 341 8.2 no no yes yes none 
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Ferencz 1993 USA 81-89 906646 4224 4.7 yes yes yes yes embryological 
Kidd 1993 AUS 81-84 343521 1190 3.5 yes yes yes yes anatomical 
Manetti 1993 ITA 75-84 46895 579 12.3 no no yes yes none 
Cerboni 1993 GLP 88-90 22855 139 6.1 yes yes yes yes none 
Khalil 1994 IND n/a 10964 43 3.9 yes no hosp yes none 
Bower 1994 AUS 80-89 233502 1787 7.7 no no yes no anatomical 
Andersen 1994 NOR 87-90 14194 145 10.2 no yes yes yes "leading" 
Roy 1994 CAN 66-89 682625 5461 8.0 no no yes yes "clinical judgement" 
Tikanoja 1995 FIN 89-92 12841 139 10.8 no yes no yes none 
Anand 1996 USA 92-93 15949 156 9.8 no yes yes yes none 
Jackson 1996 GBR 79-88 203880 1543 7.6 no no yes yes physiological 
Montana 1996 USA 90-94 194754 1589 8.2 yes yes yes no embryological 
Schoetzau 1997 DEU 84-91 984570 7020 7.1 no yes yes yes embryological 
Robida 1997 QAT 84-94 49887 550 11.1 no yes yes yes none 
Grech 1998 MLT 90-94 26117 231 8.8 yes yes yes yes physiological 
Samanek 1999 CZE 80-90 816569 5030 6.2 no yes yes yes physiological 
Cloarec 1999 FRA 91-94 26082 256 9.8 no yes yes no "predominant" 
Zhang 1999 CHN ? 115836 431 3.7 no no yes yes none 
Bosi 1999 ITA 92-93 341647 1445 4.2 no ? yes yes "complex" 
Wren 2000 GBR 85-97 477960 2671 5.6 yes yes yes yes anatomical 
Guitti 2000 BRA 89-98 80262 441 5.5 no yes yes yes anatomical 
Subramanyan 2000 OMN 94-96 139707 992 7.1 no yes yes yes physiological 
Mogyorosy 2000 HUN 94-98 26932 334 12.4 no yes yes no none 
Guía 2000 ESP 78-90 203783 1118 5.5 no yes yes yes none 
Botto 2001 USA 68-97 937195 5656 6.2 yes no yes no embryological 
Bache 2002 DEN 86-95 55750 446 8.0 no yes yes no as "complex" 
Begić 2003 BIH 94-99 39699 243 6.1 no no yes yes none 
Bosi 2003 ITA 80-00 480793 2442 5.1 yes no yes yes as "miscellaneous" 
Putarek 2003 HRV 95-00 276565 2204 8.0 no yes yes yes embryological 
Pradat  2003 FRA 83-92 950000 2749 2.9 yes n/a yes no as "complex" 
ײ 2003 SWE 81-92 1270000 3171 2.5 yes yes yes no as "complex" 
ײ 2003 USA 85-92 2200000 7012 3.2 yes yes yes no as "complex" 
Abushaban 2003 KWT 86-89 82531 326 4.0 yes yes yes yes double counting 
ײ 2003 KWT 92-00 229981 2378 10.3 yes yes yes yes double counting 
Cleves 2003 USA 93-98 213870 1983 9.3 yes yes yes yes double counting 
Garne 2004 DEN 86-98 72519 573 7.9 yes yes yes yes specific or misc 
Bolisetty 2004 AUS 93-00 6156 105 17.1 yes yes yes yes physiological 
Stephensen 2004 ISL 90-99 44013 740 17.0 no yes yes yes physiological 
Arbour 2004 CAN 89-94 2567 77 30.0 yes yes yes no none 
Forrester 2004 USA 86-99 264236 2268 8.6 yes yes yes yes selected diagnoses 
Samson 2004 ARE 01-02 11085 83 7.5 no yes hosp yes none 
Chehab 2004 LBN 99-02 27834 249 8.9 yes yes yes yes "dominant" or "other" 
Meberg 2005 NOR 82-02 49458 553 11.2 no no yes yes "arbitrary" 
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 Other specific inclusions and exclusions varied.  Uncommon inclusions were 
pulmonary artery branch stenosis [Botto 2001], anomalies of systemic veins 
[Montana 1996], complete atrioventricular block [Montana 1996, Giutti 2000], mitral 
valve prolapse [Guitti 2000, Roy 1994] and bicuspid aortic valve [Roy 1994, 
Stephensen 2004].  No mechanism for classification of infants with more than one 
cardiovascular malformation was mentioned in 41 (48%) papers.   The hierarchies 
employed by others varied widely but the commonest were anatomical, 
physiological, or embryological (see table 5.4).  Other reports listed multiple 
malformations separately, [Garne 2004] or grouped them as “complex” [Bosi 1999, 
Bache 2002] or “miscellaneous” [Bosi 2003], or counted them twice [Abushaban 
2003, Cleves 2003].   
 
Trends over time – study size 
As can be seen from figure 5.3, there is a trend to larger study size over time.  The 
first three reports with denominators of more than 500,000 live births appeared in 
the 1970s and other reports of that size were mostly published in the 1990s.  Fifty-
two papers (61%) have a denominator of fewer than 100,000 live births, 22 have 


















Figure 5.3.  The relationship between final year of data collection and study size (denominator 
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 Trends over time – prevalence at live birth 
The reported live birth prevalence of cardiovascular malformation in the 84 papers 
varied from 2.1 to 30 per 1000 live births with a mean prevalence of 5.2 per 1000 
and a median of 6.7.  Figure 5.4 shows the increase in the prevalence at live birth 





















Figure 5.4.  The relationship between final year of study and prevalence at live birth of cardio-
vascular malformations.  Similar results are obtained by plotting middle year of study or year of 
publication. 
 
Relationship between prevalence and study size 
Figure 5.5 plots the denominator population size against the prevalence at live birth 
of cardiovascular malformations.  No study with more than 250,000 live births found 
a prevalence higher than 7 per 1000 whereas 13 smaller studies reported more than 
10 per 1000 cardiovascular malformations. 
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Figure 5.5.  The relationship between study size (denominator live births) and prevalence at live 
birth of cardiovascular malformations.  Red lines are drawn at 10 per 1000 live births and 
250,000 live births. 
 
Figure 5.6 plots the number of cardiovascular malformations reported against the 
prevalence.  No study with more than 1000 cases of cardiovascular malformation 
found a prevalence greater than 10 per 1000 whereas 13 smaller studies reported a 





















Figure 5.6.  The relationship between study size (numerator cases of cardiovascular 
malformation (CVM)) and prevalence at live birth of cardiovascular malformations.  Red lines 
are drawn at 10 per 1000 live births and 1000 cases of malformation. 
               C Wren 2008                                      Page 97
 Trends over time – reported prevalence of individual malformations 
Ventricular septal defect is the most common cardiovascular malformation and is 
one predicted in table 5.3 to be one of the most susceptible to ascertainment bias.  
Of the six malformations selected from table 6.3 for more detailed analysis, 
ventricular septal defect is the only one to show a significant trend to more 
diagnoses with time (see figure 6.7).  This increase is almost certainly from 
improved diagnosis rather than a true increase in frequency.  Several papers have 
noted the increase, probably mainly due to the ability of colour Doppler 
echocardiography to confirm diagnoses. [Mayberry 1990, Meberg 1990, Manetti 



















Figure 5.7.  The relationship between year of publication and prevalence at live birth of 
ventricular septal defect. 
 
Colour Doppler echocardiography was widely introduced in the mid-1980s and 
figure 5.7 shows no report of more than 500 per 105 ventricular septal defects before 
that time but seven reports with more than that later. 
 
In a previous report discussed in section 4.5 we noted an increase in the total 
number of ventricular septal defects but no change in the number which required 
surgical closure or were associated with death within the first 12 months of life. 
[Wren 2000].  In other words, all the increase is from diagnosis of a greater number 
of small ventricular septal defects.  Other reports, of studies involving 
echocardiography of consecutive neonates, have found tiny ventricular septal 
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 defects in up to 5% of all live births. [Roguin 1995, Sands 1999, Du 1996]  Many 
small ventricular septal defects (up to 85 or 90%) close spontaneously in the first 
year of life.  Thus the prevalence will be higher if the diagnosis is made after 
systematic examination of neonatal murmurs and early echocardiography. [Du 1998] 
 
Ventricular septal defects relative to other diagnoses 
Because ventricular septal defect is by far the most common malformation, any 
increase in the number of ventricular septal defects will obviously produce an overall 
increase in the number of malformations.  The relationship between the prevalence 
of ventricular septal defect and the prevalence of all cardiovascular malformations is 
plotted in figure 5.8.  There is an obvious strong association with more ventricular 
septal defects in papers with more malformations overall.  However, the slope of the 
linear trend line is around 1.7 (y = 1.68x + 246) showing that papers reporting more 
ventricular septal defects also find more cases of other malformations. This is shown 
more clearly in figure 5.9 where the prevalence of ventricular septal defect is plotted 
against the prevalence of all other malformations (excluding ventricular septal 
defect).  The slope (y = 1.69x + 246) shows that on average for every extra 100 
ventricular septal defects per 105 live births, reports will include another 70 per 105 
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Figure 5.8.  The relationship between prevalence at live birth of ventricular septal defect (VSD) 
and total cardiovascular malformations (CVM).  l.b.= live births 
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Figure 5.9.  The relationship between prevalence at live birth of ventricular septal defect (VSD) 
and all other cardiovascular malformations (CVM).  l.b.= live births 
 
This higher ascertainment is almost certainly due to more recognition of more cases 
of other minor malformations.  Better echocardiography detects more ventricular 
septal defects but also allows confirmation of the presence of small atrial septal 
defect, small patent ductus, mild pulmonary stenosis, and mild aortic stenosis.   
 
Confirmation that the higher reported prevalence of ventricular septal defect is not 
associated with a higher prevalence of significant malformations comes from figure 
5.10 which plots the prevalence of ventricular septal defect against the combined 
prevalence of transposition of the great arteries and tetralogy of Fallot (the two most 
common types of cyanotic congenital heart disease, predicted in table 5.3 to be the 
least susceptible to ascertainment bias).  As can be seen, there is no association.   
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Figure 5.10.  Scatter plot of the relationship between prevalence at live birth of ventricular 
septal defect (VSD) and combined prevalence of transposition of the great arteries (TGA) and 
tetralogy of Fallot (ToF).  l.b.= live births 
 
The same lack of association is seen if birth prevalence of ventricular septal defect 
is plotted against the combined prevalence of transposition of the great arteries, 
tetralogy of Fallot, coarctation of the aorta, hypoplastic left heart, and complete 
atrioventricular septal defect, the other five malformations selected from table 5.3 for 
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Figure 5.11.  Scatter plot of the relationship between prevalence at live birth of ventricular 
septal defect (VSD) and combined prevalence of transposition of the great arteries (TGA), 
tetralogy of Fallot (ToF), complete atrioventricular septal defect (CAVSD), coarctation of the 
aorta (CoA) and hypoplastic left heart (HLH). 
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 Box and whisker plots for analysis of variation in prevalence of specific 
malformations 
Box and whisker plots provide a graphical presentation which is especially useful for 
comparing two or more data sets with large numbers of observations, especially if 
the data are skewed and contain outliers. They give a dramatic visual comparison 
as the median, spread, skew and range are all immediately apparent.  First 
described by Tukey, the box shows the interquartile range and the median.  The 
whiskers extend to the highest and lowest points which are not outliers (i.e. within 



























Figure 5.12.  Basic box and whisker plot to show variance in reported prevalence of 
transposition of the great arteries (TGA), tetralogy of Fallot (ToF), complete atrioventricular 
septal defect (CAVSD), coarctation of the aorta (CoA), hypoplastic left heart (HLH) and 
ventricular septal defect (VSD). 
 
A basic box and whisker plot of the six selected malformations is shown in figure 
5.12.  The obvious problem is the wide variation in birth prevalence which means 
that the first five are dwarfed by the representation of ventricular septal defect.  It so 
happens that the individual rates of transposition of the great arteries, complete 
atrioventricular septal defect, tetralogy of Fallot and coarctation of the aorta are all 
very close to 30 per 105 while hypoplastic left heart is around 20 per 105 and 
ventricular septal defect around 240 per 105.  Therefore, if we multiply the data for 
hypoplastic left heart by 1.5 and divide the data for ventricular septal defect by 8 the 
data for each malformation will be more easily compared, as in figure 5.13.  This 
figure shows both the median (heavy horizontal line) and the mean (large X) to give 
some impression of skew.  It is easily seen that the least variation is shown for 
tetralogy of Fallot and transposition of the great arteries with more for the other 
               C Wren 2008                                      Page 102
 malformations, especially ventricular septal defect, as predicted in table 6.3.  In 
figure 5.14, the plots have been augmented by adding the outliers to give the most 





























Figure 5.13.  Box and whisker plot of the reported prevalence of transposition of the great 
arteries (TGA), tetralogy of Fallot (ToF), complete atrioventricular septal defect (CAVSD), 
coarctation of the aorta (CoA), plus 1.5 times the prevalence of hypoplastic left heart (HLH) and 































Figure 5.14.  Complete box and whisker plot (including outliers) of the reported prevalence of 
transposition of the great arteries (TGA), tetralogy of Fallot (ToF), complete atrioventricular 
septal defect (CAVSD), coarctation of the aorta (CoA), plus 1.5 times the prevalence of 
hypoplastic left heart (HLH) and 0.125 times the prevalence of ventricular septal defect (VSD). 
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 Analysis of variation in reported prevalence of individual malformations 
Transposition of the great arteries 
Data on 4699 cases of transposition of the great arteries were included in 68 of the 
84 papers in table 5.4.  The simplest way to analyse variation is to plot the 
prevalence against study size (denominator live births) as shown in figure 5.15. The 
mean prevalence was 29 per 105 live births and it can be seen that the distribution 
approximates well to a bell shaped curve.  This suggests that there is very little 
ascertainment bias.  There are two possible outliers with high prevalence of 
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Figure 5.15.  The relationship between prevalence at live birth of transposition of the great 
arteries (TGA), and study size.  The red line indicates the mean prevalence of 29 per 105 live 
births (l.b.). 
 
Tetralogy of Fallot  
Seventy papers included 4893 cases of tetralogy of Fallot and reported a mean 
prevalence of 30 per 105 live births.  The relationship with study size is shown in 
figure 5.16.  Again there is a good approximation to a Gaussian distribution with 
possible outliers with a high prevalence in very small studies. 
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Figure 5.16.  The relationship between prevalence at live birth of tetralogy of Fallot (ToF), and 
study size.  The red line indicates the mean prevalence of 30 per 105 live births (l.b.). 
 
Complete atrioventricular septal defect 
Sixty-five papers included 4345 cases of complete atrioventricular septal defect and 
reported a mean prevalence at live birth of 27 per 105.  The relationship to study size 







0 20 40 60 80 1













Figure 5.17.  The relationship between prevalence at live birth of complete atrioventricular 
septal defect (CAVSD), and study size.  The red line indicates the mean prevalence of 27 per 105 
live births (l.b.). 
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 Hypoplastic left heart 
Sixty-five papers reported 3207 cases of hypoplastic left heart with a mean 
prevalence at live birth of 21 per 105.  Figure 5.18 plots the prevalence against study 
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Figure 5.18.  The relationship between prevalence at live birth of hypoplastic left heart (HLH), 
and study size.  The red line indicates the mean prevalence of 21 per 105 live births (l.b.). 
 
All four malformations discussed above were predicted in table 5.3 to be relatively 
unaffected by ascertainment bias and all show a fairly symmetrical distribution 
around the mean, suggesting that they are little affected by ascertainment bias (or 
other types of bias).   
 
Coarctation of the aorta 
Data on coarctation of the aorta were included in 66 of 84 papers.  They reported 
4175 cases with a mean prevalence at live birth of 26 per 105.  Figure 5.19 shows a 
much wider distribution in relation to study size.  There is less symmetry and an 
apparent skew.  It seems likely that this is evidence of bias – most probably 
ascertainment bias.  Coarctation was predicted in table 5.3 to be significantly 
affected by two types of ascertainment bias.  Coarctation will be under reported if an 
anatomical rather than physiological hierarchy is used (as discussed in section 2.6).  
In a previous report we found 64% more cases of coarctation using a physiological 
hierarchy compared with an anatomical hierarchy. [Wren 2000]  Open-ended 
ascertainment (as opposed to ascertainment limited to infancy) gives the opportunity 
for a higher prevalence.  In a further previous report we found that 31% of all cases 
of coarctation diagnosed in children first came to notice after infancy.  [Wren 2001]  
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 The data in figure 5.19 show a skew to a lower prevalence in larger studies.  Studies 
based on smaller populations are likely to have open-ended recruitment to increase 
the numbers.  Analysis of data in table 5.4 shows that the mean number of live 
births in the denominator population in studies which limited ascertainment to 
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Figure 5.19.  The relationship between prevalence at live birth of coarctation of the aorta (CoA), 
and study size.  The red line indicates the mean prevalence of 26 per 105 live births (l.b.). 
 
Ventricular septal defect 
Data on ventricular septal defect were included in 74 of 84 papers.  They reported 
28,586 cases with a mean prevalence at live birth of 174 per 105.  The relationship 
with study size is shown in figure 5.20.  Again the data are very asymmetrical and 
skewed to lower prevalence in larger studies.  Ventricular septal defect is predicted 
to be susceptible to various types of ascertainment bias as discussed in section 5.4 
and table 5.3. 
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Figure 5.20.  The relationship between prevalence at live birth of ventricular septal defect (VSD), 
and study size.  The red line indicates the mean prevalence of 174 per 105 live births (l.b.). 
 
Assessment of skew for analysis of ascertainment bias 
Bias is strongly suggested by asymmetry or skew in the distribution of the data 
points.  Detailed analysis of skew is very complicated and requires a regression 
analysis programme.  However, a good approximation can be obtained by plotting 
data on a log scale with a linear regression line (D Spiegelhalter, personal 
communication).  Two examples are given below using data from hypoplastic left 
heart which is symmetrical, and ventricular septal defect, which is asymmetrical. 
 
Figure 5.21 plots the same data for hypoplastic left heart as shown in figure 5.18 but 
the X and Y axes are reversed.  The appearance of symmetry is confirmed.   































Figure 5.21.  The relationship between prevalence at live birth of hypoplastic left heart (HLH), 
and study size.  These are the same data as shown in fig 5.18 with the X and Y axes reversed. 
Figure 5.22 plots the birth prevalence on a log scale and a linear regression line is 
also shown.  There is very little separation between the regression line and the 



























Figure 5.22.  The relationship between prevalence at live birth of hypoplastic left heart (HLH), 
and study size, plotted with a log scale on the Y axis.  The red line indicates the mean 
prevalence of 21 per 105 live births; the green line is the linear regression line (see text). 
 
Figure 5.23 plots the data for ventricular septal defect from figure 5.20 with the X 
and Y axes reversed. The appearance of asymmetry is confirmed with lower 
prevalence in larger studies.  























Figure 5.23.  The relationship between prevalence at live birth of ventricular septal defect (VSD), 
and study size.  These are the same data as shown in fig 5.20 with the X and Y axes reversed. 
Figure 5.24 plots the same data on a log scale with a linear regression line.  The 





























Figure 5.24.  The relationship between prevalence at live birth of ventricular septal defect (VSD), 
and study size, plotted with a log scale on the Y axis.  The red line indicates the mean 
prevalence of 21 per 105 live births; the green line is the linear regression line (see text). 
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 Funnel plots for analysis of ascertainment bias 
The graphs in figures 5.15-5.20 are in effect a type of funnel plot.  A true funnel plot 
extends the analysis by applying a mean and lines showing the limits of two and 
three standard deviations.  Funnel plots for all six malformations are shown in 
figures 5.25-5.30.  95% of data points should lie within two standard deviations of 
the mean and 99.73% within 3 standard deviations.  The data points are most tightly 
distributed in plots of transposition of the great arteries (figure 5.25) and hypoplastic 
left heart (figure 5.26), supporting the suggestion that they are minimally affected by 




















Figure 5.25.  Funnel plot of the relationship between prevalence at live birth of transposition of 





















Figure 5.26.  Funnel plot of the relationship between prevalence at live birth of hypoplastic left 
heart (HLH), and denominator live births (l.b.).   
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 The distribution is also fairly symmetrical for tetralogy of Fallot (figure 5.27) and 




















Figure 5.27.  Funnel plot of the relationship between prevalence at live birth of tetralogy of 
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Figure 5.28.  Funnel plot of the relationship between prevalence at live birth of complete 
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 The asymmetry, skew, and wide variation in the reported prevalence of coarctation 
(figure 5.29) and ventricular septal defect (figure 5.30) are confirmed.  This is 





















Figure 5.29.  Funnel plot of the relationship between prevalence at live birth of coarctation of 

























Figure 5.30.  Funnel plot of the relationship between prevalence at live birth of ventricular septal 
defect (VSD), and denominator live births (l.b.). 
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 5.7 FURTHER ANALYSIS OF PAPERS WITH A COMMON METHOD 
The 15 papers that included only live births, limited ascertainment to infancy, 
excluded clinical diagnoses, and had a population base to permit calculation of birth 
prevalence are listed in Table 5.5.  Their denominator populations range from just 
over 6,000 to >900,000 but only five papers have >250,000 live births.  The 15 
papers include 2,875,384 denominator live births and 17,836 cardiovascular 
malformations.  The reported prevalence at live birth ranges from 346 to 1706 per 
105 live births with a mean of 620 per 105.  
 
All 15 papers give details of prevalence of the most common individual diagnoses 
although other diagnoses that are included vary between reports.  The method of 
classifying cases with more than one cardiovascular malformation also varies 
considerably.  Two papers have a physiological hierarchy, two an anatomical 
hierarchy, two an embryological or mechanistic hierarchy, and two double-count 
multiple malformations.  Five papers make no mention of how cases with multiple 
malformations were classified.  One included only selected diagnoses and one used 
specific sub categories.  The papers also differed in the method of classifying 
pulmonary atresia, double outlet right ventricle, and other less common diagnoses. 
 
All 15 papers find that ventricular septal defect is the most common diagnosis with a 
prevalence ranging from 86-1007 per 105 live births, being greater in later series.  
The prevalence of diagnoses that are rare, or subject to variability of definition or 
ascertainment, varies the most.  Only one of the papers defines pulmonary valve 
stenosis [Chehab 2004] and the reported prevalence of this malformation varies 
from 19-165 per 105 live births.  The prevalence of diagnoses likely to have a 
constant definition and more or less full ascertainment is fairly constant, e.g. 
coarctation of the aorta (23-32 per 105 live births), complete atrioventricular septal 
defect (16-38 per 105 live births), transposition of the great arteries (16-30 per 105 
live births), and total anomalous pulmonary venous connection (7-16 per 105 live 
births).  Rare diagnoses are known to be subject to more variability because of the 








 1st Author Grabitz Sung Ferencz Kidd Cerboni Robida Grech Wren Mogyorosy Abushaban Bolisetty Cleves Garne Forrester Chehab Hoffman & Kaplan 
                                      
 Year 1988 1991 1993 1993 1993 1997 1998 2000 2000 2003 2004 2003 2004 2004 2004       
 Era 81-84 87-89 81-89 81-84 88-90 84-94 90-94 85-97 94-98 86-00 93-00 93-98 86-98 86-99 99-02       
 Origin CAN CHN USA AUS GLP QAT MLT GBR HUN KWT AUS USA DEN USA LBN       
 Livebirths 103411 20928 906646 343521 22855 49887 26117 477960 26932 312512 6156 213870 72519 264236 27834       
                                lower Q median upper Q 
 Prevalence 554 597 468 346 608 1108 884 559 1240 1429 1706 927 676 858 849 534 767 1382 
                                      
 VSD 191 296 156 99 196 473 394 238 360 287 1007 463 265 417 341 176 283 448 
 PDA 25 62 11 12 39 62 19 23 100 165 130 excluded 25   36 32 57 78 
 ASD 58 24 38 12 74 86 42 28 434 84 179 382 88 206 68 37 56 106 
 CAVSD 24 14 36 21 22 30 38 35 41 36 16 45 26 22 47 24 34 40 
 PS   76 44 23 22 102 165 44 74 66 32 108 41 33 86 36 53 84 
 AS     14 10 9 16 8 20 59 18 16 49 25 12 50 16 26 39 
 CoA   5 22 27 31 38 23 24 33 41 32 63 29 25 25 29 36 49 
 ToF 20 48 33 27 26 50 80 31 30 28 32 33 30 39 29 29 36 58 
 TGA 28 33 23 33 18 38 23 30 19 28 16 33 29 39 25 23 30 39 
 HLH   10 18 23 35 22 0 14 7 13 49 29 30 14   15 23 28 
 
Table 5.5.  The prevalence of the ten most common cardiovascular malformations in the 15 papers with common basic 
methods selected for further analysis.  Data from the review by Hoffman and Kaplan are presented for comparison.  Q = 
quartile.  Prevalence is per 105 live births.  The country abbreviations are taken from the standard United Nations 
abbreviations, details of which can be found at: http://unstats.un.org/unsd/methods/m49/m49alpha.htm.  Other abbreviations 
are as in table 5.3.
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 As with the 84 papers in table 5.4, the reported birth prevalence of cardiovascular 
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Figure 5.31.  The relationship between midpoint year of ascertainment and prevalence at live 
birth of cardiovascular malformations in the 15 papers in table 5.5.  Similar results are obtained 



























Figure 5.32.  The relationship between study size (denominator live births) and prevalence at 
live birth of cardiovascular malformations in the 15 papers in table 5.5. 
 
Table 5.5 also compares the prevalence at live birth of the 10 most common 
malformations in the 15 papers with the findings of a review by Hoffman and Kaplan. 
[Hoffman 2002]  Published in 2002, this was a seminal review entitled “The 
incidence of congenital heart disease”.  As discussed in section 1.4 in chapter 1, 
Hoffman and Kaplan are in the minority who prefer the term incidence to describe 
               C Wren 2008                                      Page 116
 what is known in this review as the prevalence at live birth of cardiovascular 
malformations.  Although it is comprehensive, a limitation of their review is that it has 
no inclusion or exclusion criteria but simply includes all published reports and gives 
them equal weight in the analysis.  Thus papers limited to symptomatic neonates or 
diagnoses made before first discharge from hospital are included alongside those 
with ascertainment which includes termination of pregnancy and stillbirth to the 
whole of childhood. 
 
Figure 5.33 is derived from the data in table 5.5 and compares the median 
prevalence and interquartile range of individual malformations in the 15 papers 
selected for secondary analysis with the findings of Hoffman’s review.  The greater 
homogeneity and selectivity of the 15 papers, and the fact that they are more recent, 


















































 Figure 5.33.  Comparison of reported median prevalence and interquartile range in the 15 
papers with common methodology in table 5.5 (blue bars) and the Hoffman review (orange bars) 
of: atrial septal defect (ASD), pulmonary valve stenosis (PS), patent ductus arteriosus (PDA), 
tetralogy of Fallot (ToF), complete atrioventricular septal defect (CAVSD), coarctation of the 
aorta (CoA), transposition of the great arteries (TGA), hypoplastic left heart (HLH), and aortic 
valve stenosis (AS).  The reported prevalence of ventricular septal defect (VSD) was similar in 
the two series but is omitted so as not to distort the scale.  Malformations are ranked according 
to median prevalence in the 15 papers in table 5.5. 
 
The 15 papers have roughly the same median prevalence as Hoffman for 
malformations where ascertainment is expected to be complete or more or less 
complete in infancy (eg transposition of the great arteries, tetralogy of Fallot, 
hypoplastic left heart and complete atrioventricular septal defect) but have a 
narrower interquartile range for some – particularly tetralogy of Fallot and 
transposition of the great arteries.  They find fewer than Hoffman of the 
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 malformations predicted in table 5.3 to be more affected by open-ended 
ascertainment (eg patent ductus arteriosus, coarctation of the aorta, and aortic valve 
stenosis).  The interquartile ranges for these diagnoses are notably wider.  
Interestingly, the 15 papers find more atrial septal defects than Hoffman’s review, 
probably a reflection of the fact that all were written in the echocardiographic era 
and were, therefore, subject to overdiagnosis of small and clinically unimportant 
atrial septal defects early in life. [Sands 2002] 
 
Summary of findings 
Even when analysis is confined to the papers in table 5.5 there are still significant 
differences between them.  Despite a common basic method - being population-
based, confined to live births, and including only confirmed diagnoses in infancy - 
there is marked variation in the detailed methods of these 15 papers.   
 
The 15 papers also use different diagnostic hierarchies so infants with more than 
one malformation (such as coarctation of the aorta and ventricular septal defect or 
truncus arteriosus with interruption of the aortic arch) are classified differently in 
different studies.  The threshold for diagnosis probably varies as well.  For instance 
what is the definition of pulmonary valve stenosis?  Only one of the 15 defines it. 
 
They find a prevalence at live birth of around 30 per 105 transposition of the great 
arteries, tetralogy of Fallot, complete atrioventricular septal defect, and coarctation 
of the aorta, around 20 per 105 for hypoplastic left heart and around 300 per 105 for 
ventricular septal defect.  Interquartile ranges are narrow in comparison with findings 
of the unselective approach of Hoffman’s review, despite their small number and 
generally small size. 
 
5.8 DISCUSSION  
Comparisons between reports in different populations or different countries are 
potentially of great interest.  The papers analysed for this study show wide variation 
in the prevalence at live birth of cardiovascular malformations.  Before comparisons 
can be made it is important to analyse the study methods in detail.  There are a 
number of potential explanations for the differences in reported prevalence of 
congenital cardiovascular malformations.  Only when all of these have been 
excluded can we conclude that there is a real difference between the findings in 
different populations.   
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 Ascertainment bias and selection bias 
Some of the largest studies have a low prevalence of cardiovascular malformations, 
presumably because of low ascertainment. [Fyler 1980, Ferencz 2003]  Some of 
those with the highest reported prevalence are from very small study populations, 
where resources probably permit much more careful evaluation and ascertainment 
is likely to be fairly complete. [Arbour 2004, Bolisetty 2004]  There are obvious 
potential problems with ascertainment in multicentre studies, especially those 
performed over several years. [Fyler 1980, Ferencz 2003]  All specialist centres rely 
on referrals from other primary, secondary or tertiary providers of health care and 
none of the papers has defined the referral pattern or threshold for referral.  Mild 
disease (such as small ventricular septal defect or mild pulmonary valve stenosis) 
may not be referred and very severe malformations may cause early death before 
diagnosis. [Abu-Harb 1994]  Infants with severe non-cardiac malformations (such as 
lethal trisomy) may not be referred for investigation if there is already no prospect of 
survival. [Wyllie 1994, Embleton 1996]  Ascertainment may also be limited by the 
availability of paediatricians or paediatric cardiologists in countries with less well 
developed health care systems. 
 
The prevalence of cardiovascular malformations is generally lower in earlier studies, 
due in part to the later wide availability of colour Doppler echocardiography.  
Hoffman drew attention to the influence of the ascertainment of small ventricular 
septal defects on the overall prevalence, also discussed above. [Hoffman 2002]  In 
several studies demonstrating an apparent increase in prevalence of cardiovascular 
malformations over time this was almost entirely due to increased recognition of 
minor defects, principally small ventricular septal defects. [Wren 2000] 
 
Most cardiovascular malformations, especially the more serious, are diagnosed in 
the first year of life.  However, 26% of cardiovascular malformations in children are 
first diagnosed beyond infancy so studies which continue ascertainment beyond 
infancy are likely to report a higher overall prevalence. [Wren 2001] 
 
Inheritability of cardiovascular malformations 
Although there is no evidence of a true increase in the prevalence of cardiovascular 
malformation with time, other effects on birth prevalence have been identified.  
There is known to be an increased risk to offspring of parents who had 
malformations themselves.  The risk is around 5% (roughly a fivefold increase) for 
affected mothers and 2% for affected fathers. [Whittemore 1994, Burn 1998]  More 
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 and more children with congenital heart disease are surviving to adult life and are 
likely to have their own children. [Taussig 1979, Wren 2001]  All other things being 
equal, these effects will lead to an increase in prevalence at live birth of 
cardiovascular malformations in the population.  Carter estimated that the birth 
prevalence of malformations would double in seven generations. [Carter 1974] 
 
Other genetic factors 
The influence of parental consanguinity on the prevalence at live birth of 
cardiovascular malformations is intriguing but has proved difficult to investigate – 
mainly because of the problem of identifying consanguinity in denominator 
populations. [Sadiq 1995, Robida 1997, Becker 2001]  In a recent report, Chehab et 
al compared rates of consanguinity in Beirut in the parents of 1585 children with 
cardiovascular malformation with parents of 1979 children with normal hearts. 
[Chehab 2007]  Another reference group was provided by data from 1625 children 
investigated by UNICEF in Lebanon.  First-cousin consanguinity was found in 19.4% 
of the study sample compared with 14.4% of the control group (p<0.001).   The 
small numbers of individual malformations precluded detailed analysis but 
consanguinity was more common in cases of atrial septal defect, aortic valve 
stenosis and tetralogy of Fallot.  Outside the Middle East and a few other 
populations, consanguinity is uncommon or rare and will have little influence on the 
prevalence of cardiovascular malformation. 
 
Antenatal diagnosis and termination of pregnancy 
Termination of pregnancy after antenatal diagnosis is an increasing influence on the 
live birth prevalence of cardiovascular malformations in many populations.  It has yet 
to be shown that termination of pregnancy has a major influence on the overall 
prevalence at live birth of cardiovascular malformations although it may do so in 
future. [Montana 1996, Allan 2000, Gardiner 2001]  It is likely that the effect of 
termination will be greatest on the most severe and most easily recognised 
malformations and those with the worst prospect of survival.  Thus the prevalence at 
live birth of those diagnoses most amenable to antenatal diagnosis and therefore 
likely to undergo termination of pregnancy (such as hypoplastic left heart, pulmonary 
atresia with intact septum), are likely to show the effect soonest.  The overall effect 
on the prevalence at live birth of malformations is likely to be limited. [Abu-Harb 
1995, Acharya 2004] 
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 We cannot easily correct for the epidemiological effects of termination of pregnancy.  
We lack precise knowledge of the natural history in utero of defects selected for 
termination, selected to continue pregnancy or not diagnosed before birth.  Another 
problem is that termination of pregnancy may follow detection of a non-cardiac 
malformation (such as neural tube defect) or chromosomal abnormality (such as 
fatal trisomy) before assessment for co-existent cardiac abnormalities.  Inclusion of 
cases ending in stillbirth or termination distorts epidemiological assessment of 
prevalence of malformation but exclusion of cases which may well have been live 
born does likewise. 
 
Bull reported results from a UK wide study of births in 1993-1995. [Bull 1999]  She 
found that the pregnancy termination rate was strongly influenced by the specific 
type of cardiovascular malformation, ranging from 47% in hypoplastic left heart to 
3% in tetralogy of Fallot.  The termination rate was also related to the gestational 
age at diagnosis, being 70% with diagnoses before 19 weeks, 61% for a diagnoses 
before 23 weeks and 50% overall.  Diagnoses were strongly skewed towards those 
producing more obvious abnormalities on the fetal scan.   Hypoplastic left heart was 
the commonest, accounting for 20% of all antenatal diagnoses whereas it accounts 
for only 3.9% of malformations in the 84 papers analysed in table 5.4.  By contrast, 
transposition of the great arteries accounts for 5.5% of all live born cardiovascular 
malformations but represented only 0.01% of antenatal diagnoses in the UK study. 
  
Bull also provided valuable data on the fetal mortality by individual diagnosis. [Bull 
1999]  Excluding terminations, the fetal mortality in continuing pregnancies was 16% 
for tetralogy of Fallot, 13% for complete atrioventricular septal defect, 12% for 
hypoplastic left heart, 10% for transposition, and 12% overall.  A study from Italy 
reported similar findings with a 12% in utero mortality in pregnancies continuing after 
diagnosis of a cardiovascular malformation. [Fesslova 1999] 
  
Thus, depending on the diagnosis, inclusion or exclusion of cases resulting in 
termination of pregnancy may have a substantial impact on the reported prevalence 
of cardiovascular malformations.  The ideal solution is probably to report data 
separately for terminations, stillbirths and live births from the same population. 
  
Inclusion of data for termination of pregnancy in the numerator for all cardiovascular 
malformations is problematic as the antenatal diagnosis rate varies widely between 
studies (and was zero in earlier reports) especially as the spontaneous mortality in 
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 continuing pregnancies may be up to 16%.  The converse is also true.  Cragan and 
Khoury examined the effect of prenatal diagnosis on epidemiological studies of birth 
defects, using case control studies of the aetiology of neural tube defects as a 
model. [Cragan 2000]  Prenatal diagnosis and termination of pregnancy are much 
more common in neural tube defects than in cardiovascular malformations.  Cragan 
and Khoury showed that exclusion of pregnancies electively terminated after 
prenatal diagnosis of neural tube defects may have a substantial effect on the 
results of epidemiological studies of these defects.  Study precision may be reduced 
or results may be biased (towards or away from the null) depending on how the risk 
factor of being studied is related to the likelihood of diagnosis or termination. 
  
Another factor to be taken into account is that prenatal diagnostic techniques may 
lead to increased rates of diagnosis of some malformation in continuing 
pregnancies.  This effect is likely to be limited in cardiovascular malformations but it 
is probable that small muscular ventricular septal defects are even more common in 
utero than they are after live birth.  Although they are not easy to see with current 
imaging, more and more are being recognised and yet may well undergo 
spontaneous closure even before birth. 
 
Cardiovascular malformations in stillbirths 
Hoffman has highlighted the greatly increased prevalence of cardiovascular 
malformations in spontaneous abortions and stillbirths compared with live births. 
[Hoffman 1995]  There are significant and obvious difficulties with ascertainment of 
cardiovascular malformations in stillbirths and the reported prevalence varies very 
widely from 0.5 to 39.5% with a median of 7.9%.  Ascertainment varies with 
gestational age and with many other factors.  Exclusion of cardiovascular 
malformations in stillbirths underestimates their true “incidence” but variable 
inclusion precludes comparison between studies.   
  
Hoffman estimates that 25-30% of pregnancies of at least four weeks duration end 
in spontaneous abortion or stillbirth.  Early fetal losses have a very high proportion 
of chromosomal defects - around 40% before 28 weeks compared with 0.7% in live 
births.  Beyond 28 weeks, the percentage of chromosomal defects in stillbirths is 
lower, being around 7-16%. [Hoffman 1995]  These findings have significant 
implications for our understanding of the true prevalence or incidence of 
cardiovascular malformations.  Chromosomal defects are present in about 5% of live 
births with cardiovascular malformations but the overall prevalence of cardiovascular 
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 malformations in all chromosomal abnormalities is over 30%. [Pierpont 2007]  
However, it ranges from around 25% in Turner’s syndrome (monosomy X) to almost 
100% in trisomy 18 (Edward’s syndrome). [Pierpont 2007]  Thus exclusion of 
stillbirths will significantly underestimate the true incidence of cardiovascular 
malformations.   
  
The true prevalence of cardiovascular malformations in stillbirths is difficult to 
ascertain, partly because of problems with morphological and pathological 
examination which are likely to produce a bias towards more recognition of more 
major malformations.  Stillbirths have an increased prevalence of coarctation of the 
aorta and or more complex abnormalities such as double inlet left ventricle, 
hypoplastic left heart, truncus arteriosus, and atrioventricular septal defect. [Hoffman 
1995]  Hoffman has calculated the influence of stillbirths on the true incidence of 
cardiovascular malformations.  Modifying his calculations a little, in 100,000 
pregnancies of four weeks duration or more one might expect 25,000 early 
spontaneous abortions, 2000 still births, and 73,000 live births.  If the prevalence of 
cardiovascular malformations is 20%, 10% and 1% respectively, the true number of 
cardiovascular malformations is 5000 + 200 + 730 = 5930 or 6%.  It follows from this 
that only about 10 or 15% of all cardiovascular malformations reach live birth with 
the majority ending in death in early pregnancy, often associated with fatal 
chromosomal defects.  The implication of this that any study that includes a 
significantly high ascertainment of stillbirths will increase the number and skew the 
spectrum of reported cardiovascular malformations.  If cardiovascular malformations 
in spontaneous abortions and stillbirths are ignored, however, the significance of 
genetic, chromosomal and environmental influences will be greatly underestimated.  
 
Implications for future studies 
How is it best to deal with the data to get around these problems?  Future 
epidemiological studies should use a standard basic method: this should define a 
birth cohort; exclude or list separately stillbirths and terminations; exclude 
unconfirmed diagnoses; and define ascertainment, hierarchy, and diagnostic 
classification.  Findings in live births, stillbirths and terminations should be listed 
separately if available in the same study population.  Analysis of studies could group 
diagnoses into categories such as mild, moderate, and severe to increase numbers 
– although this obviously limits the detail available.  Comparison between studies 
might be best limited to analysis of marker malformations, i.e. those which cause no 
diagnostic confusion, are usually isolated (to avoid problems with hierarchy), and 
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 which are likely to survive to diagnosis.  The disadvantage of such a limitation is that 
one then cannot analyse any effects on the total number and spectrum of 
malformations.  It seems likely that genetic or environmental influences will affect 
specific malformations rather than the overall prevalence [Mone 2004, Jenkins 
2007]. 
 
5.9 CONCLUSIONS  
There is wide variation in the reported prevalence at live birth of all congenital 
cardiovascular malformations (2.0-30.0 per 1000 live births) and of individual 
malformations.  Comparisons between studies take little account of potential 
sources of bias – mostly ascertainment bias.  Specific malformations predicted to 
show least susceptibility to ascertainment bias show least variation in reported 
prevalence.  There is no good evidence of real differences in the prevalence of all or 
of individual malformations in different populations.  Future investigations should use 
a common method to allow comparisons between studies. 
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CHAPTER 6: FUTURE DIRECTIONS FOR EPIDEMIOLOGY STUDIES OF 
CARDIOVASCULAR MALFORMATIONS 
 
6.1 INTRODUCTION  
Epidemiological studies of cardiovascular malformations have many roles other than 
being simply descriptive, as discussed at length in section 1.2.  Measurement of the 
amount of disease in the population can be extended to measure the disease 
burden, such as the contribution to mortality, the demand for surgical and other 
treatments, and the implications for workforce planning.  Studies of survival rates 
can yield important information about predictions of survival into adult life and have 
predicted the linear growth of demand for adult congenital heart disease services. 
 
Changes likely to occur in the next few years will have an impact on the occurrence 
of cardiovascular malformations.  For example, the trend of increasing maternal age 
in the population is likely to increase the incidence of certain chromosomal 
anomalies (particularly Down syndrome) and their associated heart defects.  As 
discussed in section 5.8, increased prenatal detection followed by termination of 
pregnancy will reduce the apparent, though not the real incidence of cardiovascular 
malformations. 
 
Advances in our understanding of the causes of cardiac malformations have been 
limited to so far but identification of the genetic contribution to these malformations 
is likely to make significant progress in coming years.  Although environmental 
causes amenable to manipulation for primary prevention are likely to be few, there 
are intriguing results from some investigations of folic acid supplementation.  The 
contribution of epidemiological investigations to the study of cardiovascular 
malformations is discussed further below. 
 
6.2 THE IMPACT OF CARDIOVASCULAR MALFORMATIONS – THE DISEASE 
BURDEN  
Population prevalence of cardiovascular malformations  
The relative merits of the various terms used to measure the frequency of disease in 
a population were discussed in section 1.4.  Prevalence at live birth was preferred to 
describe the identification of new cases of malformation detected in infancy.  The 
simple term “prevalence” measures the total disease burden in a population at any 
given time.  Hoffman et al estimated the total prevalence of cardiovascular 
malformations by modelling the possible survival of individual malformations with 
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and without treatment over the period 1940-2002. [Hoffman 2004]  They thus 
produced high and low estimates and predicted the range of malformations to be 
found within the total population.  Rosamond et al, in the 2007 update of US Heart 
Disease and Stroke Statistics, assumed that the true prevalence is two thirds of the 
way between Hoffman’s estimated high and low ranges. [Rosamond 2007]  This 
leads to predictions that the total population prevalence of all cardiovascular 
malformations is 3.9‰ and of severe malformations 0.46‰.  These estimates 
exclude isolated bicuspid aortic valves, which alone are thought to affect 2% of the 
population (20‰). 
 
In a different prediction of disease prevalence, Marelli used a health care 
administration database in Montreal to determine the population prevalence of 
severe and other cardiovascular malformations in 1985, 1990, 1995 and 2000 in 
Quebec. [Marelli 2007]  The prevalence was 4.1‰ adults for all malformations and 
0.38‰ for severe malformations.  The prevalence increased over the time of the 
study and they found that 49% of all the malformations in the population were in 
adults by the year 2000.  Extrapolating this predication means that by now there are 
more adults than children with cardiovascular malformations. 
 
Table 6.1 summarises these findings and applies them to the UK, EU and US 
populations. 
 
Table 6.1: Estimates of population prevalence of cardiovascular 
malformations. 
 UK EU US 
2005 population 60,266,000 491,875,000 281,422,000 
2005 birth rate (per 1000 population) 12.0 10.4 14.1 
2005 births 723,000 5,134,000 3,940,000 
    
New cases of CVM (at 10 per 1000 l.b.) 7,000 51,000 39,000 
    
Hoffman        all CVM             3.9 235,000 1,919,000 1,110,000 
                      severe CVM     0.46 28,000 226,000 129,000 
    
Marelli            all CVM            4.1 247,000 2,017,000 1,154,000 
                       severe CVM    0.38 23,000 187,000 107,000 
CVM= cardiovascular malformation.  l.b. = live births 
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As can be seen, it is predicted that around 240,000 people are living in the UK with 
a cardiovascular malformation of some sort and 23-28,000 have a severe 
malformation.  Similar figures for the European Union predict that about 2,000,000 
people have a malformation and 200,000 of these a severe malformation. 
 
In our 2001 paper on the predicted need for adult follow up, we documented an 82% 
one year survival of all cardiovascular malformations in 1985-1994 and estimated a 
total survival to adult life from birth of 78% for diagnoses made in infancy. [Wren 
2001]  Adding post infant ascertainment (cases which, by definition, have survived 
infancy) there is an overall 84% survival to adult life.  Improvements in diagnosis 
and treatment since the late 1980s mean that survival to adult life for cardiovascular 
malformations overall is now probably nearer 90%.  Our 2001 paper also predicted 
that just over 2 patients per 1000 total population per year would graduate from the 
paediatric cardiology clinic to the adult congenital heart clinic needing specialist 
follow up.  These numbers are consistent with predictions made by Hoffman and 
Marelli as discussed above. 
 
The increasing number of children with heart defects who now survive into 
adolescence and adulthood underscores the need for the health care community to 
prepare for the challenging and often complex needs of adults with congenital heart 
defects.  The predicted number of patients graduating to adult follow up each year is 
relatively small compared with the number of adults with heart disease.  However, 
these patients, their families, and their cardiologists and surgeons have already 
invested greatly in time, effort, and resources.  Rapid recent advances have led to 
the emergence of adult congenital heart disease as a distinct subspecialty and it is 
important to be able to predict its future growth to ensure appropriate provision of 
medical manpower, facilities, and resources for the care of adults with congenital 
heart disease. 
 
Predicting and measuring surgical workload  
The US Heart Disease and Stroke Statistic 2007 Update by Rosamond et al used 
predictions from Moller to suggest that cardiovascular malformations needing 
surgery within the first year of life or causing death within the first year of life occur in 
2.3 per 1000 live births. [Rosamond 2007] [Moller 1998]  United Kingdom Central 
Cardiac Audit Database (UKCCAD) data for 2005-2006 showed that 2372 
operations were performed in infancy – 3.3 per 1000 live births (another 1612 
operations were done in childhood). [UKCCAD 2005]  These data are for surgical 
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operations and another 628 catheter interventions were performed in infancy.  Thus 
there were 3000 procedures in infancy in total (4.2 per 1000 live births).  There will 
have been more than one surgical or catheter intervention per patient in infancy (for 
instance, most babies with transposition of the great arteries will have a balloon 
atrial septostomy followed by an arterial switch operation) so the number of patients 
requiring cardiac intervention in the first year is probably around 3-3.5 per 1000 live 
births.  These data can be used to predict the surgical workload and show that 
around 2,200-2,500 infants per year will require intervention in the UK and 15,000-
18,000 within the EU.  The prediction for the US of 12,000-14,000 procedures is 
close to measured activity. [Rosamond 2007] 
 
6.3 MEASUREMENT OF OUTCOME  
Measurement of mortality  
As shown below there have been enormous improvements in outcome after cardiac 
surgery over the past 20 years.  Despite this mortality rates rather than survival 
rates are still used to assess outcome. [Ma 2007]  It is generally thought that a lower 
“operative” mortality is an indicator of better performance but this is not necessarily 
the case.  Comparison of variations in risk of paediatric cardiac surgery between 
institutions is complicated by the diverse nature and rarity of individual 
cardiovascular malformations, differing case-mix, and the current low operative risk.  
Analysis of results will be affected by data quality, different case-mix and chance.  
Data quality is dependent on dedicated personnel who must achieve and maintain 
data integrity, and the use of standard nomenclature and definitions. [Mavroudis 
2000]   Verification of data completeness is crucial because it has been previously 
shown that patients not included in medical audit have worse outcomes than those 
included. [Elfstrom 1996] 
 
As Williams has pointed out, the long term mortality after any cardiac surgery is 
100% - it is only the timing of death which is variable. [Williams 2005]  The 
traditional measurement of mortality has been either mortality within 30 days from a 
procedure, or mortality during the same hospital stay.  Both have been used to 
measure surgical mortality, even in contemporaneous reports from the same 
surgical centre. [Bull 2000, van Doorn 2000, de Leval 2000, Stark 2001]  The 
situation becomes complicated in patients undergoing multiple procedures or those 
transferred between hospitals.  New guidelines have recently been published by an 
international taskforce [Jacobs 2006] and reviewed by Bill Williams from Toronto 
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[Williams 2006].  Whatever the guidelines and the definitions involved, nothing can 
detract from the importance of the accuracy, validity and completeness of the data. 
 
The first 30 postoperative days or the same hospital admission have been used as 
points at which to measure mortality mainly for convenience.  However, the risk of 
death continues beyond these points, even though it is then lower.  In the UK every 
child’s record in the Central Cardiac Audit Database (UKCCAD) is linked to the 
Office for National Statistics to provide an outcome (alive or dead) one year after the 
operation.  Access to central tracking of mortality identified errors in institutional data 
and provided a more complete assessment of institutional performance without the 
limits imposed by the arbitrary 30-day or in-hospital limit. [Gibbs 2004]  Central 
tracking of 5494 paediatric cardiac procedures in the UK identified 469 deaths within 
one year, including 194 within the first 30 days.  Contributing hospitals had identified 
only 78% of the deaths within 30 days.  Furthermore, institutional records for 30 day 
mortality accounted for only 32% of all deaths within 1 year.  These data further 
support the concept that the early hazard of death extends well beyond the initial 30 
day period.  It is also worth pointing out that mortality may be nothing to do with the 
operation and the later the death, the lower the chance that it is related to the 
surgery or even to the heart problem.  One of the operations with the highest late 
mortality in the UKCCAD data was ligation of patent ductus in prematurity – a 
relatively minor procedure.  Late mortality here almost certainly reflects the risk of 
preterm birth rather than the risk of surgery. 
 
Trends in mortality  
Mortality associated with cardiovascular malformations has been assessed in 
several studies although most concentrate only on surgical or postoperative 
mortality. [Ma 2007]  Boneva analysed death certificate data to investigate trends in 
mortality associated with cardiovascular malformations in the United States in 1979-
1997. [Boneva 2001]  During that time mortality decreased from 2.5 to 1.5 per 
100,000
 
persons in the whole population.  Mortality in infancy declined by 39% 
although in 1995-1997, 51% of all deaths still occurred in infancy.  The median age 
at death increased from 6 to 12 months during the study period, suggesting an 
overall increase in survival.  In Western populations it is estimated that 44% of all 
deaths from malformations are due to cardiovascular malformations [Botto 2003a] 
and that cardiovascular malformations cause around 10% of all infant deaths 
[Rosano 2000]. 
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Figure 6.1 shows the 30-day postoperative mortality data from our own unit in 
Newcastle upon Tyne.  Outcome data have been collected and validated since 
1989.  Validated national data have been collected since 2000 but so far have been 
published in a format to allow comparison with our own only for 2000 and 2001.  The 














































Figure 6.1. Trends in postoperative mortality in Freeman Hospital, Newcastle upon Tyne (FH) for 
1985-2005 compared with data from the United Kingdom Central Cardiac Audit Database 
(UKCCAD) for 2000-2001, the only two years for which validated outcomes are available. 
 
The contribution of individual malformations to total mortality can be derived from 
published data. [Boneva 2001]  Figure 6.2, adapted from Botto [2003a], shows that 
in the United States hypoplastic left heart made the highest individual contribution to 
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Figure 6.2. The contribution of individual diagnoses to infant mortality.  Redrawn from data in 
Boneva 2001.  AV = atrioventricular 
 
Figure 6.3 shows our own data, calculated from infant survival in our study of 
predictions of the need for adult congenital heart disease follow up. [Wren 2001] 
 
Figure 6.3. The contribution of individual diagnoses to infant mortality. 
Calculated from data in Wren 2001. 
 
A different picture emerges, with ventricular septal defect making the largest 
contribution to infant deaths.  The discrepancy between these two findings is 
explained by the fact that the American study investigated the cause of death 
whereas we looked at death or survival in infants with a malformation.  Most of the  
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deaths in infants with ventricular septal defects were not caused by the malformation 
but represent the total mortality in patients who have associated severe non-cardiac 
malformations or chromosomal and genetic problems such as fatal trisomy.  This 
also explains the high mortality associated with (but not caused by) atrial septal 
defect in our data.  Data from Boneva show that at least 24% of deaths in persons 
with a cardiovascular malformation are not caused by the malformation and this 
proportion is very probably higher in infancy. [Boneva 2001] 
 
Our own data were collected in 1985-1994. [Wren 2001]  The perioperative mortality 
has declined very significantly since then although we have not yet analysed up to 
date data on total mortality.  As seen in section 4.11, our study of life-threatening 
cardiovascular malformations showed a fall in mortality from around 50% to around 
20% in the years 1985-2004. [Wren 2008]  Most of the decline in mortality will have 
come in improved treatment of common malformations such as transposition of the 
great arteries, tetralogy of Fallot, and atrioventricular septal defect, all of which 
currently have a surgical mortality of around 1%.  This means that hypoplastic left 
heart and other severe malformations now make a more significant proportional 
contribution to total mortality than that shown in figures 6.1 and 6.2. 
 
Remaining surgical challenges  
The perioperative mortality for many cardiovascular malformations is now so low 
that survival is expected in all.  The mortality risk of correction of common major 
malformations such as ventricular septal defect, transposition of the great arteries, 
tetralogy of Fallot, coarctation of the aorta and complete atrioventricular septal 
defect, most of which were universally fatal in the pre-surgical era, is now <2%.  The 
cumulative surgical mortality of staged surgical procedures for complex 
malformations with “single ventricle” physiology, such as tricuspid atresia, double 
inlet left ventricle etc, is well under 10%.  Because of this increasing surgical 
success, attention is switching to areas that continue to present a challenge, 
particularly management of hypoplastic left heart, complex pulmonary atresia, and 
failing ventricular function late after previous palliation.  More resources will need to 
be devoted to medical and surgical management of adolescents and young adults 
requiring repeat surgery or, in some cases, transplantation.  Accurate validated data 
relating to the occurrence of, survival with, and results of, surgical repair of 
cardiovascular malformations are vital if improvements in management are to be 
maintained and the validity of developments in management strategies is to be 
proven. 
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Measuring morbidity and disability  
If defining and measuring mortality are difficult, the challenges in assessing 
morbidity are even greater and have so far proved insuperable.  The UKCCAD has 
recently been considering how to tackle the problem but no proposals for collecting 
and validating data have yet been agreed.  Cardiac surgery and interventional 
cardiac catheterisation procedures are very invasive and have the potential to do 
harm.  They are often performed in ill patients with multiple other problems and any 
late effects may be subtle – such as the potential influence on IQ or development 
and behaviour.  The complexities of these problems are beyond the scope of this 




Reports of high mortality from paediatric cardiac surgery at Bristol Royal Infirmary 
led to the establishment of an independent public inquiry. [Bristol Royal Infirmary 
Inquiry 2001]  One of the key terms of reference was whether or not the mortality of 
children receiving complex cardiac surgical services at the Bristol Royal Infirmary 
was unusual compared with other specialist centres. 
 
A retrospective comparison of UK paediatric cardiac surgical performance was 
reported by the team which had analysed the data for the Bristol Inquiry. [Aylin 
2001]  The report concluded that: 
“Bristol was an outlier, and we do not believe that statistical variation, 
systematic bias in data collection, case-mix, or data quality can explain a 
divergence in performance of this size.” 
 
Amongst the Bristol Inquiry’s conclusions was the following: 
“Bristol was awash with data.  There was enough information from the late 
1980s onwards to cause questions about mortality rates to be raised both in 
Bristol and elsewhere had the mindset to do so existed.  Little, if any, of this 
information was available to the parents or to the public.  Such information 
as was given to parents was often partial, confusing and unclear.  For the 
future, there must be openness about clinical performance.  Patients should 
be able to gain access to information about the relative performance of a 
hospital, or a particular service or consultant unit.” 
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Subsequent analysis based on hospital episode statistics confirmed the 
interpretation of the data relating to Bristol, showed that performance had improved 
after changes in management and personnel, and highlighted concern about 
performance in Oxford. [Aylin 2004]  Analysis of hospital episode statistics may be 
misleading [Singleton 2007] and a further analysis of data from Oxford in the UK 
Central Cardiac Audit Database (UKCCAD) has reached different conclusions 
[Westaby 2007].  Earlier allegations of problems at Harefield Hospital and Brompton 
Hospital were also the subject of an investigation which found that in some areas 
mortality was higher than average. [Wise 2001]  For example, in 1991-1995 there 
was strong evidence of excess mortality for open heart surgery in children aged over 
1 year.  Fontan procedures were associated with a high mortality and there was 
another run of poor performance in 1995-1999, when there were identifiable areas 
of higher mortality in infants, particularly for repair of tetralogy of Fallot.  The report 
concluded: 
 “… the two available national sources on clinical outcomes - hospital 
episodes statistics and the cardiac surgical register - are inadequate in 
providing accurate, reliable, verified, comparative data that are 
understandable and usable”. 
 
All these problems mean that the importance of collecting complete and accurate 
data and subjecting them to appropriate analysis to enable publication of 
appropriate indicators of performance assessment is now widely recognised.  For 
many reasons it would be helpful to compare the performance of individual units and 
of individual surgeons doing individual operations.  This would provide choice for 
cardiologists and parents and would also identify substandard results to allow an 
early corrective process such as retraining, reallocation etc.  However, there are 
many pitfalls.  The first, and perhaps the most important, is concern over the 
integrity, validity and completeness of data.  This depends fundamentally on the 
accuracy of coding of diagnoses, operation and risk factors.  The second difficulty is 
in measuring outcome.  As discussed above, even mortality can be difficult to define 
and assessment of morbidity (which may be more important now that mortality is so 
low) is very difficult.  Another major problem is accounting for variations in case-mix.  
A surgeon who limits himself to simpler “lower risk” operations would be expected to 
have better results.  If no allocation is made for case-mix, publication of unadjusted 
results may deter surgeons from taking on more complex or more difficult cases. 
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Two risk-adjustment systems have been introduced in an attempt to measure 
performance in paediatric cardiac surgery.  The first, the Risk Adjustment In 
Congenital Heart Surgery (RACHS-1) system, was developed in Boston. [Jenkins 
2002]  RACHS-1 was developed in 1993-1995 and stratified congenital cardiac 
operations into one of six categories developed by consensus by a panel of experts.  
The risk category of some procedures also varied with patient age. RACHS-1 has 
been validated and found to have good predictive value. [Boethig 2004, Larsen 
2005].  The other system, the Aristotle Basic Complexity score was devised by a 
panel of experts from fifty centres in 23 countries. [Lacour-Gayet 2004]  It allocated 
up to five points each for the potential for mortality, potential for morbidity, and 
technical difficulty to devise a continuous score with a range of 1.5 – 15.  The score 
then grouped procedures into four levels, depending on complexity.  The Aristotle 
System also defined complexity as the sum of mortality, morbidity and technical 
difficulty and performance as the product of complexity and survival. 
 
Two attempts have been made to compare these two systems.  Al-Radi et al, in a 
combined report from Toronto, Tennessee and Florida found that 96% of operations 
could be given an Aristotle Score and 84% a RACHS-1 score. [Al-Radi 2007]  They 
concluded that both systems are useful but that the RACHS-1 gave a better 
prediction of mortality and length of hospital stay.  Kang et al also compared the two 
systems in a retrospective analysis of 1058 operations at Great Ormond Street 
Hospital. [Kang 2006]  They found that 99.4% of operations could be scored using 
the Aristotle Basic score and 92% using RACHS-1.  They concluded that the 
Aristotle score was only weakly associated with postoperative mortality whereas 
RACHS-1 was a powerful predictor of mortality.  They speculated that their analysis 
might have been affected by the relatively high overall complexity in their practice.  
There are efforts being made to combine the two systems to produce an improved 
mortality score based on outcome data from the European Association of 
Cardiothoracic Surgeons (EACTS) and the US Society of Thoracic Surgeons (STS) 
databases. [Lacour-Gayet 2006]. 
 
In a comment on the Al-Radi report, Marc de Leval said that if the aim is to be able 
to compare performance of individuals or institutions it is important that patient-
specific and procedure-specific factors should not overwhelm potential institution-
specific or surgeon-specific factors. [Al-Radi 2007]  He went on to say it would be 
better to try to understand the reasons for variability between institutions which 
would not be explained by minutely detailed analysis of case-mix.  Dr de Leval had 
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previously encountered a problem with his own performance of arterial switch 
operations at Great Ormond Street. [de Leval 1997]  The run of poor performance 
was eventually recognised and remedial action was taken but not before there had 
been an excess number of deaths.  de Leval and his team developed the concept of 
analysis of “near-misses” and “human factors” to improve the sensitivity of early 
warning analysis of surgical and institutional performance. [de Leval 2000] 
 
A further problem with performance analysis is that some operations, for example 
the arterial switch operation, are very operator-specific, whereas others, such as 
repair of complete atrioventricular defect, are more dependent on the performance 
of the whole team which includes cardiac anaesthetists, intensivists etc. 
 
Performance analysis is here to stay. The ideal method of data collection, data 
validation, and data interpretation has not been developed.  Similarly the ideal 
method of publishing and displaying information derived from analysis is yet to be 
defined.  What is clear is that collection of accurate data and continuing analysis of 
performance is now an accepted part of routine clinical practice. [Keogh 2005] 
 
6.4 AETIOLOGY OF CARDIOVASCULAR MALFORMATIONS  
Every malformation presumably has a cause although most have not yet been 
identified.  Even when a “cause” seems obvious, for instance in atrioventricular 
septal defect or other malformation in Down’s syndrome, the precise mechanism 
usually remains obscure.  Over the past few years, there have been major 
developments in our understanding of inherited causes of congenital cardiovascular 
malformations, including the identification of specific genetic abnormalities for some 
types of malformations.  Although relatively less information has been available on 
non-inherited modifiable factors that may have an adverse effect on the fetal heart, 
there is a growing body of epidemiological literature on this topic. 
 
Environmental causes and opportunities for prevention  
Although the expression ‘‘environmental cause’’ suggests toxic pollution from a 
landfill site or traffic, it refers more broadly to any factor which is not genetic.  Most 
of the environmental causes of cardiovascular malformations occur within the fetal-
placental-maternal ‘‘environment.’’ 
 
Jenkins et al recently published an extensive review of evidence of non-inherited 
risk factors which may affect the occurrence of cardiovascular malformations. 
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[Jenkins 2007]  Factors associated with increase risk include maternal illness and 
infection, maternal nutritional excesses and deficiencies, maternal drug exposure, 
and other environmental exposure and are summarised in table 7.2.  Avoidance of 
such factors may reduce the risk.  Progress in prevention of cardiovascular 
malformations has been hampered by a lack of information about modifiable risk 
factors for abnormalities in cardiac development.  The proportion of cases that are 
potentially preventable through changes in the fetal environment is unknown.  One 
study suggests that the fraction of cases attributable to identifiable and potentially 
modifiable factors may be as high as 30% for some types of defects. [Wilson 1998] 
 
Table 6.2 Exposures associated with definite or possible increased risk of 
offspring with cardiovascular malformations. 
 
 












Maternal environmental exposure 
 



















Although a case-control study is an appropriate model for investigation of 
associations between multiple risk factors, it is open to many types of bias.  To give 
only a few examples, the Baltimore Washington Infant Study reported significant 
associations between transposition of the great arteries and paternal marijuana use 
or maternal influenza; between tetralogy of Fallot and paternal anaesthesia; 
between atrioventricular septal defect in Down’s syndrome and paternal welding or 
ibuprofen; and between hypoplastic left heart and paternal exposure to degreasing 
agents etc. [Ferencz 1993]  To some observers it may not be biologically plausible 
that there is such a wide variety of “causative” associations.  It is possible, however, 
that there is variable genetic susceptibility to environmental influences.  
Unfortunately other investigations of possible environmental “causes” or 
associations come up with different findings. [Jenkins 2007]. 
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Folic acid supplementation  
There is good evidence that maternal use of multivitamin supplements containing 
folic acid, or folic acid alone, is associated with a reduction in occurrence of neural 
tube defects.  Factors known to, or suspected of being able to reduce the 
occurrence of cardiovascular malformations are few.  One intriguing recent 
discovery is the possibility that periconceptional intake of multivitamin supplements 
containing folic acid might reduce the risk of cardiovascular malformations in 
offspring, similar to the proven risk reduction for neural tube defects.  This first came 
to light after analysis of data from a Hungarian randomized trial on birth defects. 
[Czeizel 1998]  Findings from subsequent case-control studies offer some support to 
the findings but are certainly not conclusive [Scanlon 1998], while others have failed 
to show any benefit [Werler 1999, Botto 2004]. 
 
In addition to these reports investigating the association between multivitamin use 
and risk reduction for cardiovascular malformations, other studies have shown that 
women who took folic acid antagonist medications, such as dihydrofolate reductase 
inhibitors (eg trimethoprim) or antiepileptic drugs, had an increased risk of offspring 
with cardiovascular malformations.  In the same studies this risk was reduced for 
women who also took multivitamin supplements containing folic acid. [Hernandez-
Diaz 2000, Czeizel 2001] 
 
The findings of a possible protective effect for cardiovascular malformations from 
multivitamin supplements containing folic acid are interesting but inconclusive.  
Associations between environmental factors and cardiovascular malformations may 
be causal, but they may also be a result of chance, bias, or confounding.  An 
exploratory study can produce an association as a result of multiple comparisons.  
Confounding is also a concern in that the apparent protective effect of multivitamin 
supplement use might be due not to the use itself but to the behaviour of the user.  
Given the large number of studies of folic acid supplementation related to risk 
reduction for neural tube defects, it is surprising that, if the association were real, 
more evidence has not come to light before now.  Additional studies may be 
warranted to determine whether the association of specific phenotypes with 
multivitamins can be corroborated.  Large population-based studies would be 
needed in which multivitamin intake can be validated, potential confounders such as 
maternal age and diabetes can be taken into account, and the components of the 
supplements responsible for the association can be identified. 
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Genetic causes of cardiovascular malformations  
Previous investigations have shown that cardiovascular malformations are 
associated with non-cardiac malformations in about 25% of individuals, about one 
third of whom have a recognizable syndrome. [Ferencz 1993, Pierpont 2007]  In one 
report on patients undergoing an interventional procedure or cardiac surgery, a 
syndrome was identified in 39% [Rope 2004].  Population-based studies have 
reported chromosome abnormalities in approximately 13% of newborns with 
cardiovascular malformations. [Ferencz 1993]  The autosomal trisomies (of 
chromosomes 21, 18, and 13) have long been recognized as having a causative 
association with cardiovascular malformations.  More recently chromosome 22q11 
microdeletion has also been identified as a chromosome cause of cardiovascular 
malformation. [Botto 2003b] 
 
Nora first proposed the “multifactorial” model in 1968 to explain the aetiology of 
isolated cardiovascular malformations in which several genetic loci interact together, 
with or without environmental factors. [Nora 1968]  The overall recurrence risk was 
quoted as 2-4%.  Since then, however, many studies have produced data that do 
not seem to fit a polygenic or multifactorial model. [Burn 1987] 
 
Further support for the more widespread influence of genetic factors in the aetiology 
of cardiovascular malformations comes from studies of recurrence risk.  The 
occurrence of malformations among first-degree relatives of a proband with a 
cardiovascular malformation varies depending on the relationship.  John Burn, 
professor of clinical genetics at Newcastle University, with colleagues from around 
the UK, studied the offspring of adults who survived surgery for selected major 
cardiovascular malformations – abnormalities of situs, abnormalities of 
atrioventricular or ventriculoarterial connection, anomalous pulmonary venous 
connection, atrioventricular septal defect, or tetralogy of Fallot. [Burn 1998]  He 
found that recurrence among offspring (4.1%) was significantly greater than among 
siblings (2.1%) and that recurrence in the offspring of affected mothers (5.7%) was 
higher than in those with affected fathers (2.2%).  The reasons for this maternal 
excess are not clear although several theories have been proposed. [Burn 1998] 
 
A study from Guy’s Hospital, the United Kingdom’s largest fetal cardiology unit, 
examined the recurrence risk of cardiovascular malformations using fetal 
echocardiography in 6640 consecutive pregnancies where a first-degree relative 
had a cardiovascular malformation. [Gill 2003]  The recurrence rate for 
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cardiovascular malformations overall was 2.7%, with a high concordance for the 
specific type of malformation (37%), or for malformation of the same group (44%). In 
families with two or more recurrences, the concordance rate was higher still (55%).  
While the concordance rates of the various cardiovascular malformations varied, two 
specific types of malformations, isolated atrioventricular septal defect and laterality 
defects, showed the highest concordance at 80% and 64%, respectively. 
 
The Baltimore-Washington Infant Study also provided information on the heritability 
of cardiovascular malformations, weakening support for the multifactorial model and 
suggesting a substantial genetic component in the aetiology of some groups of 
cardiovascular malformations. [Boughman 1987]  As an example, although the 
overall frequency of having a previous sibling with a cardiovascular malformation 
(precurrence risk) was 3.1%, the rate was higher when the proband had either 
hypoplastic left heart (8.0%) or coarctation of the aorta (6.3%).  The familial 
aggregation of obstructive left-sided malformations has been examined in studies 
including echocardiograms on first-degree relatives. [Loffredo 2004] 
 
Recent research has shown that variations or alterations in genes contribute to the 
origin of cardiovascular malformations to a greater degree than was previously 
suspected.  Further developments are likely to lead to greater understanding of the 
causes and implications of these defects. 
 
6.5 CONCLUSIONS  
Cardiovascular malformations are the commonest congenital malformations and are 
important because of their frequency and severity and because of the burden they 
impose on medical resources and on families.  From the epidemiological point of 
view, research priorities include monitoring of the prevalence at live birth to detect 
trends which might indicate changes in, or introduction of, risk factors in the 
population.  Monitoring of outcome, including measurement of mortality and 
morbidity, is equally important to predict requirements for medical and surgical care 
and the wider effects on malformations in the population.  If confirmed, newer 
evidence, including the increasing evidence of a possible protective effect of 
maternal multivitamin supplements containing folic acid may lead to opportunities for 
primary prevention. 
                C Wren 2008                                      Page 140
REFERENCES 
 
Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised heart disease. 
Arch Dis Child 1994;71:3-7. 
 
Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C. Presentation of obstructive left 
heart malformations in infancy. Arch Dis Child 1994;71:F179-F183. 
 
Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C. Antenatal diagnosis of 
congenital heart disease and Down’s syndrome: the potential effect on the practice 
of paediatric cardiology. Br Heart J 1995;71:192-8. 
 
Abushaban L, Al-Hay A, Uthaman B, Salama A, Selvan J.  Impact of the Gulf war on 
congenital heart diseases in Kuwait.  Int J Cardiol 2004:93:157-62. 
 
Acharya G, Sitras V, Maltau JM, Dahl LB, Kaaresen PI, Hanssen TA, Lunde P. 
Major congenital heart disease in Northern Norway: shortcomings of pre- and 
postnatal diagnosis. Acta Obstet Gynecol Scand 2004;83:1124-9. 
 
Adams MM, Mulinare J, Dooley K.  Risk factors for conotruncal cardiac defects in 
Atlanta. J Am Coll Cardiol 1989;14:432-42. 
 
Allan L. Antenatal diagnosis of heart disease. Heart 2000;83:367-70. 
 
Al-Radi OO, Harrell FE Jr, Caldarone CA, McCrindle BW, Jacobs JP, Williams MG, 
Van Arsdell GS, Williams WG. Case complexity scores in congenital heart surgery: 
a comparative study of the Aristotle Basic Complexity score and the Risk 
Adjustment in Congenital Heart Surgery (RACHS-1) system. J Thorac Cardiovasc 
Surg 2007;133:865-75. 
 
Andersen S, Vik T, Linker DT. Medfødte jhertefeil i Sør-Trøndelag. Insidens, 
diagnostikk, forl Sør-Trøndelagp og behandling. (Congenital heart diseases in Sør-
Trøndelag. Incidence, diagnosis, course and treatment.) Tidsskr Nor Laegeforen 
1994;114:29-32. 
 
               C Wren 2008 Page 141
Anderson RH.  Terminology.  In Anderson RH, Baker, EJ, Macartney FJ, Rigby ML, 
Shinbourne EA, Tynan M, editors.  Paediatric Cardiology 2nd edition. 2002 Churchill 
Livingstone. London 19-36. 
 
Arbour L, Gilpin C, Millor-Roy V, Platt R, Pekeles G, Egeland GM, Hodgins S, 
Eydoux P.  Heart defects and other malformations in the Inuit in Canada: a baseline 
study.  Int J Circumpolar Health 2004;63:251-66. 
 
Aylin P, Alves B, Best N, Cook A, Elliott P, Evans S, Lawrence A, Murray G, Pollock 
J, Spiegelhalter D. Comparison of UK paediatric cardiac surgical performance by 
analysis of routinely collected data 1984–96: was Bristol an outlier? Lancet 
2001;358:181-7. 
 
Aylin P, Bottle A, Jarman B, Elliott P.  Paediatric cardiac surgical mortality in 
England after Bristol: descriptive analysis of hospital episode statistics 1991-2002.  
BMJ 2004;329:825-9. 
 
Bailey LL, Gundry SR, Razzouk AJ, Wang N, Sciolaro CM, Chiavarelli M. Bless the 
babies: one hundred fifteen late survivors of heart transplantation during the first 
year of life. The Loma Linda University Pediatric Heart Transplant Group. J Thorac 
Cardiovasc Surg 1993;105:805-14. 
 
Becker SM, Halees ZA, Molina C, Paterson RM. Consanguinity and congenital heart 
disease in Saudi Arabia. Am J Med Gen 2001;99:8-13. 
 
Bell R, Glinianaia SV, Rankin J, Wright C, Pearce MS, Parker L. Changing patterns 
of perinatal death, 1982-2000: a retrospective cohort study.  Arch Dis Child 
2004;89:F531-F536. 
 
Boethig D, Jenkins KJ, Hecker H, Thies WR, Breymann T. The RACHS-1 risk 
categories reflect mortality and length of hospital stay in a large German pediatric 
cardiac surgery population. Eur J Cardiothorac Surg 2004;26:12-7. 
 
Bolisetty S, Daftary A, Ewald D, Knight B, Wheaton G. Congenital heart defects in 
Central Australia. Med J Aust 2004;180:614-7. 
 
               C Wren 2008 Page 142
Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality 
associated with congenital heart defects in the United States: trends and racial 
disparities, 1979-1997. Circulation 2001;103:2376-81. 
 
Borman B, Chapman C, Howard K, Buckfield P, Findlay J. Using a national register 
for the epidemiological study of congenital heart defects. New Zealand Med J 
1987;100:404-6. 
 
Bosi G, Scorrano M, Tosato G, Forini E, Chakrokh R. The Italian multicentric study 
on epidemiology of congenital heart disease: first step of the analysis. Working Party 
of the Italian Society of Pediatric Cardiology. Cardiol Young 1999;9:291-9. 
 
Bosi G, Garani G, Scorrano M, Calzolari E. Temporal variability in birth prevalence 
of congenital heart defects as recorded by a general birth defects registry. J Pediatr 
2003;142:690-8. 
 
Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of 
heart defects. Pediatrics 2001;107:E32. 
 
Botto LD, Correa A. Decreasing the burden of congenital heart anomalies: an 
epidemiologic evaluation of risk factors and survival.  Prog Pediatr Cardiol 
2003;18:111-21. 
 
Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, 
O'Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM. A population-based 
study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth 
defects in the population. Pediatrics 2003;112:101-7. 
 
Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital 
anomalies other than neural tube defects. Am J Med Genet 2004;125C:12-21. 
Boughman JA, Berg KA, Astemborski JA, Clark EB, McCarter RJ, Rubin JD, 
Ferencz C, Opitz JM, Reynolds JF. Familial risks of congenital heart defect 
assessed in a population-based  epidemiologic study. Am J Med Genet 
1987;26:839-49. 
 
               C Wren 2008 Page 143
Boyd PA, Armstrong B, Dolk H, Botting B, Pattenden S, Abramsky L, Rankin J, 
Vrijheid M, Wellesly D.  Congenital anomaly surveillance in England – ascertainment 
deficiencies in the national system.  BMJ 2005;330:27-30. 
 
BRI Inquiry Panel. Learning from Bristol: the report of the public inquiry into 
children's heart surgery at the Bristol Royal Infirmary 1984-1995.  London: 
Department of Health, 2001. 
 
Bristol Royal Infirmary Inquiry 2001. www.bristol-inquiry.org.uk/ 
 
Brown MD, Wernovsky G, Mussatto KA, Berger S. Long-term and developmental 
outcomes of children with complex congenital heart disease. Clin Perinatol 
2005;3:1043-57. 
 
Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum 
of serious congenital heart disease at term in the UK. Lancet 1999;354:1242-7. 
 
Bull C, Yates R, Sarkar D, Deanfield J, de Leval M.  Scientific, ethical and logistical 
considerations in introducing a new operation: a retrospective cohort study from 
paediatric cardiac surgery.  BMJ 2000;320:1168-73. 
 
Burn J. The aetiology of congenital disease. In: Anderson RH, Macartney FI, 
Shinebourne EA, Tynan M, eds. Paediatric cardiology. Edinburgh: Churchill 
Livingstone, 1987:15-63. 
 
Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, Dennis NR, Allan L, 
Arnold R, Deanfield JE, Godman M, Houston A, Keeton B, Oakley C, Scott O, Silove 
E, Wilkinson J, Pembrey M, Hunter AS. Recurrence risks in offspring of adults with 
major heart defects: results from first cohort of British collaborative study. Lancet 
1998;351:311-6. 
 
Carter CO. Recurrence risk of common congenital malformations. Practitioner 
1974;213:667-74. 
 
Chehab G, Bittar Z.  Cumulative incidence and distribution of congenital heart 
diseases in newborns in Beirut and its southern suburb (1999-2002).  J Med Liban 
2004;52:121-5. 
               C Wren 2008 Page 144
Chehab G, Chedid P, Saliba Z Bouganet P. Congenital heart disease and 
inbreeding: specific defects escape higher risk due to parental consanguinity. 
Cardiol Young 2007;17:414-22. 
 
Cleves MA, Ghaffar S, Zhao W, Mosley BS, Hobbs CA.  First-year survival of infants 
born with congenital heart defects in Arkansas (1993-1998): A survival analysis 
using registry data. Birth Defects Res A Clin Mol Teratol 2003;67:662-8. 
 
Cloarec S, Magontier N, Vaillant MC, Paillet C, Chantepie A. Prevalence and 
distribution of congenital heart diseases in Indre-et-Loire. Evaluation of prenatal 
diagnosis (1991-1994). Arch Pediatr 1999;6:1059-65. 
 
Cragan JD, Khoury MJ. Effect of prenatal diagnosis on epidemiologic studies of birth 
defects.  Epidemiology 2000;11:695-9. 
 
CRD 2001. Centre for Reviews and Dissemination. Undertaking systematic reviews 
of research on effectiveness: CRD's guidance for those carrying out or 
commissioning reviews. CRD Report 4 (2nd edition) March 2001. available from: 
http://www.york.ac.uk/inst/crd/report4.htm 
 
Czeizel E, Kamaras J, Balogh O, Szentpeteri J. The incidence of congenital heart 
defects in Budapest. Orv Hetil 1972;113:1899-902. 
 
Czeizel AE. Periconceptional folic acid containing multivitamin supplementation. Eur 
J Obstet Gynecol Reprod Biol 1998;78:151-61. 
 
Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. The teratogenic risk of 
trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 
2001;15:637-46. 
 
Daniels SR. Epidemiology. In Long WA, ed. Fetal and Neonatal Cardiology.1990.  
WB Saunders Co. Philadelphia. 425-38. 
 
de Leval MR. Human factors and surgical outcomes: a Cartesian dream. Lancet 
1997;349:723-5. 
 
               C Wren 2008 Page 145
de Leval MR, Carthey J, Wright DJ, Farewell VT, Reason JT.  Human factors and 
cardiac surgery: a multicenter study.  J Thorac Cardiovasc Surg 2000;119:661-72. 
 
Du ZD, Roguin N, Barak M, Bihari SG, Ben-Elisha M. High prevalence of muscular 
ventricular septal defect in preterm neonates. Am J Cardiol 1996;78:1183-5. 
 
Du ZD, Roguin N, Wu XJ. Spontaneous closure of muscular ventricular septal defect 
identified by echocardiography in neonates. Cardiol Young 1998;8:500-5. 
 
Egger M, Jüni P, Bartlett C, Holenstein F, Sterne J. How important are 
comprehensive literature searches and the assessment of trial quality in systematic 
reviews? Empirical study. Health Technol Assess 2003;7(1). 
 
Elfstrom J, Stubberod A, Troeng T. Patients not included in medical audit have a 
worse outcome than those included. Int J Qual Health Care 1996;8:153-7. 
 
Embleton ND, Wyllie JP, Wright MJ, Burn J, Hunter S. Natural history of trisomy 18. 
Arch Dis Child 1996;75:F38-F41. 
 
Ferencz C, Neill CA, Boughman JA, Rubin JD, Brenner JI, Perry LW. Congenital 
cardiovascular malformations associated with chromosome abnormalities: an 
epidemiologic study. J Pediatr 1989;114:79-86. 
 
Ferencz C, Czeizel A, Lys A. The problem of comparative analysis of birth 
prevalence of congenital cardiovascular malformations. Acta Paediatr Hung 
1990;30:169-89. 
 
Ferencz C. On the birth prevalence of congenital heart disease. J Am Coll Cardiol 
1990;16:1701-2. 
 
Ferencz C, Neill CA. Cardiovascular malformations: prevalence at livebirth. In 
Freedom RM, Benson LN, Smallhorn JF eds. Neonatal Heart Disease. London: 
Springer-Verlag 1992:19-29. 
 
Ferencz C, Rubin JD, Loffredo CA, Magee CA, eds. Epidemiology of congenital 
heart disease. The Baltimore Washington infant study: Perspectives in pediatric 
cardiology, vol 4. Futura Publishing Co., Mount Kisco, 1993. 
               C Wren 2008 Page 146
Fesslova V, Nava S, Villa L. Evolution and long term outcome in cases with fetal 
diagnosis of congenital heart disease: Italian multicentre study. Heart 1999;82:594-
9. 
 
Forrester MB, Merz RD.  Descriptive epidemiology of selected congenital heart 
defects, Hawaii, 1986-1999.  Paediatr Perinat Epidemiol 2004;18:415-24. 
 
Franklin RC, Beland MJ, Krogmann ON.  Mapping and coding of nomenclatures for 
paediatric and congenital heart disease.  Cardiol Young 2006;16:105-6. 
 
Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, 
Benjamin EJ.  Prevalence and clinical outcome of mitral valve prolapse.  N Engl J 
Med 1999;341:1-7. 
 
Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, Lehman B, 
Levine RA.  Mitral valve prolapse in the general population: the benign nature of 
echocardiographic features in the Framingham Heart Study.  J Am Coll Cardiol 
2002;40:1298-304. 
 
Fyler DC. Report of the New England Regional Infant Cardiac Program. Pediatrics 
1980;65(suppl):377-461. 
 
Gardiner HM. Fetal echocardiography: 20 years of progress. Heart 2001;86:12-22. 
 
Garne E.  Congenital heart defects -- occurrence, surgery and prognosis in a Danish 
county. Scand Cardiovasc J 2004;38:357-62. 
 
Gibbs JL, Monro JL, Cunningham D, Rickards A. Survival after surgery or 
therapeutic catheterization for congenital heart disease in children in the UK: 
analysis of the central audit database for 2000-1. BMJ 2004;328:611-5. 
 
Gielen H Daniels O, van Lier H.  Natural history of congenital pulmonary valvar 
stenosis: an echo and Doppler cardiographic study.  Cardiol Young 1999;9:129-35. 
 
Gill JK, Splitt M, Sharland GK, Simpson JM. Patterns of recurrence of congenital 
heart disease. An analysis of 6,640 consecutive pregnancies evaluated by detailed 
fetal echocardiography. J Am Coll Cardiol 2003;42:923-9. 
               C Wren 2008 Page 147
Gillum RF. Epidemiology of congenital heart disease in the United States. Am Heart 
J 1994;127:919-27. 
 
Goldberg SJ, Lebowitz MD, Graver EJ, Hicks S. An association of human congenital 
cardiac malformations and drinking water contaminants. J Am Coll Cardiol 
1990;16:155-64 
 
Gordis L. Epidemiology. 3rd edition. 2004 Elsevier Philadelphia PA. 
 
Guitti JC. Epidemiological characteristics of congenital heart diseases in Londrina, 
Paraná, South Brazil. Arq Bras Cardiol 2000;74:395-404. 
 
Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists 
during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608-14. 
 
Higgins JPT, Green S, editors. Analysing and presenting results. Cochrane 
Handbook for Systematic Reviews of Interventions 8.11.1 [updated September 
2006]; Section 8. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John 
Wiley & Sons, Ltd. 
http://www.cochrane.org/resources/handbook/hbook.htm 
 
Hoffman JIE. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr 
Cardiol 1995;16:155-65. 
 
Hoffman JIE.  Incidence and natural history.  In Anderson RH, Baker, EJ, Macartney 
FJ, Rigby ML, Shinbourne EA, Tynan M.  Paediatric Cardiology 2nd edition. 2002 
Churchill Livingstone. London 111-39. 
 
Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll 
Cardiol 2002;39:1890-900. 
 
Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am 
Heart J 2004;147:425-39. 
 
Howie RN, Phillips LI.  Congenital malformations in the newborn: a survey at the 
National Women’s Hospital, 1964-67.  N Z Med J 1970;71:65-71. 
 
               C Wren 2008 Page 148
Jackson M, Walsh KP, Peart I, Arnold R.  Epidemiology of congenital heart disease 
in Merseyside – 1979 to1988.  Cardiol Young 1996;6:272-80. 
 
Jacobs JP, Franklin RC, Jacobs ML, Colan SD, Tchervenkov CI, Maruszewski B, 
Gaynor JW, Spray TL, Stellin G, Aiello VD, Beland MJ, Krogmann ON, Kleinert S, 
Sano T, Weintraub RG, Mee RBB, Karl TR, Wilkinson JL.  Anatomic features and 
surgical strategies in double outlet right ventricle.  Circulation 1997;96:1233-9. 
 
Jacobs JP, Lacour-Gayet FG, Jacobs ML, Clarke DR, Tchervenkov CI, Gaynor JW, 
Spray TL, Maruszewski B, Stellin G, Gould J, Dokholyan RS, Peterson ED, Elliott 
MJ, Mavroudis C.  Initial application in the STS congenital database of complexity 
adjustment to evaluate surgical case mix and results.  Ann Thorac Surg 
2005;79:1635-49. 
 
Jacobs JP, Mavroudis C, Jacobs ML, Maruszewski B, Tchervenkov CI, Lacour-
Gayet FG, Clarke DR, Yeh T, Walters HL, Kurosawa H, Stellin G, Ebels T, Elliott 
MJ. What is Operative Mortality? Defining Death in a Surgical Registry Database: A 
Report of the STS Congenital Database Taskforce and the Joint EACTS-STS 
Congenital Database Committee. Ann Thorac Surg 2006;81:1937-41. 
 
Jacobs JP, Mavroudis C, Jacobs ML, Maruszewski B, Tchervenkov CI, Lacour-
Gayet FG, Clarke DR, Gaynor JW, Spray TL, Kurosawa H, Stellin G, Ebels T, Bacha 
EA, Walters HL, Elliott MJ.  Nomenclature and data bases – the past, the present 
and the future.  Pediatr Cardiol 2007;28:105-15. 
 
Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. 
Consensus-based method for risk adjustment for surgery for congenital heart 
disease. J Thorac Cardiovasc Surg 2002;123:110-8. 
 
Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, 
Warnes CA, Webb CL. Noninherited risk factors and congenital cardiovascular 
defects: current knowledge: a scientific statement from the American Heart 
Association Council on Cardiovascular Disease in the Young: endorsed by the 
American Academy of Pediatrics. Circulation 2007;115:2995-3014. 
 
Johnson MC, Hing A, Wood MK, Watson MS. Chromosome abnormalities in 
congenital heart disease. Am J Med Genet 1997;70:292-8. 
               C Wren 2008 Page 149
Kang N, Tsang VT, Elliott MJ, de Leval MR, Cole TJ. Does the Aristotle Score 
predict outcome in congenital heart surgery? Eur J Cardiothorac Surg 2006;29:986-
8. 
 
Keogh B. Surgery for congenital heart conditions in Oxford. BMJ 2005;330:319-20. 
 
Kitchiner DJ, Jackson M, Walsh K, Peart I, Arnold R.  Incidence and prognosis of 
congenital aortic valve stenosis in Liverpool (1960-1990).  Br Heart J 1993a;69:71-9. 
 
Kitchiner DJ, Jackson M, Walsh K, Peart I, Arnold R.  The progression of mild 
congenital aortic valve stenosis from childhood into adult life.  Int J Cardiol 
1993b;42:217-23. 
 
Kleinert S, Sano T, Weintraub RG, Mee RBB, Karl TR, Wilkinson JL. Anatomic 
features and surgical strategies in double-outlet right ventricle. Circulation 
1997;96:1233-9. 
Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C.  Newborn screening 
for congenital heart defects: a systematic review and cost-effectiveness analysis.  
Health Technol Assess 2005;9(44). 
 
Kurosawa H, Weinberg PM, Elliott MJ, Mavroudis C, Anderson RH.  Classification of 
the functionally univentricular heart: unity from mapped codes.  Cardiol Young 
2006;16(Suppl 1):9-21. 
 
Lacour-Gayet F, Clarke D, Jacobs J, Comas J, Daebritz S, Daenen W, Gaynor W, 
Hamilton L, Jacobs M, Maruszsewski B, Pozzi M, Spray T, Stellin G, Tchervenkov 
C, Mavroudis C. The Aristotle score: a complexity-adjusted method to evaluate 
surgical results. Eur J Cardiothorac Surg 2004;25:911-24. 
 
Lacour-Gayet F. The goal is performance evaluation not outcome prediction. Eur J 
Cardiothorac Surg 2006;29:989-90. 
 
Landwirth J. Should anencephalic infants be used as organ donors? Pediatrics 
1988;82:257-9. 
 
Larsen SH, Pedersen J, Jacobsen J, Johnsen SP, Hansen OK, Hjortdal V. The 
RACHS-1 risk categories reflect mortality and length of stay in a Danish population 
               C Wren 2008 Page 150
of children operated for congenital heart disease. Eur J Cardiothorac Surg 
2005;28:877-81. 
 
Larson EW, Edwards WD.  Risk factors for aortic dissection: a necropsy study of 
161 cases.  Am J Cardiol 1984;53:849-55. 
 
Lin AE, Ardinger HH.  Genetic epidemiology of cardiovascular malformations. Prog 
Cardiovasc Cardiol  2005;20:113-26. 
 
Loffredo CA. Epidemiology of cardiovascular malformations: Prevalence and risk 
factors.  Am J Med Genet 2000;97:319-325. 
 
Loffredo CA, Chokkalingam A, Sill AM, Boughman JA, Clark EB, Scheel J, Brenner 
JI. Prevalence of congenital cardiovascular malformations among relatives of infants 
with hypoplastic left heart, coarctation of the aorta, and d-transposition of the great 
arteries. Am J Med Genet 2004;124A:225-30. 
 
Ma M, Gauvreau K, Allan CK, Mayer JE, Jenkins KJ. Causes of death after 
congenital heart surgery. Ann Thorac Surg 2007;83:1438-45. 
 
Manetti A, Pollini I, Cecchi F, de Simone L, Cianciulli D, Carbone C, Romanelli A, 
Bianchi F, Dolara A.  Epidemiologia delle malfomazioni cardiovasculari. III. 
Prevalenza a decorso in 46,895 nati vivi all maternita di Careggi, Firenze, nel 
periodo 1975-84.  G Ital Cardiol 1993;23:145-52. 
 
March of Dimes. Infant deaths by cause of death. US, 2001.  (Accessed 31 January 
2007, at http://www.marchofdimes.com/peristats/) 
 
Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease 
in the general population: changing prevalence and age distribution. Circulation 
2007;115:163-72.  
 
Martin GR, Perry LW, Ferencz C. Increased prevalence of ventricular septal defect: 
epidemic or improved diagnosis? Pediatrics 1989;83:200-3. 
 
               C Wren 2008 Page 151
Mavroudis C, Jacobs JP. Congenital heart surgery nomenclature and database 
project. Ann Thorac Surg 2000;69(Suppl 4):S2–S17. 
 
Mayberry JC, Scott WA, Goldberg SJ. Increased birth prevalence of cardiac defects 
in Yuma, Arizona. J Am Coll Cardiol 1990;16:1696-700. 
 
Meberg A, Otterstad JE, Frøland G, Hals J, Sörland SJ. Early clinical screening of 
neonates for congenital heart defects: the cases we miss. Cardiol Young 
1999;9:169-74.  
 
Meberg A, Lindberg H, Thaulow E.  Congenital heart defects: the patients who die.  
Acta Paediatr 2005;94:1060-5. 
 
Mitchell SC, Korones SB., Berendes HW.  Congenital heart disease in 56,109 births. 
Incidence and natural history. Circulation 1971;43:323-32. 
 
Moher D, Cook DJ, Eastwood S, Rennie D, Stroup DF. Improving the quality of 
reports of meta-analyses of randomised controlled trials: the QUORUM statement. 
Lancet 1999;354:1896-900. 
 
Moller JH. Surgery of congenital heart disease: Pediatric Cardiac Care Consortium, 
1984-1995. Perspectives in pediatric cardiology, volume 6. 1998 Armonk, NY: 
Futura Pub. Co. 
 
Moller JH, Hills CB, Pyles LA.  A multi-center cardiac registry.  A method to assess 
outcome of catheterization intervention or surgery.  Pediatr Cardiol 2005;20:7-12. 
 
Mone SM, Gillman MW, Miller TL, Herman EH, Lipshultz SE.  Effects of 
environmental exposures on the cardiovascular system; prenatal period through 
adolescence.  Pediatrics 2004;113:1058-69. 
 
Montana E, Khoury MJ, Cragan JD, Sharma S, Dhar P, Fyfe D. Trends and 
outcomes after prenatal diagnosis of congenital cardiac malformations by fetal 
echocardiography in a well defined birth population, Atlanta, Georgia, 1990-1994. J 
Am Coll Cardiol 1996;28:1805-9. 
 
               C Wren 2008 Page 152
Murphy M, Seagroatt V, Hey K, O'Donnell M, Godden M, Jones N, Botting B. Neural 
tube defects 1974-94--down but not out. Arch Dis Child 1996;75:F133-F134. 
 
Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart 
diseases: the genetic-environmental interaction. Circulation 1968;38:604-17. 
 
Northern Regional Health Authority Co-ordinating Group. Perinatal mortality: a 
continuing collaborative regional survey. BMJ 1984;288:1717-20. 
 
Northern Regional Survey Steering Group. Fetal abnormality; an audit of its 
recognition and management. Arch Dis Child 1992;67:770-4.  
 
O’Brien NG, Gill DG. Congenital heart disease in the newborn.  J Irish Med Assoc 
1972;65:199-201. 
 
Ooshima A, Fukushige J, Ueda K. Incidence of structural cardiac disorders in 
neonates: an evaluation by color Doppler echocardiography and the results of a 1-
year follow-up.  Cardiology 1995;86:402-6. 
 
Parkes SE. Legal aspects of records based medical research. Arch Dis Child 
2004:89:899-901. 
 
Pasquerella L, Smith S, Ladd R. Infants, the dead donor rule, and anencephalic 
organ donation: should the rules be changed? Med Law 2001;20:417-23. 
 
Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee 
G, Sable CA, Srivastava D, Webb CL. Genetic basis for congenital heart defects: 
current knowledge: a scientific statement from the American Heart Association 
Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the 
Young. Circulation 2007;115:3015-38. 
 
Pradat P, Francannet C, Harris JA, Robert E.  The epidemiology of cardiovascular 
defects, part I: a study based on data from three large registries of congenital 
malformations. Pediatr Cardiol 2003;24:195-221. 
 
               C Wren 2008 Page 153
Radzik D, Davignon A, van Doesburg N, Fournier A, Marchand T, Ducharme G.  
Predictive factors for spontaneous closure of atrial septal defects diagnosed in the 
first 3 months of life.  J Am Coll Cardiol 1993;22:851-3. 
 
Richmond S, Wren C. Early diagnosis of congenital heart disease. Semin Neonatol 
2001;6:27-35. 
 
Richmond S, Reay G, Abu-Harb M. Routine pulse oximetry in the asymptomatic 
newborn. Arch Dis Child 2002;87:F83-F88. 
 
Richmond S, Atkins J. A population-based study of the prenatal diagnosis of 
congenital malformation over 16 years. BJOG 2005;112;1349-57.  
 
Roberts WC.  The congenitally bicuspid aortic valve.  A study of 85 autopsy cases.  
Am J Cardiol 1984;53:849-55. 
 
Robida A, Folger GM, Hajar HA.  Incidence of congenital heart disease in Qatari 
children. Int J Cardiol 1997;60:19-22. 
 
Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. High prevalence 
of muscular ventricular septal defect in neonates. J Am Coll Cardiol 1995;26:1545-
1548. 
 
Rope AF, Hopkins RJ, Saal HM. Evaluation of infants with cardiovascular 
malformations for recognizable etiologies. Proc Greenwood Genet Cent 
2004;23:169-70. 
 
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, 
Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, 
Nichol G, O’Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, 
Wasserthiel-Smoller S, Hong Y. American Heart Association Statistics Committee 
and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2007 
update. Circulation 2007;115:e69–e171. 
 
Rosano A, Botto LD, Botting B, Mastroiacovo P. Infant mortality and congenital 
anomalies from 1950 to 1994: an international perspective. J Epidemiol Community 
Health 2000;54:660-6. 
               C Wren 2008 Page 154
Roy DL, McIntyre L, Human DG, Nanton MA, Sherman GJ, Allen LM, Finley JP. 
Trends in the prevalence of congenital heart disease: comprehensive observations 
over a 24-year period in a defined region of Canada. Can J Cardiol 1994;10:821-6. 
 
Sadiq M, Stűmper O, Wright JGC, De Giovanni JV, Billingham C Silove ED. 
Influence of ethnic origin on the pattern of congenital heart defects in the first year of 
life. Br Heart J 1995;73:173-6. 
 
Samanek M, Voriskova M.  Congenital heart disease among 815,569 children born 
between1980 and 1990 and their 15 year survival: a prospective Bohemia natural 
history study.  Paediatr Cardiol 1999;20:411-7. 
 
Sands AJ, Casey FA, Craig BG, Dornan JC, Rogers J, Mulholland HC. Incidence 
and risk factors for ventricular septal defect in "low risk" neonates. Arch Dis Child 
1999;81:F61-F63. 
 
Sands A, Craig B, Mulholland C, Patterson C, Dornan J, Casey F. 
Echocardiographic screening for congenital heart disease: a randomized study. J 
Perinat Med 2002;30:307-12. 
 
Scanlon KS, Ferencz C, Loffredo CA, Wilson PD, Correa-Villaseñor A, Khoury MJ, 
Willett WC. Preconceptional folate intake and malformations of the cardiac outflow 
tract. Epidemiology 1998;9:95-8. 
 
Schultz AH, Wernovsky G. Late outcomes in patients with surgically treated 
congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 
2005;8:145-56. 
 
Sharland G. Changing impact of fetal diagnosis of congenital heart disease.  Arch 
Dis Child 1997;77:F1-F3. 
 
Singleton S. Data sources and performance measurement. BMJ 2007;335:730. 
 
Stark JF, Gallivan S, Davis K, Hamilton JR, Monro JL, Pollock JCS, Watterson KG.  
Assessment of mortality rates for congenital heart defects and surgeons’ 
performance.  Ann Thorac Surg 2001;72:169-75. 
 
               C Wren 2008 Page 155
Stephensen SS, Sigfusson G, Eiriksson H, Sverrisson JT, Torfason B, Haraldsson 
A, Helgason H. Congenital cardiac malformations in Iceland from 1990 through 
1999. Cardiol Young 2004;14:396-401. 
 
STROBE 2006. Standards for the reporting of observational studies in epidemiology.  
available from http://www.strobe-statement.org/. 
 
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, 
Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in 
epidemiology; a proposal for reporting. JAMA 2000;283:2008-12. 
 
Stuart AG, Wren C, Sharples PM, Hunter S, Hey EN. Hypoplastic left heart 
syndrome: more potential transplant recipients than suitable donors. Lancet 
1991;337:957-9. 
 
Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Systematic reviews of trials 
and other studies. Health Technol Assess 1998;2(19). 
 
Sullivan ID. Prenatal diagnosis of structural heart disease: does it make a difference 
to survival? Heart 2002;87:405-6. 
 
Taussig HB. Tetralogy of Fallot: early history and late results. Am J Roentgenol 
1979;133:423-31. 
 
Tikanoja T. Effect of technical development on the apparent incidence of congenital 
heart disease. Pediatr Cardiol 1995;16:100-1. 
 
Tikkanen J, Heinonen OP. Risk factors for cardiovascular malformations in Finland. 
Eur J Epidemiol 1990;6:348-56. 
 
Tutar E, Ekici F, Atalay S, Nacar N.  The prevalence of bicuspid aortic valve in 
newborns by echocardiographic screening. Am Heart J 2005;150:513-5. 
 
UKCCAD Congenital Heart Disease Website 2005 to 06 National aggregate 
summary data.  Available from: 
http://www.ccad.org.uk/002/congenital.nsf/0/DC6C9FE1F8062131802573CA0005B
9C9?OpenDocument?Summary 
               C Wren 2008 Page 156
van Doorn C, Yates R, Tsang V, de Leval M, Elliott M.  Mitral valve replacement in 
children: mortality, morbidity, and haemodynamic status up to medium term follow 
up.  Heart 2000;84:636-42.  
 
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The 
strengthening the reporting of observational studies in epidemiology (STROBE) 
statement: guidelines for reporting observational studies. Bull World Health Org 
2007;85:867-72.  
 
Ward C. Clinical significance of the bicuspid aortic valve. Heart 2000;83:81-5. 
 
Warth DC, King ME, Cohen JM, Tesoriero VL, Marcus E, Weyman AE.  Prevalence 
of mitral valve prolapse in normal children.  J Am Coll Cardiol 1985;5:1173-7. 
 
Watson RE, Jacobson CF, Williams AL, Howard AB, DeSesso JM. Trichloro-
ethylene-contaminated drinking water and congenital heart defects: A critical 
analysis of the literature.  Reprod Toxicol 2006;21:117-47. 
 
Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. Multivitamin supplementation 
and risk of birth defects. Am J Epidemiol 1999;150:675-82. 
 
Wernovsky G, Shillingford A, Gaynor JW.  Central nervous system outcomes in 
children with complex congenital heart disease. Curr Opin Cardiol 2005;20:94-9. 
 
Westaby S, Archer N, Manning N, Adwani S, Grebenik C, Ormerod O, Pillai R, 
Wilson N. Comparison of hospital episode statistics and central cardiac audit 
database in public reporting of congenital heart surgery mortality. BMJ 
2007;335:759-63. 
 
Whittemore R, Wells JA, Castellsague X. A second-generation study of 427 
probands with congenital heart defects and their 837 children. J Am Coll Cardiol 
1994;23:1459-67. 
 
Williams WG, McCrindle BW. Practical experience with databases for congenital 
heart disease; a registry versus an academic database. Semin Thorac Cardiovasc 
Surg Pediatr Card Surg Annu 2002;5:132-42. 
 
               C Wren 2008 Page 157
Williams WG. Surgical outcomes in congenital heart disease: expectations and 
realities. Eur J Cardiothorac Surg 2005;27:937-44. 
 
Williams W.  Defining operative mortality: it should be easy, but is it? Ann Thorac 
Surg 2006;81:1557-60. 
 
Wilson PD, Loffredo CA, Correa-Villasenor A, Ferencz C. Attributable fraction for 
cardiac malformations. Am J Epidemiol 1998;148:414-23. 
 
Wise J. Review clears Harefield surgeons. BMJ 2001;322:635. 
 
Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy 
– implications for routine examination. Arch Dis Child 1999;80:F49-F53. 
 
Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of 
cardiovascular malformations. Heart 2000;83:414-9. 
 
Wren C, O’Sullivan JJ. Survival with congenital heart disease and need for follow up 
in adult life. Heart 2001;85:438-43. 
 
Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of diabetic 
mothers. Heart 2003;89:1217-20. 
 
Wyllie JP, Wright MJ, Burn J, Hunter S. Natural history of trisomy 13. Arch Dis Child 
1994;71:343-5. 
 
Wyllie JP, Madar RJ, Wright M, Burn J, Wren C. Strategies for antenatal detection of 
Down’s syndrome. Arch Dis Child 1997;76:F26-F30. 
 
 
               C Wren 2008 Page 158
APPENDIX A.  PROPOSALS FOR META-ANALYSIS OF 
OBSERVATIONAL STUDIES IN EPIDEMIOLOGY 
 
 
               C Wren 2008                                      Page 159
APPENDIX B.  STANDARDS FOR THE REPORTING OF 
OBSERVATIONAL STUDIES IN EPIDEMIOLOGY   
 
 




               C Wren 2008                                      Page 161
APPENDIX C:  REFERENCES INCLUDED IN ANALYSIS IN THE SYSTEMATIC 
REVIEW IN CHAPTER 5 
 
Abushaban L, Al-Hay A, Uthaman B, Salama A, Selvan J. Impact of the Gulf war on 
congenital heart diseases in Kuwait. Int J Cardiol 2004:93:157-62. 
 
Anand R, Mehta AV. Incidence of cardiovascular malformation in the northeast 
Tennessee and southwest Virginia area. Am J Cardiol 1996;78:610-1. 
 
Andersen S, Vik T, Linker DT. Medfødte jhertefeil i Sør-Trøndelag. Insidens, 
diagnostikk, forl Sør-Trøndelagp og behandling. (Congenital heart diseases in Sør-
Trøndelag. Incidence, diagnosis, course and treatment.) Tidsskr Nor Laegeforen 
1994;114:29-32. 
 
Arbour L, Gilpin C, Millor-Roy V, Platt R, Pekeles G, Egeland GM, Hodgins S, 
Eydoux P. Heart defects and other malformations in the Inuit in Canada: a baseline 
study. Int J Circumpolar Health 2004;63:251-66. 
 
Bache A, Garne E. Medfødte hjertesygdomme i Fyns Amt. Epidiologi og mortalitet 
1986-1995. (Congenital heart defects in the county of Fyn. Epidemiology and 
mortality 1986-1995.) Ugeskr Laeger 2002;164:4169-72. 
 
Begic H, Tahirovic H, Mesihovic-Dinarevic S, Ferkovic V, Atic N, Latifagic A. 
Epidemiological and clinical aspects of congenital heart disease in children in Tuzla 
Canton, Bosnia-Herzegovina. Eur J Pediatr. 2003;162:191-3. 
 
Bolisetty S, Daftary A, Ewald D, Knight B, Wheaton G. Congenital heart defects in 
Central Australia. Med J Aust 2004;180:614-7. 
 
Borman B, Chapman C, Howard K, Buckfield P, Findlay J. Using a national register 
for the epidemiological study of congenital heart defects. New Zealand Med J 
1987;100:404-6. 
 
Bosi G, Scorrano M, Tosato G, Forini E, Chakrokh R. The Italian multicentric study 
on epidemiology of congenital heart disease: first step of the analysis. Working Party 
of the Italian Society of Pediatric Cardiology. Cardiol Young 1999;9:291-9. 
 
               C Wren 2008                                      Page 162
Bosi G, Garani G, Scorrano M, Calzolari E. Temporal variability in birth prevalence 
of congenital heart defects as recorded by a general birth defects registry. J Pediatr 
2003;142:690-8. 
 
Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of 
heart defects. Pediatrics 2001;107:E32. 
 
Bound JP, Logan WF. Incidence of congenital heart disease in Blackpool 1957-
1971. Br Heart J 1977;39:445-50. 
 
Bower C, Ramsay JM. Congenital heart disease: a 10 year cohort. J Paediatr Child 
Health 1994;30:414-8. 
 
Carlgren LE. The incidence of congenital heart disease in children born in 
Gothenburg 1941-1950. Br Heart J 1959;21:40-50. 
 
Carlgren LE, Ericson A, Kallen B. Monitoring of congenital cardiac defects. Pediatr 
Cardiol 1987;8:247-56. 
 
Cerboni P, Robillard PY, Hulsey TC, Sibille G, Ngyuen J. Congenital heart disease 
diagnosed in Guadeloupe. Bull Pan Am Health Organ 1993;27:151-3. 
 
Chehab G, Bittar Z. Cumulative incidence and distribution of congenital heart 
diseases in newborns in Beirut and its southern suburb (1999-2002). J Med Liban 
2004;52:121-5. 
 
Cleves MA, Ghaffar S, Zhao W, Mosley BS, Hobbs CA. First-year survival of infants 
born with congenital heart defects in Arkansas (1993-1998): A survival analysis 
using registry data. Birth Defects Res A Clin Mol Teratol 2003;67:662-8. 
 
Cloarec S, Magontier N, Vaillant MC, Paillet C, Chantepie A. Prevalence and 
distribution of congenital heart diseases in Indre-et-Loire. Evaluation of prenatal 
diagnosis (1991-1994). Arch Pediatr 1999;6:1059-65. 
 
Czeizel E, Kamaras J, Balogh O, Szentpeteri J. The incidence of congenital heart 
defects in Budapest. Orv Hetil 1972;113:1899-902. 
 
               C Wren 2008                                      Page 163
Darsinos J, Athanassiadis P, Papadatos K, Moulopoulos S. Incidence and types of 
congenital heart disease among 99245 new-borns. Acta Cardiol 1971;26:28-37. 
 
Dickinson DF, Arnold R, Wilkinson JL. Congenital heart disease among 160 480 
liveborn children in Liverpool 1960 to 1969. Implications for surgical treatment. Br 
Heart J 1981;46:55-62. 
 
Diez Thomas JJ, Borreiro J, Ramos A, Solis G, Crespo M. Cardiopatias congenitas 
en una serie de 53,578 ninos nacidos en Oviedo (1976-1985). Ann Esp Pediatr 
1989;31:229-32. 
 
Dolara A, Manetti A, Cecchi F, Santoro G, Zuppiroli A, Cianciulli D, Panero C, 
Paradiso M. Epidemiology of the cardiovascular malformations. II. Follow-up of 337 
newborn in 1975-1980 at the Maternity of Florence. G Ital Cardiol 1981;11:713-8. 
 
Feldt RH, Avasthey P, Yoshimasu F, Kurland LT, Titus JL. Incidence of congenital 
heart disease in children born to residents of Olmsted County, Minnesota, 1950-
1969. Mayo Clin Proc 1971;46:794-9. 
 
Ferencz C, Rubin JD, Loffredo CA, Magee CA, eds. Epidemiology of congenital 
heart disease. The Baltimore Washington infant study: Perspectives in pediatric 
cardiology, vol 4. Futura Publishing Co., Mount Kisco, 1993. 
 
Fischer H., Sonnweber N, Sailer M, Fink C, Trawoger R, Hammerer I. Incidence of 
congenital heart disease in Tyrol, Austria 1979-1983. Padiatrie und Padologie 
1991;26:57-60. 
 
Fixler DE, Pastor P, Chamberlin M, Sigman E, Eiffler CW. Trends in congenital heart 
disease in Dallas County births 1971-84. Circulation 1990;81:137-42. 
 
Forrester MB, Merz RD. Descriptive epidemiology of selected congenital heart 
defects, Hawaii, 1986-1999. Paediatr Perinat Epidemiol 2004;18:415-24. 
 
Fyler DC. Report of the New England Regional Infant Cardiac Program. Pediatrics 
1980;65(suppl):377-461. 
 
               C Wren 2008                                      Page 164
Gardiner J, Keith J. Prevalence of heart disease in Toronto children. Pediatrics 
1951;7:713-21. 
 
Garne E. Congenital heart defects -- occurrence, surgery and prognosis in a Danish 
county. Scand Cardiovasc J 2004;38:357-62. 
 
Grabitz RG, Joffres MR, Collins-Nakai RL. Congenital heart disease: incidence in 
the first year of life. The Alberta Heritage Pediatric Cardiology Program. Am J 
Epidemiol 1988;128:381-8.  
 
Gravinghoff L, Mikat D, Keck EW. Incidence and distribution of congenital heart 
defects in the patient material of a large city. Mschr Kinderheilk 1975;123:356-7. 
 
Grech V. Spectrum of congenital heart disease in Malta. An excess of lesions 
causing right ventricular outflow tract obstruction in a population-base study. Eur 
Heart J 1998;19:521-5. 
 
Guía Torrent JM, Bosch V, Castro FJ, Téllez C, Gracián M, Marset P. Cardiopatías 
congénitas entre 203.783 nacidos vivos en la Comunidad Autónoma de Murcia. 
Incidencia previa a la ecocardiografía bidimensional y Doppler color (1978-1990). 
Rev Esp Pediatr 2000;56:399-406.  
 
Guitti JC. Epidemiological characteristics of congenital heart diseases in Londrina, 
Paraná, South Brazil. Arq Bras Cardiol 2000;74:395-404. 
 
Gupta B, Antia AU. Incidence of congenital heart disease in Nigerian children. Br 
Heart J 1967;29:906-9. 
 
Hay S. Incidence of selected congenital malformations in Iowa. Am J Epidemiol 
1971;94:572-84. 
 
Henriksen JB. Congenital heart defects in children born in Norway 1967-1968. 
Tidsskr Nor Laegeforen 1974;94:624-7. 
 
Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births 
with long-term follow-up. Am J Cardiol 1978;42:641-7. 
 
               C Wren 2008                                      Page 165
Howie RN, Phillips LI. Congenital malformations in the newborn: a survey at the 
National Women’s Hospital, 1964-67. N Z Med J 1970;71:65-71. 
 
Ishihara Y, Tanaka K, Onaka M, Otabe E, Kawase M. Survey on the birth rate and 
prognosis of infants with congenital heart disease. Nippon Kyobu Geka Gakkai 
Zasshi 1974;22:501-3. 
 
Jackson M, Walsh KP, Peart I, Arnold R. Epidemiology of congenital heart disease 
in Merseyside – 1979 to1988. Cardiol Young 1996;6:272-80. 
 
Kenna AP, Smithells RW, Fielding DW. Congenital heart disease in Liverpool: 1960-
-69. Quarterly J Med 1975;44:17-44. 
 
Khalil A, Aggarwal R, Thirupuram S, Arora R. Incidence of congenital heart disease 
among hospital live births in India. Indian Pediatr 1994;31:519-27. 
 
Kidd SA, Lancaster PA, McCredie RM. The incidence of congenital heart defects in 
the first year of life. J Paediatr Child Health 1993;29:344-9. 
 
Klimentova T, Cernay J, Bircak J, Raisova A. Vrodené chyby srdca u deti 
narodenych v rokov 1981-1987 v okresoch Bratislava a Bratislava-vidiek. Cs Pediat  
1990;45:327-30. 
 
Kopecka B. Incidence of congenital heart defects in children in the Central 
Bohemian Region from 1957 to 1977. Cesk Pediatr 1979;34:577-82. 
 
Laursen HB. Some epidemiological aspects of congenital heart disease in Denmark. 
Acta Paediatrica Scandinavica 1980;69:619-24. 
 
Levin SE, Kanarek KS. The incidence of congenital heart disease in Johannesburg. 
A 5-year study of liveborn infants at the Queen Victoria Maternity Hospital. S Afr 
Med J 1973;47:1855-8. 
 
Manetti A, Pollini I, Cecchi F, de Simone L, Cianciulli D, Carbone C, Romanelli A, 
Bianchi F, Dolara A. Epidemiologia delle malfomazioni cardiovasculari. III. 
Prevalenza a decorso in 46,895 nati vivi all maternita di Careggi, Firenze, nel 
periodo 1975-84. G Ital Cardiol 1993;23:145-52. 
               C Wren 2008                                      Page 166
Mayberry JC, Scott WA, Goldberg SJ. Increased birth prevalence of cardiac defects 
in Yuma, Arizona. J Am Coll Cardiol 1990;16:1696-700. 
 
Meberg A, Lindberg H, Thaulow E. Congenital heart defects: the patients who die. 
Acta Paeditr 2005;94:1060-5. 
 
Mitchell SC, Korones SB., Berendes HW. Congenital heart disease in 56,109 births. 
Incidence and natural history. Circulation 1971;43:323-32. 
 
Mogyorosy G, Belicza E, Karacsonyi T, Szucs E. Incidence and invasive treatment 
of congenital heart diseases in Hajdu-Bihar county. Orv Hetil  2000;141:1287-92.   
 
Montana E, Khoury MJ, Cragan JD, Sharma S, Dhar P, Fyfe D. Trends and 
outcomes after prenatal diagnosis of congenital cardiac malformations by fetal 
echocardiography in a well defined birth population, Atlanta, Georgia, 1990-1994. J 
Am Coll Cardiol 1996;28:1805-9. 
 
Nakazawa M, Seguchi M, Takao A. Prevalence of congenital heart disease in 
Japanese children. J Jpn Pediatr Soc 1986;90:2578-86. 
O’Brien NG, Gill DG. Congenital heart disease in the newborn. J Irish Med Assoc 
1972;65:199-201. 
 
Olorón PM, Ibarra CR, de Aguila VA. Incidence of congenital heart disease in 
Navarra (1989-1998). Rev Esp Cardiol 2005;58:1428-34. 
 
Pentek E, Szendrei E. Incidence of congenital heart disease in Hungary: Pecs and 
County Baranya. Acta Paediatrica Hung 1975;16:55-7. 
 
Philippi O, Rencoret G, Pinto M, Alvarez ML, Arriaza M, Espinoza M, Philippi MA, 
Valenzuela C. Incidence of congenital heart diseases in liveborn infants. Rev Chil 
Pediatr 1986;57:447-51. 
 
Pongpanich B, Chesdavanijkul W, Chiemchanya S, Ayuthya PS, Tejavej A. 
Congenital heart disease in children born at Ramathibodi Hospital. J Med Assoc 
Thailand 1978;61:261-7. 
 
               C Wren 2008                                      Page 167
Pradat P, Francannet C, Harris JA, Robert E. The epidemiology of cardiovascular 
defects, part I: a study based on data from three large registries of congenital 
malformations. Pediatr Cardiol 2003;24:195-221. 
 
Putarek NR, Malcic I. Epidemiology of congenital heart diseases in Croatia--a 
multicenter nationwide study, 1995-2000. Lijec Vjesn 2003;125:232-41. 
 
Renwick D, Miller J, Paterson D. Estimates of incidence and prevalence of 
mongolism and of congenital heart disease in British Columbia. Can Med Assoc J 
1964;91:365-71. 
 
Richards MR, Merritt KK, Samuels MH, Langmann AG. Congenital malformations of 
the cardiovascular system in a series of 6053 infants. Pediatrics 1955;15:12-29. 
 
Robida A, Folger GM, Hajar HA. Incidence of congenital heart disease in Qatari 
children. Int J Cardiol 1997;60:19-22. 
 
Roy DL, McIntyre L, Human DG, Nanton MA, Sherman GJ, Allen LM, Finley JP. 
Trends in the prevalence of congenital heart disease: comprehensive observations 
over a 24-year period in a defined region of Canada. Can J Cardiol 1994;10:821-6. 
 
Samanek M, Voriskova M. Congenital heart disease among 815,569 children born 
between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival 
study. Pediatr Cardiol 1999;20:411-7. 
 
Samson GR, Kumar SR. A study of congenital cardiac disease in a neonatal 
population – the validity of echocardiography undertaken by a neonatologist. Cardiol 
Young 2004;14:585-93. 
 
Schmidt H. The incidence of congenital angiocardiopathies. Kinderarztl Prax 
1989;57:283-8. 
 
Schoetzau A, van Santen F, Sauer U, Irl C. Cardiovascular abnormalities in Bavaria 
1984-1991. Z Kardiol 1997;86:496-504. 
 
               C Wren 2008                                      Page 168
Squarcia U, Agnetti A, Carano N, Zavota L, Viola P, Haitink O. Epidemiological 
study of congenital heart diseases in the province of Parma during the years 1972-
80. Pediatr Med Chir 1981;3:459-62. 
 
Stephensen SS, Sigfusson G, Eiriksson H, Sverrisson JT, Torfason B, Haraldsson 
A, Helgason H. Congenital cardiac malformations in Iceland from 1990 through 
1999. Cardiol Young 2004;14:396-401. 
 
Stocker F, Arbenz U, Desbaillets P, Freidli B, Geiger K, Haenni B, Kunzler R, 
Kursteiner W, Mottu T, Oberhansli J, Rutishauser M, Schwartzenbach P, Weber JW, 
Wyler F. Vorkommen und Verlauf angeborener Herzfehler im ersten Lebensjahr in 
der Schweiz. Padiat FortbildK Praxis 1980;51:98-100. 
 
Stoll C, Alembik Y, Roth MP, Dott B, De Geeter B. Risk factors in congenital heart 
disease. Eur J Epidemiol 1989;5:382-91. 
 
Subramanyan R, Joy J, Venugopalan P, Sapru A, al Khusaiby SM. Incidence and 
spectrum of congenital heart disease in Oman. Ann Trop Paediatr 2000;20:337-41. 
 
Sung RY, So LY, Ng HK, Ho JK, Fok TF. Echocardiography as a tool for 
determining the incidence of congenital heart disease in newborn babies: a pilot 
study in Hong Kong. Int J Cardiol 1991;30:43-7. 
 
Tikanoja T. Effect of technical development on the apparent incidence of congenital 
heart disease. Pediatr Cardiol 1995;16:100-1. 
 
Tikkanen J, Heinonen OP. Risk factors for cardiovascular malformations in Finland. 
Eur J Epidemiol 1990;6:348-56. 
 
Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of 
cardiovascular malformations. Heart 2000;83:414-9. 
 
Zajadacz B. Epidemiological analysis of congenital heart defects in the Gora region. 
Pol Tyg Lek 1979;34:657-9. 
 
Zhang Z, Li Z, Ji C. Prevalence study of congenital heart disease in children aged 0-2 in 
Zhejiang Province. Zhonghua Liu Xing Bing Xue Za Zhi 1999;20:155-7. 
               C Wren 2008                                      Page 169
APPENDIX D:  REFERENCES NOT SUITABLE FOR ANALYSIS IN THE 
SYSTEMATIC REVIEW IN CHAPTER 6 
 
Abbag F. Pattern of congenital heart disease in the South Western Region of Saudi 
Arabia. Ann Saudi Med 1998;18:393-5. 
 
Abdulla R. What is the prevalence of congenital heart diseases? Pediatr Cardiol 
1997;18:269. 
 
Abdullah AA, Alabdulgader. Congenital heart disease in 740 subjects: 
epidemiological aspects. Ann Trop Paediatr 2001;21:111-8. 
 
Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart 
disease. Arch Dis Child 1994;71:3-7. 
 
Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C. Presentation of obstructive left 
heart malformations in infancy. Arch Dis Child 1994;71:F179-F183. 
 
Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C. Antenatal diagnosis of 
congenital heart disease and Down’s syndrome: the potential effect on the practice 
of paediatric cardiology.  Br Heart J 1995;71:192-8. 
 
Adeyemo AA, Okolo CM, Omotade OO. Major congenital malformations among 
paediatric admissions at University Challenge Hospital, Ibadan, Nigeria. Ann Trop 
Paediatr 1994;14:75-9. 
 
Ainsworth SB, Wyllie JP, Wren C. Prevalence and significance of cardiac murmurs 
in neonates. Arch Dis Child 1999;80:F43-F45. 
 
Allan LD, Sharland GK, Milburn A, Lockhart SM, Groves AM, Anderson RH, Cook 
AC, Fagg NLK. Prospective diagnosis of 1,006 consecutive cases of congenital 
heart disease in the fetus. J Am Coll Cardiol 1994;23:1452-8. 
 
Anderson RC. Congenital heart malformations in North American Indian children.  
Pediatrics 1977;59:121-3. 
 
               C Wren 2008                                      Page 170
Ardura Fernandez J. Epidemiology of the congenital cardiopathies in Spain. The 
need for a permanent evaluation. An Esp Pediatr 1984;21:610-5. 
 
Aryanpur-Kashani I, Mehranpur M, Paydar P, Yazdanyar A, Siassi B, Shakibi JG. A 
profile of heart disease in children in developing country. Ann Trop Paediatr 
1981;1:221-7. 
 
Asani MO, Sani MU, Karaye KM, Adeleke SI, Baba U. Structural heart diseases in 
Nigerian children. Niger J Med 2005;14:374-7. 
 
Asou T, Rachmat J. Pediatric cardiac surgery in Indonesia. Cardiol Young 
1998;8:437-9. 
 
Aziz K. Incidence of heart disease in children at the National Institute of 
Cardiovascular Diseases. J Pak Med Assoc 1984;34:300-5. 
 
Badaruddoza, Afzal M, Akhtaruzzaman. Inbreeding and congenital heart diseases in 
a north Indian population. Clin Genet 1994;45:288-91. 
 
Baekgaard Laursen H. Some epidemiological aspects of congenital heart disease 
en Denmark. 1980. Acta Paediatr Scand1980;69:619-24. 
 
Bahadur KC, Sharma D, Shrestha MP, Gurung S, Rajbhandari S, Malla R, 
Rajbhandari R, Limbu YR, Regmi SR, Koirala B. Prevalence of rheumatic and 
congenital heart disease in schoolchildren of Kathmandu valley in Nepal. Indian 
Heart J 2003;55:615-8. 
 
Bannerman CH, Mahalu W. Congenital heart disease in Zimbabwean children. Ann 
Trop Paediatr 1998;18:5-12. 
 
Baron AM, Donnerstein RK. Kanter E, Meaney FJ, Goldberg SJ. Congenital heart 
disease in the Medicaid population of Southern Arizona. Am J Cardiol 2001;88:462-
5. 
 
Bassili A, Mokhtar SA, Dabous NI, Zaher SR, Mokhtar MM, Zaki A. Risk factors for 
congenital heart diseases in Alexandria, Egypt. Eur J Epidemiol 2000;16:805-14. 
 
               C Wren 2008                                      Page 171
Becker SM, Halees ZA, Molina C, Paterson RM. Consanguinity and congenital heart 
disease in Saudi Arabia. Am J Med Gen 2001;99:8-13. 
 
Beramendi Calero JR, Pastor Menchaca E, Galdeano Miranda JM, Beltran de 
Heredia P, Perez Garcia J, Alcibar Villa J, Rodrigo Carbonero D, Cabrera Duro A. 
Interventricular communication in the neonatal period. An Esp Pediatr 1998;49:284-
8. 
 
Bitar FF, Baltaji N, Dbaibo G, El-Jawad MA, Yunis KA, Obeid M. Congenital heart 
disease at a tertiary care center in Lebanon. Middle East J Anesthesiol 
1999;15:159-65. 
 
Bleuer B, Stocker F, Weber JW. Congenital heart defects, incidence and course up 
to the 8th year of life. Schweiz Med Wochenschr 1985;115:407-11. 
 
Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson. Mortality associated 
with congenital heart defects in the United States. Trends and racial disparities, 
1979–1997.  Circulation 2001;103:2376. 
 
Borlée-Grimée I, De Wals P, Bouckaert A, Vincotte-Mols M, Lechat MF.  Prévalence 
des malformations congénitales á la naissance étude de 31.613 naissances dans 9 
maternités de la région Sud du Hainaut, Belgique, 1979–1982. Louvain Med 
1984;103:65-75. 
 
Borman B, Chapman C, Howard K, Buckfield P, Findlay J. Using a national register 
for the epidemiological study of congenital heart defects. N Z Med J 1987;100:404-
6. 
 
Boughman JA, Berg KA, Astemborski JA, Clark EB, McCarter RJ, Rubin JD, 
Ferencz C. Familial risks of congenital heart defect assessed in a population-based 
epidemiologic study. Am J Med Gen 1987;26:839-49. 
 
Burki MK, Babar GS. Prevalence and pattern of congenital heart disease in Hazara. 
J Ayub Med Coll Abbottabad 2001;13:16-8. 
 
Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, Dennis MR, Allan L, 
Arnold R, Deanfield JE, Godman M, Houston A, Keeton B, Oakley C, Scott O, Silove 
               C Wren 2008                                      Page 172
E, Wilkinson J, Pembrey M, Hunter AS. Recurrence risks in offspring of adults with 
major heart defects: results from first cohort of British collaborative study. Lancet 
1998;351:311-6. 
 
Busch R, Voigt M, Rothe J. Cogenital heart defects as a cause of still birth and 
infant mortality. Gegenbaurs Morphol Jahrb 1985;131:253-9. 
 
Caddell JL, Connor DH. Congenital heart disease in Ugandan children. Br Heart J 
1966;28:766-7. 
 
Calzolari E, Garani G, Cocchi G, Magnani C, Rivieri F, Neville A, Astolfi G, Baroncini 
A, Garavelli L, Gualandi F, Scorrano M, Bosi G & IMER Working Group. Congenital 
heart defects: 15 years of experience of the Emilia-Romagna registry (Italy). Eur J 
Epidemiol 2003;18:773-80. 
 
Carlgren LE. Congenital heart diseases in children born in Goteborg in the period 
1941-60. Lakartidningen 1969;66:4883-8. 
 
Carlgren LE. Incidence and prevalence of congenital heart disease. Acta Paediatr 
Scand  1970;206(suppl):14. 
 
Carlgren LE. Congenital heart defects. Frequency of congenital heart defects in 
newborn infants. Nord Med 1970;84:1213-4. 
 
Cernay J, Klimentova T. Incidence of congenital heart defects in the children of 
Bratislava and Bratislava district (from 1960 to 1970). Bratisl Lek Listy 1973;59:172-
7. 
 
Cernay J, Jakubcova I, Jadronova E. Incidence of congenital heart disease among 
children in a selected population sample. Cor Vasa 1981;23:14-20. 
 
Chaabouni M, Kamoun T, Mekki N, Mahfoudh A, Karray A, Daoud M, Triki A. 
Aspects epidemiologiques et evolutifs des cardiopathies congenitales dans le 
service de pediatrie de sfax: a propos de 123 cas. Tunis Med 1999;77:264-70. 
 
Chadha SL, Singh N, Shukla DK. Epidemiological study of congenital heart disease. 
Indian J Pediatr  2001;68:507-11. 
               C Wren 2008                                      Page 173
Chan KY, Yip WC, Tay JS. Rajan U, Ng MP. Results of screening for cardiac 
disease among school children in Singapore. J Singapore Paediatr Soc 
1988;30:125-8. 
 
Chang AC, Hanley FL, Lock JE, Castaneda AR, Wessel DL. Management and 
outcome of low birth weight neonates with congenital heart disease. J Pediatr 
1994;124:461-6. 
 
Chinn A, Fitz Simmons J, Shepard TH, Fantel AG. Congenital heart disease among 
spontaneous abortuses and stillborn fetuses: prevalence and associations. 
Teratology 1989;40:475-82. 
 
Cook DH, Izukawa T, Mulholland HC, Fay JE, Li MD, Sellers FJ, Teixeira OH, Rose 
V, Rowe RD. The accuracy and completeness of neonatal mortality statistics for 
congenital heart disease. Can J Public Health 1982;73:420-3. 
 
Cronk CE, Pelech AN, Malloy ME, McCarver DG. Excess birth prevalence of 
hypoplastic left heart syndrome in Eastern Wisconsin for birth cohorts 1997 – 1999. 
Birth Defects Res A Clin Mol Teratol 2004:70;114-20. 
 
Cullen S, Sharland GK, Allan LD, Sullivan ID. Potential impact of population 
screening for prenatal diagnosis of congenital disease. Arch Disc Child 
1992;67:775-8. 
 
Davis JT, Detweiler D, Robert S. Prevalence of paediatric cardiac disease in rural 
Kenya. East Afr Med J 1991;68:751-6. 
 
De Buse P. Congenital heart disease in Papua New Guinean children. Papua New 
Guinea Med J 1974;17:278-81. 
 
Dees E, Lin H, Cotton RB, Graham TP, Dodd DA. Outcome of preterm infants with 
congenital heart disease. J Pediatr 2000;137:653-9. 
 
DiGiovanna EL. Family cluster of atrial septal defect. J Am Osteopath Assoc 
1999;99:620-5. 
 
               C Wren 2008                                      Page 174
Diop IB, Ba SA, Ba K, Sarr M, Kane A, Fall M, Guisse A, Sow D, Diouf SM. 
Congenital cardiopathies: anatomo-clinical, prognostic, and therapeutic features 
apropos of 103 cases seen at the cardiology clinic of the Dakar University Hospital 
Center. Dakar Med 1995;40:181-6. 
 
Diop IB, Ba SA, Sarr M, Kane A, Hane L, Dieye O, Ndiaye M, Ba K, Sow D, Fall M, 
Diouf SM. Tetralogy of Fallot:anatomo-clinical, prognostic and therapeutic features. 
Dakar Med 1997;42:118-22. 
 
Distefano G, Sciacca P, Parisi MG, Marletta M, Mattia C, Tornambene G, Romeo 
MG. Rilievi epidemiologici e clinici sulle cardiopatie congenite in epoca neonatale. 
Contributo casistico personale. Ped Med Chir (Med Surg Ped) 1997;19:425-31. 
 
Dolara A, Manetti A, Carbone C, Cianciulli D, Gambi R, Mainardi G, Panero C, 
Paradiso M.  Epidemiologia delle cardiopatie congenite. G Ital Cardiol 1978;8:135-
44. 
 
Domenech E, Perera C, García A, Torres ML, Castro R, Méndez A, Cortabarria C. 
Análisis de las cardiopatías congénitas durante el primer año de vida (1987-92). 
Rev Esp Pediatr 1993;49:407-14. 
 
Du ZD, Roguin N, Wu XJ. Spontaneous closure of muscular ventricular septal defect 
identified by echocardiography in neonates. Cardiol Young 1998;8:500-5. 
 
Du ZD, Roguin N, Barak M, Bihari SG, Ben-Elisha M. High prevalence of muscular 
ventricular septal defect in preterm neonates. Am J Cardiol 1996;79:1183-5. 
 
Dulskiene V, Maroziene L. Impact on environmental factors on the reproductive 
system and fetal development. Medicina (Kaunas) 2002;38:1072-7. 
 
Dzhumadilov ShD. Incidence of congenital heart defects among the pediatric 
population of Naryn and Osh provinces, Kirghizia. Zdravookhr Kirg 1980;1:9-13. 
 
el Hag AI. Pattern of congenital heart disease in Sudanese children. East Afr Med J 
1994;71:580-6. 
 
               C Wren 2008                                      Page 175
Esscher E, Michaelsson M, Smedby B. Cardiovascular malformation in infant 
deaths. 10 year clinical and epidemiology study. Br Heart J 1975;37:824-9. 
 
Faella HJ. Cardiopatías congénitas en el adulto: hacia un intervencionismo no 
quirúrgico. Rev Esp Cardiol 2004;57:33-8.  
 
Feldkamp M, MacLeod L, Young L, Lecheminant K, Carey JC. The methodology of 
the Utah Birth Defect Network: congenital heart defects as an illustration. Birth 
Defects Res A Clin Mol Teratol 2005;73:693-9. 
 
Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW, Hepner SI, 
Downing JW. Congenital heart disease: prevalence at livebirth. The Baltimore-
Washington Infant Study. Am J Epidemiol 1985;121:31-6. 
 
Ferencz C, Czeizel A, Lys F. The problem of comparative analysis of birth 
prevalence of congenital cardiovascular malformations. Acta Paediatr Hung 
1990;30:169-89. 
 
Ferencz C. On the birth prevalence of congenital heart disease. J Am Coll Cardiol 
1990;16:1701-2. 
 
Ferencz C, Villaseńor. Epidemiology of cardiovascular malformations: The state of 
the art. Cardiol Young 1991;1:264-84. 
 
Ferencz C, Neill CA. Cardiomyopathy in infancy: observations in an epidemiologic 
study. Pediatr Cardiol 1992;13:65-71. 
 
Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. Genetic and 
environmental risk factors of major cardiovascular malformations: the Baltimore-
Washington infant study: 1981-1989. Perspectives in Pediatric Cardiology 
1997;5:1044-4157. 
 
Ferreira SMAG, Ferreira Jr AG, Gomes, Gomes MdLC, Linhares AdC, Decourt LV. 
Detection of cardiovascular abnormalities in the nursery of a general hospital in the 
Amazon region: correlation with potential risk factors. Cardiol Young 1999;9:163-8. 
 
               C Wren 2008                                      Page 176
Francannet C, Lancaster PAL, Pradat P, Cocchi G, Stoll C. The epidemiology of 
three serious cardiac defects. A joint study between five centres. Eur J Epidemiol 
1993;9:607-16. 
 
Frank M, Rossler J, Steiner I. Severe congenital heart defects in children below 2 
years of age. Occurrence in the East-Bohemian Region, 1970-1974. Sb Ved Pr Lek 
Fak Karlovy Univerzity Hradei Kralove 1976;19:575-84. 
 
Frohnert BK, Lussky RC, Alms MA, Mendelsohn NJ, Symonik DM, Falken MC. 
Validity of hospital discharge data for identifying infants with cardiac defects. J 
Perinatol 2005;25:737-42. 
 
Frontera-Izquierdo P, Cabezuelo-Huerta G. Relative incidence and mortality of 
congenital heart defects diagnosed by angiohemodynamic methods: a 17-year 
study. Pediatr Cardiol 1992;13:159-63. 
 
Guía JM, Bosch V, Castro FJ, Tellez C, Mercader B, Gracian M. Factores 
influyentes en la evolución de la mortalidad de las cardiopatías congénitas. Estudio 
sobre 1.216 niños en la Comunidad Autónoma de Murcia (1978-1990). Rev Esp 
Cardiol 2001;54:299-306. 
 
Gillum RF. Epidemiology of congenital heart disease in the United States. Am Heart 
J 1994;127:919-27. 
 
Goetzova J, Benesova D. Congenital heart diseases at autopsy of still-born and 
deceased children in the Central Bohemian Region. Cor Vasa 1981;23:8-13. 
 
Goldberg SJ, Lebowitz MD, Graver EJ, Hicks S. An association of human congenital 
cardiac malformations and drinking water contaminants. J Am Coll Cardiol 
1990;16:155-64. 
 
Goldmuntz E. The epidemiology and genetics of congenital heart disease. Clin 
Perinatol 2001;28:1-10. 
 
Grech V. Epidemiology and diagnosis of ventricular septal defect in Malta. Cardiol 
Young 1998;8:329-36. 
 
               C Wren 2008                                      Page 177
Grech V, Elliott MJ. Evolution of surgical trends in congenital heart disease: a 
population based study. Int J Cardiol 1998;66:285-92. 
 
Grech V, Savona-Ventura C. Declining mortality from congenital heart disease 
related to innovations in diagnosis and treatment: a population-based study. Cardiol 
Young 1999;9:78-80. 
 
Grech V, Gatt M. Syndromes and malformations associated with congenital heart 
disease in a population-based study. Int J Cardiol 1999;68:151-6. 
 
Grech V. Seasonality in live births with congenital heart disease in Malta. Cardiol 
Young  1999;9:396-401. 
 
Grech V. Decreased prevalence of hypoplastic left heart syndrome in Malta. Pediatr 
Cardiol 1999;20:355-7. 
 
Grech V. The evolution of diagnostic trends in congenital heart disease: A 
population-based study. J Paediatr Child Health 1999;35:387-91. 
 
Grech V. Trends in presentation of congenital heart disease in a population-based 
study in Malta. Eur J Epidemiol 1999;15:881-7. 
 
Greer W, Sandridge AL, Al-Menieir M, Al Rowais A. Geographical distribution of 
congenital heart defects in Saudi Arabia. Ann Saudi Med 2005 ;25:63-9. 
 
Gregory J, Emslie A, Wyllie JP, Wren C. Examination for cardiac malformations at 
six weeks of age. Arch Dis Child 1999;80:F46-F48. 
 
Gryaznova TP. The incidence of congenital heart defects. Sov Med 1968;31:30-3. 
 
Guia JM, Bosch V, Castro FJ, Tellez C, Mercader B, Gracian M. Influential factors in 
mortality rate from congenital heart disease. Study of 1,216 children in the 
autonomous community of Murcia (1978-1990). Rev Esp Cardiol 2001;54:299-306. 
 
Gupta I, Gupta ML, Parihar A, Gupta CD. Epidemiology of rheumatic and congenital 
heart diseases in school children. J Indian Med Assoc 1992;90:57-9. 
 
               C Wren 2008                                      Page 178
Harris JA, Francannet C, Pradat P, Robert E. The epidemiology of cardiovascular 
defects, part 2: a study based on data from three large registries of congenital 
malformations. Pediatr Cardiol 2003;24:222-35. 
 
Harris LE, Steinberg AG. Abnormalities observed during the first six days of life in 
8,716 live-born infants. Pediatrics 1954;14:314-26.  
 
Hashida E, Shirai T, Onishi T. The incidence and relative frequencies of congenital 
heart disease in school children in Otsu (1960-1966). Jpn Circ J 1968;32:145-8. 
 
Hassan I. Haleem AA. Bhutta ZA. Profile and risk factors for congenital heart 
disease. J Pak Med Assoc 1997;47:78-81. 
 
Hernández-Díaz S, Hernán MA, Meyer K, Werler MM, Mitchell AA. Case-crossover 
and case-time-control designs in birth defects epidemiology. Am J Epidemiol 
2003;158:385-91. 
 
Ho JJ. Mortality from congenital abnormality in Malaysia 1991-1997: the effect of 
economic development on death due to congenital heart disease. Med J Malaysia 
2001;56:227-31. 
 
Hoffman JI. Natural history of congenital heart disease. Problems in its assessment 
with special reference to ventricular septal defects. Circulation 1968;37:97-125. 
 
Hoffman JI. Congenital heart disease: incidence and inheritance. Pediatr Clin North 
Am 1990;37:25-43. 
 
Hoffman JIE. Reflections on the past, present and future of pediatric cardiology. 
Cardiol  Young 1994;4:208-23. 
 
Hoffman  JIE. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr 
Cardiol 1995;16:103-13. 
 
Hoffman  JIE. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr 
Cardiol 1995;16:155-65. 
 
               C Wren 2008                                      Page 179
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 
2002;39:1890-900. 
 
Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am 
Heart J 2004;147:425-39. 
 
Hummel DB, Dansky R, Leahy B, Levin SE. A disproportionately high incidence of 
symptomatic coarctation of the aorta in white infants in the Transvaal. S Afr Med J 
1988;73:93-5. 
 
Hung LC, Mohan AJ, Soo TL, Ng HP. Pattern of congenital heart disease and 
access to tertiary cardiac care in Malaysia. Med J Malaysia 2000;55:424-32. 
 
Hurtado del Rio D, Holden B AM. Congenital cardiopathies in the newborn. Arch Inst 
Cardiol Mex 1976;46:554-61. 
 
Hwang BF, Magnus P, Jaakkola JJ. Risk of specific birth defects in relation to 
chlorination and the amount of natural organic matter in the water supply. Am J 
Epidemiol 2002 15;156:374-82. 
 
Immer FF, Haefeli-Bleuer B, Seiler A, Stocker F, Weber JW. Congenital heart 
defects: prevalence and course during the school years (8 to 16 years). Schweiz 
Med Wochenschr 1994;124:893-9. 
 
Izukawa T, Mulholland HC, Rowe RD, Cook DH, Bloom KR, Trusler GA, Williams 
WG, Chance GW. Structural heart disease in the newborn. Changing profile: 
comparison of 1975 with 1965.  Arch Dis Child 1979;54:281-5. 
 
Jacobs EGJ, Leung MP, Karlberg J. Birthweight distribution in southern Chinese 
infants with symptomatic congenital heart disease. J Paediatr Child Health 
2003:39;191-6. 
 
Jacobs EGJ, Leung MP, Karlberg J. Distribution of symptomatic congenital heart 
disease in Hong Kong. Paediatr Cardiol 2000;21:148-57. 
 
Jaiyesimi F, Antia AU. Congenital heart disease in Nigeria: a ten-year experience at 
UCH, Ibadan. Ann Trop Paediatr 1981;1:77-85. 
               C Wren 2008                                      Page 180
Jaiyesimi F, Ruberu DK, Misra VK. Pattern of congenital heart disease in King Fahd 
Specialist Hospital, Buraidah. Ann Saudi Med 993;13:407-11. 
 
Joffe HS, Chesler E, Barnard M, Beck W, Schrire V. Serious heart disease in the 
neonate. S Afr Med J 1973;47:374-6. 
 
Johnson RO, Johnson BH, Grieve AW. Congenital heart disease amongst 
Malaysian children. Med J Malaysia 1978;33:125-7. 
 
Karczenski K. The results of post-mortem examinations of 712 cases of congenital 
heart disease. Probl Medi Wieku Rozwoj 1977;7:127-33. 
 
Kasturi L, Amin A, Mashankar VA. Congenital heart disease: clinical spectrum. 
Indian Pediatr 1999;36:953. 
 
Kecskes Z, Cartwright DW. Poor outcome of very low birthweight babies with 
serious congenital heart disease. Arch Dis Child Fetal Neonatal Ed. 2002;87:F31-3. 
 
Koate P, Padonou N, Sankale M. Congenital heart diseases in the Senegalese 
(apropos of 151 patients in Dakar). Arch Mal Coeur Vaiss 1973;66:1345-9. 
 
Koate P, Diouf S, Padonou N, Sylla M. Cardiovascular abnormalities in black 
Africians (apropos of 326 cases in Senegalese). Bull Soc Med Afr Noire Lang Fr 
1977;22:433-45. 
 
Kramer HH, Trampisch HJ, Rammos S, Giese A. Birth weight of children with 
congenital heart disease. Eur J Pediatr 1990;149:752-7. 
 
Krovetz LJ. Spontaneous closure of ventricular septal defect. Am J Cardiol 
1998;81:100-1. 
 
Krymskii LD, Aleksi-Meskhishvili VV, Sharykin AS, Chernyshova EF, Vaulina TN. 
Analysis of hospital mortality of patients with congenital heart defects in the 1st year 
of life. Kardiologiia 1985;25:39-44. 
 
               C Wren 2008                                      Page 181
Labaceno Gainza D, Warner Magnus NM, Jarvis Sanchez D. Congenital 
cardiovascular malformations. January to July 1987. Rev Cubana Enferm 
1989;5:51-5. 
 
Lagana R, da Silva WN, Sawaia N, Castro e Silva EP. Incidence of congenital 
cardiopathies and rheumatic heart disease among students of the municipality of 
Santo Andre, State of Sao Paulo. Arq Bras Cardiol 1970;23:415-20. 
 
Landtman B. Epidemiological Aspects of Congenital Heart Disease. Acta Paediatr 
Scand 1965;54:467-73. 
 
Laursen HB, Lomholt P. Congenital heart disease in the first month of life. Scand J 
Thorac Cardiovasc Surg 1979:13;111-8. 
 
Lei Z. Epidemiology of birth defects among children in 8 provinces in China. 
Zhonghua Yi Xue Za Zhi 1992;72:412-5. 
 
Leung MP, Yung TC, Ng YK, Wong KY, Lee SL, Mok CK, Lee J, Chiu C. Pattern of 
symptomatic congenital heart disease among Oriental neonates – a decade’s 
experience. Cardiol Young 1996;6:291-7. 
 
Levine RS, Roberts N, Cretin S, Gelband H. Congenital heart disease in Florida. A 
predictive study. J Fla Med Assoc 1980;67:563-5. 
 
Lewis DA, Loffredo CA, Correa-Villasenor, Wilson PD, Martin GR. Descriptive 
epidemiology of membranous and muscular ventricular septal defects in the 
Baltimore-Washington Infant study. Cardiol Young 1996;6;281-90. 
 
Lin AE, Herring AH, Amstutz KS, Wesgate MN, Lacro RV, Al-Jufan M, Ryan L, 
Holmes LB. Cardiovascular malformations: changes in prevalence and birth status, 
1972-1990. Am J Med Genet 1999;84:102-10. 
 
Lin MS, Ho NK. A 10 year study of neonatal congenital heart deaths in Toa Payoh 
Hospital (1978-1987). J Singapore Paediatr Soc 1988;30:129-33. 
 
Liu CY, Tong XH, Du YH. A study on the genetic epidemiology of congenital heart 
disease. Zhonghua Liu Xing Bing Xue Za Zhi 1997;18:224-6. 
               C Wren 2008                                      Page 182
Loffredo CA. Epidemiology of cardiovascular malformations: prevalence and risk 
factors. Am J Med Genet 2000;97:319-25. 
 
Lomovtsev AE, Filimonova ZhV, Shishkina LI, Lobkovskii AG, Gelshtain VS. 
Assessment of the risk for congenital malformations in Tula region. Gig Sanit 
2003;1:26-30. 
 
Lorenzo JG, Terol I, Quintana ME, Bautista JM, Plaza L. Prevalence of congenital 
cardiac defects in a population of 38,674 students. Rev Esp Cardiol 1985;38:46-9. 
 
Lue HC. Congenital heart disease in the East and West. Zhonghua Min Guo Xiao Er 
Ke Yi Xue Hui Za Zhi 1988;29(suppl B):39B-45B. 
 
Magnani C, Bussolati G, Gambini L, Garani GP, Bosi G, Cocchi G, Garavelli L, 
Calzolari E. Congenital cardiomyopathy in a data-based population. Acta Biomed 
Ateneo Parmense 2000;71:483-6. 
 
Maitre Azcarate MJ, Fernández Pineda L, Quero Jimenez M. Congenital familial 
cardiopathies. Prenatal diagnosis. An Esp Pediatr 1993;38:221-3. 
 
Malik A. Congenital and acquired heart diseases: a survey of 7062 persons. 
Bangladesh Med Res Counc Bull 1976;2:115-9. 
 
Manetti A, Dolara A, Bianchi F, Taiti A, Pierini A, Pollini I, Romanelli AM. A long-term 
follow-up of 534 infants born with cardiovascular malformations in 1975-1984 in the 
maternity department of the Careggi Hospital in Florence. Epidemiol Prev 
1991;13:196-7. 
 
Marti Cartaya JL, Alvarez Calero A, Martin Fernandez D, Perera Carrillo C, Sanchez 
Santos C, de la Rosa Rodriguez JA. Epidemiology of congenital heart diseases in 
the island of Tenerife. Rev Esp Cardiol 1976;29:545-52. 
 
Martin GR, Perry LW, Ferencz C. Increased prevalence of ventricular septal defect: 
epidemic or improved diagnosis. Pediatrics 1989;83:200-3. 
 
Matsuo N, Oshima M, Naganuma M. Serious congenital heart disease in the 
neonatal period. Frequency in a children's hospital. Jpn Heart J 1971;12:442-9. 
               C Wren 2008                                      Page 183
McLaren MJ, Lachman AS, Barlow JB. Prevalence of congenital heart disease in 
black school children of Soweto, Johannesburg. Br Heart J 1979;41:554-8. 
 
Meberg A, Otterstad JE, Froland G, Sorland S. Children with congenital heart 
defects in Vestfold 1982-88.  Increase in the incidence resulting from improved 
diagnostics methods. Tidsskr No Laegeforen 1990;110:354-7. 
 
Meberg A, Otterstad JE, Frøland G, Sørland S, Nitter-Hauge S. Increasing incidence 
of ventricular septal defects caused by improved detection rate. Acta Paediatr 
1994;83:653-7. 
 
Meberg A, Otterstad JE, Frøland G, Hals J, Sörland SJ. Early clinical screening of 
neonates for congenital heart defects: the cases we miss. Cardiol Young 
1999;9:169-74. 
 
Meberg A, Otterstad JR, Froland G, Lindberg H, Sorland SJ. Outcome of congenital 
heart defects – a population based study. Acta Paediatr 2000;89:1344-51. 
 
Meberg A, Otterstad JR, Froland G, Lindberg H, Sorland SJ. Congenital heart 
defects. Varying degrees of severity; 25 percent of children with heart defects will 
have persistent cardiac problems in adulthood. Lakartidningen. 2002;99:378-83. 
 
Meshalkin EN, Sidorov PM, Alks DO, Bakhtina GG, Mezentseva NM. Incidence and 
periods of detection of congenital heart defects in children. Vopr Okhr Materin Det 
1977;22:64-6. 
 
Mészáros M, Nagy A, Czeizel E. Incidence of congenital heart defects in the city of 
Szolnok and the district of Szolnok. Acta Paediatr Acad Sci Hung 1974;15:109-14. 
 
Meszaros M, Nagy A, Czeizel A. Incidence of congenital heart disease in Hungary. 
Hum Hered 1975;25:513-9. 
 
Mészáros M, Nagy A, Krasznai G, Czeizel A. Birth prevalence of congenital 
cardiovascular malformations in Hungary. Acta Paediatri Acad Sci Hung 
1980;21:221-5. 
 
               C Wren 2008                                      Page 184
Metras D, Turquin H, Coulibaly AO, Quattara K. Congenital cardiopathies in a 
tropical environment. Study of 259 cases seen at Abidjan from 1969-1976. Arch Mal 
Coeur Vaiss 1979;72:305-10. 
 
Miao CY, Zuberbuhler JS, Zuberbuhler JR. Prevalence of congenital cardiac 
anomalies at high altitude. J Am Coll Cardiol 1988;12:224-8. 
 
Miller GA. Congenital heart disease in the first week of life. Br Heart J 
1974:36:1160-6. 
 
Minkkila K, Tikanoja T. Increasing incidence of congenital heart disease. Duodecim 
1996;112:199-204. 
 
Mitchell SC, Sellmann AH, Westphal MC, Park J. Etiologic correlates in a study of 
congenital heart disease in 56,109 births. Am J Cardiol 1971;28:653-7. 
 
Miyague NI, Cardoso SM, Meyer F, Ultramari FT, Araujo FH, Rozkowisk I, Toschi 
AP. Epidemiological study of congenital heart defects in children and adolescents. 
Analysis of 4,538 cases. Arq Bras Cardiol 2003:80;274-8. 
 
Moller JH, Anderson RC. 1000 consecutive children with a cardiac malformation 
with 26 to 37 year follow-up. Am J Cardiol 1992;70:661-7. 
 
Moller JH, Moodie DS, Blees M, Norton JB, Nouri S. Symptomatic heart disease in 
infants: comparison of three studies performed during 1969-1987. Pediatr Cardiol 
1995;16:216-22. 
 
Morton WE, Huhn LA. Epidemiology of congenital heart disease. Observations in 
17,366 Denver school children. JAMA 1966;195:1107-10. 
 
Mousa MJ, Daoud AS, Abuekteish F, Al Shurman A. Pattern of congenital heart 
disease in Northern Jordan. Bahrain Med Bull1997;19:18-21. 
 
Mundo L, Torchia SL, De Cicco A, Ventriglia F, Sebastiani Annicchiarico L, Colloridi 
V.  Prevalence of congenital cardiopathies among newborn infants in a department 
of pediatric cardiology. Clin Ter 1996;147:627-33. 
 
               C Wren 2008                                      Page 185
Nabulsi MM, Tamim H, Sabbagh M Obeid MY, Yunis KA, Bitar FF. Parental 
consanguinity and congenital heart malformations in a developing country. Am J  
Med Genet 2003;116A:342-7 
 
Nakazawa M. Congenital heart disease. Nippon Rinsho. 2001;59;767-74. 
 
Nojiri T, Shibata T, Hanji Y, Koike K. The natural history of neonates with congenital 
cardiovascular anomalies. Jpn Circ J 1972;36:827-31. 
 
Olshan AF, Schnitzer PG, Baird PA. Paternal age and the risk of congenital heart 
defects. Teratology 1994;50:80-4. 
 
O’Malley CD, Shaw GM, Wasserman CR, Lammer EJ. Epidemiologic characteristics 
of conotruncal heart defects in California, 1987-1988. Teratology 1996;53:374-7. 
 
Onishi T, Hashida E, Rin K, Inoue T. The incidence and relative frequencies of 
congenital heart disease in school children aged 7 to 16 in Shiga Prefecture. Jpn 
Circ J 1971;35:899-902. 
 
Ooshima A, Fukushige J, Ueda K. Incidence of structural cardiac disorders in 
neonates: an evaluation by color Doppler echocardiography and the results of a 1-
year follow-up. Cardiology 1995;86:402-6. 
 
Pai BV, Varkey CC. Spectrum of congenital heart disease in a general hospital 
(study of 200 cases). Indian J Pediatr 1974;41:317-21. 
 
Pradat P. Epidemiology of major congenital heart defects in Sweden, 1981-1986. J 
Epidemiol Community Health 1992;46:211-5. 
 
Pradat P. Noncardiac malformations at major congenital heart defects. Pediatr 
Cardiol 1997;18:11-18. 
 
Radzik D, Davignon A, van Doesburg N, Fournier A, Marchand T ,Ducharme G. 
Predictive factors for spontaneous closure of atrial septal defects diagnosed in the 
first 3 months of life. J Am Coll Cardiol 1993;22:851-3. 
 
               C Wren 2008                                      Page 186
Raffa H, Toonisi T. Congenital cardiopathies in Arab children. Indian Heart J 
1989;41:123-6. 
 
Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. High prevalence 
of muscular ventricular septal defect in neonates. J Am Coll Cardiol 1995;26:1545-8. 
 
Rokicki W, Leung M, Kohut J, Durmala J, Borowicka E. Population dependent 
differences of distribution of congenital heart malformations. Wiadomosci Lekarskie 
2003;56;35-39. 
 
Rubin JD, Ferencz C, McCarter RJ, Wilson PD, Boughman JA, Brenner JI, Neill CA, 
Perry LW, Hepner SI, Downing JW. Congenital cardiovascular malformations in the 
Baltimore-Washington area. Md Med J 1985;34:1079-83. 
 
Sadeck Ldos S, Azevedo R, Barbato AJ, Calil VM, Latorre Mdo R, Leone CR, 
Ramos JL. Clinical-epidemiologic indications for echocardiographic assessment in 
the neonatal period. Value of risk groups. Arq Bras Cardiol 1997;69:301-7. 
 
Sadiq M, Stűmper O, Wright JGC, De Giovanni JV, Billingham C Silove ED. 
Influence of ethnic origin on the pattern of congenital heart defects in the first year of 
life. Br Heart J 1995;73:173-6. 
 
Sahasakul Y, Chaithiraphan S, Thongtang V, Jootar P, Charoenchob N, Srivanasont 
N, Kochaseni S. Congenital heart disease in the selected catheterized adolescents 
and adults at Siriraj Hospital. J Med Assoc Thai 1983;66:668-73. 
 
Samanek M, Slavik Z, Zborilova B, Hrobonova V, Voriskova M, Skovranek J. 
Prevalence, treatment, and outcome of heart disease in live-born children: a 
prospective analysis of 91,823 children. Paediatr Cardiol 1989;10:205-11. 
 
Samanek M, Slavik Z. Differences in the incidence of congenital heart defects in 
boys and girls. Cesk Pediatr 1990;45:214-6. 
 
Samanek M, Slavik Z, Krejcir M. Seasonal differences in the occurrence of 
congenital heart defects. Cas Lek Cesk 1991;130:134-8. 
 
               C Wren 2008                                      Page 187
Samanek M. Congenital heart malformations: prevalence, severity, survival, and 
quality of life. Cardiol Young 2000;10:179-85. 
 
Sampayo F, Pinto FF. The sex distribution of congenital cardiopathies. Acta Med 
Port 1994;7:413-8. 
 
Sands AJ, Casey FA, Craig BG, Dornan JC, Rogers J, Mulholland HC. Incidence 
and risk factors for ventricular septal defect in “low risk” neonates. Arch Dis Child 
Fet Neonatal Ed 1999;81:61-3. 
 
Schober KL, Panzner R. Epidemiology of congenital heart abnormalities. Z Arztl 
Fortbild (Jena). 1965;59:817-20. 
 
Schultrich S. Congenital heart disease found in autopsies from the University 
Institute of Pathology in Leipzig. Zentralbl Allg Pathol 1977;121:429-39. 
 
Scott DJ, Rigby ML, Miller GAH, Shinbourne EA. The presentation of symptomatic 
heart disease in infancy based on 10 years’ experience (1973-82). Implications for 
the provision of services.  Br Heart J 1984;52:248-57. 
 
Shaffer K, Hofschire PJ, McConnell D. Congenital heart disease – Outstate 
Nebraska. Nebraska Med J 1984;69:269-71. 
 
Shima Y, Takechi N, Ogawa S, Fukazawa R, Fukumi D, Uchikoba Y, Kuramochi Y, 
Yamauchi H. Clinical characteristics of congenital heart disease diagnosed during 
neonatal period. J Nippon Med Sch 2001;68:510-5. 
 
Shrestha NK, Padmavati S. Congenital heart disease in Delhi school children. Indian 
J Med Res 1980;72:403-7. 
 
Siregar A, Halim S, Rusdidjas, Siregar H, Noeriman AJ, Tambunan S. Congenital 
heart disease in Medan. Paediatr Indonesiana 1980;20:225-228. 
 
Sissman NJ. Incidence of congenital heart disease. JAMA 2001;285:2579. 
 
               C Wren 2008                                      Page 188
Smeeton NC, Rona RJ, Sharland G, Botting BJ, Barnett A, Dundas R. Estimating 
the prevalence of malformation of the heart in the first year of life using capture-
recapture methods. Am J Epidermiol 1999;150:778-85. 
 
Smythe JF, Copel JA, Kleinman CS. Outcome of prenatally detected cardiac 
malformations. Am J Cardiol 1992;69:1471-4. 
 
Stoermer J, Fehlig E. Frequency of congenital heart defects in infancy and 
corresponding therapeutic consequences. Monatsschr Kinderheilkd 1969;117:137-9. 
 
Storch TG, Mannick EE. Epidemiology of congenital heart disease in Louisiana: an 
association between race and sex and the prevalence of specific cardiac 
malformations. Teratology 1992:46;271-6. 
 
Stukovsky R, Karasova M, Durikova M, Pagacova E. Seasonal birth rate for 
children.  Bratislavske Lekarske Listy 1987;87:726-31. 
 
Sukumar IP, Das NK, Begum S, Cherian G, Krishnaswami S, Abraham T, John S. 
Incidence and distribution frequency of congenital heart disease. Indian Heart J 
Teach Ser 1980;3:1-6. 
 
Suresh V, Rao AS, Yavagal ST. Frequency of various congenital heart diseases: 
analysis of 3790 consecutively catheterised patients. Indian Heart J 1995;47:125-8. 
 
Swan SH, Shaw G, Harris JA, Neutra RR. Congenital cardiac anomalies in relation 
to water contamination, Santa Clara County, California, 1981-1983. Am J Epidemiol 
1989;129:885-93. 
 
Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm 
infants. Pediatrics 2005;116:e839-e845. 
 
Tapia J, Zilleruelo R, Jaeger H. Infant mortality due to heart disease in Chile 1988. 
Rev Chil Pediatr 1991;62:190-7. 
 
Tefuarani N, Hawker R, Vince J, Sleigh A, Williams G. Congenital heart disease in 
Papua New Guinean children. Ann Trop Paediatr 2001;21:285-92. 
 
               C Wren 2008                                      Page 189
Thakur JS, Negi PC, Ahluwalia SK, Sharma R, Bhardwaj R. Congenital heart 
disease among school children in Shimla hills. Indian Heart J 1995;47:232-5. 
 
Tilch G. Abnormalities of the heart and great vessels in 19,622 obductions. Zdrav 
Prac 1968;111:260-71. 
 
Tomimatsu H, Monma K. Japanese clinical statistical data of patients with congenital 
heart diseases. Nippon Rinsho 1992;50(Suppl):273-9. 
 
Trungelliti HA. Epidemiología de las cardiopatías congénitas en el Hospital de Niños 
Eva Perón de Santiago del Estero. Arch Argent Pediatr 2002;100:130-5.  
 
Ueda K, Nakano H, Saito A, Yokota M, Aoshima M, Shiraishi Y, Kyoku I, Kitano M, 
Shimada I. Congenital heart disease in newborn infancy: non-surgical death and 
surgical results. Nihon Kyobu Geka Gakki Zasshi 1986;34:1931-6. 
 
Urriola P, Muhlhausen G. Heart defects in hospitalized newborn infants. Rev Chil 
Pediatr 1986;57:422-5. 
 
Urs RA, Desouza VN. The incidence and the pattern of congenital heart defects in 
Tanzanian children – A clinical study. East Afr Med J 1976;53:36-42. 
 
Van der Horst RL, Winship WS, Pittaway D, Gibb BH, Lapinsky GB. Congenital 
heart disease in the South African Bantu: a report of 117 cases. S Afr Med J 
1968;42:1271-3. 
 
Van der Horst RL. The pattern and frequency of congenital heart disease among 
blacks. S Afr Med J 1985;68:375-8. 
 
Vashishtha VM, Kalra A, Kalra K, Jain VK. Prevalence of congenital heart disease in 
school children. Indian Pediatr 1883;30:1337-40. 
 
Vesterby A, Nielsen K, Borg L, Paulsen S, Baandrup U. Congenital heart 
malformations in Jutland, Denmark: a three year necropsy study in children aged 0-
14 years. Epidemiology and classification according to sequential segmental 
analysis. Br Heart J 1987;58:653-8. 
 
               C Wren 2008                                      Page 190
Vimercati A, Greco P, Di Fazio F, Loizzi V, Balducci G, Caruso G, Ingravallo G, 
Selvaggi L. Prevalence and distribution of congenital cardiopathy at birth and in 
pregnancy termination: impact of prenatal diagnosis in 4 years of experience. Acta 
Biomed Ateneo Parmense 2000;71:487-92. 
 
Volchenko KL. Congenital defects of the heart and great vessels in children in the 
1st year of life. Vopr Okhr Materin Det 1971;16:72-6. 
 
Werler M. Additional insights into the etiology of cardiac anomalies. Epidemiology 
2001:12;482-4. 
 
Wickramasinghe P, Lamabadusuriya SP, Narenthiran S. Prospective study of 
congenital heart disease in children. Ceylon Med J 2001;46:96-8. 
 
Wilson PD, Correa-Villasenor A, Loffredo CA, Ferencz C. Temporal trends in 
prevalence of cardiovascular malformations in Maryland and the District of 
Columbia, 1981-1988. The Baltimore-Washington Infant Study Group. Epidemiology 
1993;4:259-65. 
 
Wren C, O’Sullivan JJ. Survival with congenital heart disease and need for follow up 
in adult life. Heart 2001;85:438-43. 
 
Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in 
infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed. 
1999;80:49-53. 
 
Zamora C, Espino Vela J, Padilla S, Hinojosa HR, De la Garza L. Statistical 
incidence of congenital cardiopathies. Study of 25 years at the National Institute of 
Cardiology. Arch Inst Cardiol Mex 1971;41:373-86. 
 
Zavala C, Jiménez D, Rubio R, Castillo Sosa ML, Diaz Arauzo A, Salamanca F. 
Isolated congenital heart defects in first degree relatives of 185 affected children. 
Prospective study in Mexico City. Arch Med Res 1992;23:177-82. 
 
Zhu S. Survey and analysis on correlative factors with congenital heart disease in 
12,468 pupils in Yimeng mountain area. Zhonghua Liu Xing Bing Xue Za Zhi 
1993;14:163-5. 
               C Wren 2008                                      Page 191
